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Summary	
The	type	three-secretion	system	(T3SS)	 is	a	 large	and	complex	protein	nano-machine	
that	many	gram-negative	pathogens	employ	to	infect	host	cells.	A	key	structure	of	this	
machine	 is	 a	proteinaceous	pore	 that	 inserts	 into	 the	 target	membrane	and	 forms	a	
channel	for	bacterial	toxins	to	flow	from	bacteria	into	the	host	cell.	The	pore	is	mainly	
formed	 from	 two	 large	 membrane	 proteins	 called	 “translocators”.	 Importantly,	
effective	 secretion	 and	 thus	 pore	 formation	 of	 the	 translocators	 depends	 on	 their	
binding	to	and	being	transported	by	small	specialized	chaperones	after	synthesis	in	the	
bacterial	cytosol.	Recent	crystal	structures	have	shown	these	chaperones	are	formed	
from	 modular	 tetratricopeptide	 repeats	 (TPRs).	 However,	 each	 crystal	 structure	
produced	different	homodimeric	structures,	suggesting	flexibility	in	their	topology	that	
may	be	of	importance	to	function.		
Given	 the	 crucial	 role	 of	 the	 translocator	 chaperones,	 we	 investigated	 the	
conformational	 stability	 of	 the	 chaperone	 LcrH	 (Yersinia	 pestis).	 	Mutational	 analysis	
coupled	 with	 analytical	 ultra-centrifugation	 and	 equilibrium	 chemical	 denaturations	
showed	that	LcrH	is	a	weak	and	thermodynamically	unstable	dimer	(KD	≈	15	μM,	∆𝑮H2O	
=	7.4	kcalmol-1).	The	modular	TPR	structure	of	the	dimer	allows	it	to	readily	unfold	in	a	
non-cooperative	manner	 to	 a	 one-third	 unfolded	 dimeric	 intermediate	 (∆𝑮H2O	 =	 1.7	
kcalmol-1),	 before	 cooperatively	unfolding	 to	a	monomeric	denatured	 state	 (∆𝑮H2O 	 =	
5.7	kcalmol-1).	Thus	under	physiological	conditions	the	chaperone	 is	able	to	populate	
C-terminally	unravelled	partially	folded	states,	whilst	being	held	together	by	its	dimeric	
interface.	Such	ability	suggests	a	“fly-casting”	mechanism	as	a	route	to	binding	their	far	
larger	translocator	cargo.	
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ABC	 	 	 ATP	binding	cassette	
Amp	 	 	 Ampicillin	
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IM	 	 	 Inner	membrane	
IPTG	 	 	 Isopropyl-β-D-thiogalactopyranoside	
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MS	 	 	 Inner	membrane	ring	(T3SS)	
OM	 	 	 Outer	membrane	
OMP	 	 	 Outer	membrane	pore	forming	protein	
P.	aeruginosa	 	 Pseudomonas	aeruginosa	
PAGE	 	 	 Polyacrylamide	gel	electrophoresis	
PBS	 	 	 Phosphate	buffered	saline	
PCR	 	 	 Polymerase	chain	reaction	
PDB	 	 	 Protein	data	bank	
PP	 	 	 Periplasm	
SDS	 	 	 Sodium	dodecyl	sulphate	
SEC	 	 	 Size	exclusion	chromatography	
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T4SS	 	 	 Type	IV	Secretion	System	
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Tris	 	 	 Trizma	base	
tr-LcrH		 											 truncated	LcrH	
Tm	 	 	 Melting	temperature	
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Chapter	1 Introduction	
Life	on	earth	can	be	categorised	in	numerous	ways.	One	method	classifies	the	diverse	
array	 of	 organisms	 on	 our	 planet	 through	 their	 biochemical	 characteristics.	 This	
method	divides	organisms	into	three	distinct	groups	called	domains:	
(i) Eukarya	 (eukaryotes)	 –	 Eukarya	 consist	 of	 all	 macroscopic	 organisms	
including	human	beings	as	well	as	many	microscopic,	unicellular	organisms	
such	 as	 yeast.	 The	 most	 important	 characteristic	 of	 eukaryotes	 is	 the	
presence	of	a	well-defined	nucleus	within	each	cell.			
(ii) Bacteria	 –	 These	 are	 unicellular	 organisms	 lacking	 a	 nucleus,	 and	 are	
referred	 to	 as	prokaryotes.	They	 constitute	 a	 large	 domain	 of	 prokaryotic	
microorganisms.	 	 Bacteria	 were	 among	 the	 first	 life	 forms	 to	 appear	 on	
Earth,	and	are	present	in	most	of	its	habitats.		
(iii) Archaea	 –	 Carl	 Woese	 first	 discovered	 these	 organisms	 in	 1977	 and	
classified	 them	 as	 prokaryotes	 as	 they	 were	 bacteria-like.	 However,	 they	
are	 biochemically	 quite	 distinct	 from	 bacteria.	 These	 distinctions	 include:	
archaea	have	cell	membrane	containing	ether	 linkages,	cell	walls	 that	 lack	
peptidoglycan	 and	 have	 genes	 and	 enzymes	 that	 behave	 more	 like	
eukaryotes.	Thus	they	were	reclassified	as	a	domain	of	their	own	[1-3].		
This	thesis	is	concerned	with	the	biochemical	methods	employed	by	certain	bacteria	to	
survive	in	and	around	higher	multicellular	organisms	(humans).	
1.1 Symbiosis,	Pathogenesis	&	Commensalism		
There	are	three	distinct	types	of	relationship	between	bacteria	and	higher	multicellular	
organisms.	 	 They	 can	 live	 in	 symbiosis,	 as	 commensals	 or	 as	 pathogens.	 	 Symbiosis	
occurs	when	two	organisms	obtain	a	mutually	beneficial	relationship	with	one	another	
[4-6].	 	 For	 example,	many	 bacteria	 are	 vital	 for	 the	maintenance	 of	 homeostasis	 in	
higher	 organisms.	 The	 human	 gut	 hosts	 an	 estimated	 500-1000	 species	 of	 bacteria	
[1,3,7,8].	 Here,	 the	 human	 intestine	 provides	 nutrients	 to	 the	 resident	 bacteria,	
whereas	bacteria	help	in	the	digestion	of	food,	absorption	of	nutrients,	production	of	
vitamins	 such	 as	 biotin	 and	 vitamin	 K,	 regulation	 of	 the	 immune	 system,	 and	
prevention	of	colonization	of	pathogenic	microorganisms	[4,6,9].		
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In	contrast,	pathogenesis	occurs	when	one	organism	gains	advantage	to	the	detriment	
of	 the	 other.	 	 Bacteria	 are	 another	 excellent	 example	 of	 this	 interaction,	with	many	
attacking	 higher	 organisms	 by	 damaging	 cell	 tissues	 in	 the	 search	 for	 nutrients.	 For	
example,	Yersinia	 pestis	 is	 the	 causative	 agent	 of	 bubonic	 plague	 and	many	Shigella	
species	cause	dysentery	[7,8,10].		
In	 between	 the	 two	 extremes	 of	 symbiosis	 and	 pathogenesis	 lie	 commensals.	
Commensalism	 is	 an	 association	 between	 two	 different	 species	 where	 one	 enjoys	
benefit	and	the	other	is	not	significantly	affected	[9,11].	Commensal	bacteria	are	found	
on	all	animal	body	surfaces	as	part	of	normal	microbial	flora.	However,	under	specific	
conditions	such	commensals	can	turn	pathogenic	and	exert	pathologic	effects	on	the	
host	organism	[10,12].	For	example,	Staphylococcus	aureus	normally	colonises	human	
skin	without	causing	any	harm.	However	if	the	epidermis	of	the	skin	is	broken	they	can	
cause	 skin	 infection	 and	 more	 serious	 complaints.	 Recently,	 there	 has	 been	 an	
emergence	 of	 antibiotic	 resistant	 forms	 of	 S.	 aureus	 (MRSA:	 Methicillin	 resistant	 S.	
aureus),	making	it	a	significant	health	risk	[11,13].	
	
1.2 Gram	Positive	and	Gram	Negative	Bacteria	
Bacteria	can	be	separated	into	two	groups	on	the	basis	of	their	Gram	staining:	Gram-
positive	 and	Gram-negative	 (Figure	 1.1).	 This	 simple	 staining	 process	 has	 lasted	 into	
our	high-technology	era	as	a	useful	tool	for	identifying	bacteria.	The	Danish	physician	
Hans	Christian	Gram	developed	it	 in	1884.	A	smear	of	bacterial	cells	on	a	microscope	
slide	 is	soaked	in	a	violet	dye	and	treated	with	 iodine;	 it	 is	then	washed	with	alcohol	
and	counterstained	with	saffranine	(a	red	dye).	Gram-positive	bacteria	retain	the	violet	
dye	 and	 appear	 blue	 to	 purple.	 The	 alcohol	 washes	 the	 violet	 stain	 out	 of	 Gram-
negative	cells;	these	cells	then	pick	up	the	saffranine	counterstain	and	appear	pink	to	
red.	For	many	bacteria,	 the	Gram-staining	 results	compare	roughly	with	 the	cell	wall	
structure.	 In	 Gram-positive	 bacteria,	 peptidoglycan	 forms	 a	 thick	 layer	 outside	 the	
plasma	membrane.	Whereas,	 the	Gram-negative	cell	wall	has	only	one-fifth	as	much	
peptidoglycan.	 In	 order	 to	 provide	 additional	 protection	 for	Gram-negative	 bacteria,	
outside	the	peptidoglycan	layer,	a	second,	outer	membrane	quite	distinct	in	chemical	
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makeup	from	the	plasma	membrane	surrounds	the	cell.	Between	the	inner	and	outer	
membranes	of	Gram-negative	bacteria	 is	 an	additional	periplasmic	 space.	 This	 space	
contains	enzymes	 important	 in	digesting	 specific	molecules,	 transporting	others,	 and	
detecting	chemical	gradients	in	the	environment	[2,12].		
Interestingly,	 common	 causes	 of	 infections	 are	 Gram-negative	 bacterial	 pathogens.	
The	 prevalence	 and	 the	 rate	 of	 resistance	 among	 these	 pathogens	 to	 existing	 anti-
microbial	agents	is	on	the	rise	[12,13].	The	pathogenicity	of	gram-negative	bacteria	is	
often	 associated	 with	 the	 lipopolysaccharide	 (LPS)	 layer	 present	 in	 the	 outer	
membrane.	 The	 chemical	 structure	 of	 the	 LPS	 layer	 is	 often	 unique	 to	 particular	
bacterial	 strains	 (i.e.	 sub-species)	 and	 is	 responsible	 for	 many	 of	 the	 antigenic	
properties	of	these	strains	[2,14].	
	
Figure	 1.1	 Gram	 staining	 and	 the	 bacterial	 cell	 wall:	 when	 treated	 with	 Gram	 stain,	 the	 cell	 wall	
components	of	different	bacteria	 react	 in	one	of	 two	ways.	 (a)	Gram	positive	bacteria	have	a	 thick	
peptidoglycan	 cell	 wall	 that	 retains	 the	 violet	 dye	 and	 appears	 blue	 or	 purple.	 (b)	 Gram	 negative	
bacteria	 have	 a	 thin	 peptidoglycan	 layer	 that	 does	 not	 retain	 the	 violet	 dye,	 but	 picks	 up	 the	
counterstain	and	appears	pink-red.	Figure	was	taken	from	[12,15].	
1.3 Protein	secretion	by	bacteria	
The	 cytoplasm	 of	 the	 bacterial	 cell	 is	 isolated	 from	 the	 external	 environment	 by	 a	
phospholipid	 bilayer	 termed	 as	 the	 plasma	membrane.	 In	 order	 to	 interact	with	 the	
environment	and	for	 its	sustenance	 it	becomes	essential	 for	 the	bacterium	to	export	
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elements	from	its	cytosol	to	the	external	milieu	and	vice	versa.	Until	the	1960s,	protein	
secretion	across	the	bacterial	membrane	was	thought	to	be	a	rare	phenomenon.	It	was	
believed	 that	 secretion	occurred	 in	 a	 protein	 specific	manner	 [14,16].	 This	 view	was	
dismissed	following	the	discovery	of	numerous	systems	dedicated	to	the	transport	of	
proteins	 across	 the	 plasma	 membrane.	 Furthermore,	 in	 the	 case	 of	 Gram-negative	
bacteria,	 proteins	 are	 transported	 through	 the	 periplasm	 and	 the	 outer	membrane.	
These	 secretory	 systems	 export	 proteins	 either	 to	 be	 attached	 outside	 the	 bacterial	
cell	 surface,	 released	 into	 the	 external	 environment,	 or	 in	 some	 cases	 even	 directly	
into	the	cytoplasm	of	other	cells.		
1.3.1 Secretion	through	the	inner	membrane	
The	first	challenge	faced	by	a	bacterial	cell	 is	the	transportation	of	protein	molecules	
across	 the	 inner	 plasma	 membrane,	 irrespective	 of	 whether	 it	 a	 Gram-positive	 or	
Gram-negative	bacteria.	Protein	molecules	 travel	 across	 this	barrier	with	 the	help	of	
membrane	 embedded	 protein	 transport	 systems.	 These	 proteins	 then	 enter	 the	
periplasm	 or	 they	 get	 inserted	 into	 the	 membrane.	 There	 is	 a	 remarkable	 array	 of	
protein	 transport	 systems	 found	 in	 bacteria,	 of	 which	 three	 are	 present	 in	 most	
bacterial	 species:	 The	 Sec	 (general	 secretory	 pathway	 or	 GSP),	 signal	 recognition	
particle	(SRP)	and	twin-arginine	translocation	(Tat)	pathways	[15,17].		
1.3.1.1 The	Sec	Pathway	
The	 Sec	 pathway	 is	 formed	 by	 the	 interaction	 of	 a	 numerous	 proteins,	 which	 are	
conserved	both	in	prokaryotes	and	eukaryotes	(known	as	the	Sec	61	complex,	where	it	
transports	 proteins	 across	 the	 endoplasmic	 reticulum	 [16,18].	 In	 particular,	 the	 Sec	
system	 is	 involved	 in	 the	 secretion	 of	 unfolded	 proteins	 across	 the	 cytoplasmic	
membrane	and	 the	 insertion	of	membrane	proteins	 into	 the	 cytoplasmic	membrane	
[17,19].	To	perform	the	transport,	 three	proteins	SecY,	SecE	&	SecG	(SecYEG)	 form	a	
heterotrimeric	integral	membrane	complex.	SecA	is	then	recruited	to	the	complex,	by	
binding	to	SecY	on	the	bacterial	cytoplasmic	side.	SecA	has	ATPase	activity	and	acts	as	
a	 motor	 to	 drive	 secretion	 [18,20].	 SecB	 binds	 the	 protein	 requiring	 transport	 and	
delivers	 it	 to	SecA.	Once	bound	 to	SecA,	ATP	 is	used	 to	 release	 the	cargo	of	SecB	 to	
SecA	and	translocate	the	cargo	through	the	membrane	[19,21-23].	
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1.3.1.2 Signal	Recognition	Particle	(SRP)	
The	SRP	is	very	similar	to	the	Sec	pathway,	in	as	much	as	they	use	the	same	complex	
SecY,	SecE,	SecG	(SecYEG).	However	it	does	not	use	SecA	and	SecB	to	drive	secretion	or	
recruit	 cargo.	 Instead	 the	 SRP	molecule	 is	 recruited	 to	 the	 ribosome	 to	 bind	 newly	
formed	proteins	that	need	to	be	membrane	bound	by	ribosome-nascent	chain	(RNC)	
complex	 [20,24].	 The	 SRP+RNC	 complex	 then	 targets	 the	 protein	 SRP	 receptor	 FtsY	
which	in	turn	directs	it	to	the	SecYEG	machinery	[21-23,25].		
1.3.1.3 The	Tat	System	
The	Sec	pathway	is	the	universally	conserved	pathway	in	prokaryotes.		However,	there	
also	 exists	 the	 Tat	 pathway.	 	 This	 system	 is	 found	 in	 some	 bacteria	 and	 has	 been	
identified	 as	 essential	 in	only	 a	 few	organisms.	Nevertheless,	 the	Tat	 system	plays	 a	
significant	role	in	some	cellular	processes	such	as	iron	and	phosphate	acquisition	in	E.	
coli	 and	 Salmonella	 spp.	 	 The	 Sec	 pathway	 is	 employed	 for	 the	 transportation	 of	
unstructured	 proteins	 across	 the	 bacterial	 plasma	 membrane.	 	 In	 contrast,	 the	 Tat	
pathway	is	used	for	the	transportation	of	folded	proteins.	 	Proteins	are	 identified	for	
transport	through	the	Tat	system	via	a	signal	peptide	containing	a	twin	arginine	repeat	
motif	[24,26].	
The	 Tat	 system	 comprises	 of	 two	 inner	membrane	 integrated	 subunits	 i.e.	 TatA	 and	
TatC.	 In	 some	bacterial	 systems,	 there	are	multiple	 copies	of	 components	of	 the	Tat	
system.	For	example,	Bacillus	subtilis	has	two	copies	of	 tatC	and	three	copies	of	tatA	
[25,27]	whilst	a	few	organisms	such	as	E.	coli	employ	an	additional	protein	TatB.		
	
1.3.2 Gram-negative	Bacterial	Secretion	Systems		
Secretion	 across	 the	 outer	membrane	 is	 a	 process	 specifically	 undertaken	 by	 Gram-
negative	bacteria.	In	order	to	achieve	this	task	Gram-negative	bacteria	have	evolved	a	
series	 of	 mechanisms	 which	 allow	 them	 to	 either	 export	 proteins	 as	 a	 two-step	
process,	exploiting	one	of	the	methods	mentioned	above	to	export	the	protein	across	
the	inner	membrane,	or	as	a	one	step	process,	where	the	protein	is	exported	from	the	
cytosol	 to	 outside	 of	 the	 cell	 without	 any	 intermediate	 steps.	 The	 mechanisms	
available	to	accomplish	this	task	are	named,	in	a	simple	numerical	manner.	There	are	
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at	present	six	major	systems	that	are	well	described:	the	type	I-VI	secretion	systems.	
The	following	sections	briefly	describe	each	of	those	systems.	
1.3.2.1 Type	I	Secretion	System	(T1SS)	
Type-I	 secretions	 systems	 (T1SS)	 allow	 for	 the	 movement	 of	 proteins	 from	 the	
cytoplasm	to	outside	of	the	cell	in	a	one-step	manner,	utilising	a	simple	system	of	just	
three	proteins.	These	three	proteins	are	an	ATP-binding	cassette	(ABC)	transporter,	a	
membrane	fusion	protein	(MFP)	and	an	outer	membrane	pore	forming	protein	(OMP)	
[26-28]	 (see	 Figure	 1.2).	 The	 ABC	 protein	 consists	 of	 a	 cytoplasmically	 located	
nucleotide	binding	domain,	and	a	transmembrane	domain	produced	from	six	α-helices	
[27,29].	ABC	proteins	characteristically	function	as	homodimers	or	trimers	in	producing	
a	 functional	 pore	 through	 which	 the	 secreted	 protein	 can	 pass	 through	 [27,28,30].	
Additionally,	 ABC	 protein	 provides	 substrate	 specificity	 to	 the	 secretion	 machinery	
[29,31].	 The	 MFPs	 interact	 in	 a	 trimeric	 fashion	 with	 the	 ABC	 proteins	 in	 order	 to	
create	a	periplasmic	channel	through	which	the	secreted	protein	can	traverse	[30,32].		
It	 has	 been	 suggested	 that	 the	 binding	 of	 substrates	 to	 the	 ABC	 protein	 leads	 to	 a	
conformational	 change	 in	 the	MFP,	 such	 that	 it	 interacts	with	 the	OMP	 to	 complete	
the	 channel	 to	 the	 external	 environment	 [31,33].	However,	 the	 exact	mechanism	of	
this	interaction	remains	unclear	[32,34].	The	OMP,	as	characterised	by	the	TolC	protein	
from	E.	coli	exists	as	a	trimer	anchored	in	the	outer	membrane	by	a	β-barrel	structure	
[26,33].	 It	 has	 been	 shown	 that	 the	 ABC	 and	 OM	 proteins	 can	 interact	 together	
directly,	although	this	interaction	in	vivo	requires	the	presence	of	the	MFP	[34-37].		
There	 are	 a	wide	 variety	 of	 proteins	 exported	 by	 T1SS	machinery,	 from	 enzymes	 to	
toxins	 and	 adhesins	 [26].	 Proteins	 secreted	 by	 T1SSs	 contain	 a	 C-terminal	 secretion	
system,	most	commonly	 in	the	terminal	15-30	amino	acids	[35-39],	 implying	that	the	
molecule	 must	 be	 secreted	 in	 a	 post-translational	 fashion.	 There	 is	 no	 specific	
consensus	for	this	signal	sequence,	although	it	would	seem	that	there	is	a	preference	
towards	certain	amino	acids	(LDAVTSIF)	[26,40,41].	
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Figure	1.2	Schematic	representation	of	the	Type	I	Secretion	System	(T1SS).	The	position	of	the	inner	
membrane	 (IM),	periplasm	 (PP),	outer	membrane	 (OM)	and	 the	major	 components	of	 the	T1SS	are	
shown:	ABC	–	ATP	Binding	Casette	(shown	in	red),	MFP	–	Membrane	Fusion	Protein	(shown	in	blue),	
OMP	–	Outer	Membrane	Protein.	The	structure	of	OMP	is	that	of	TolC	(PDB	entry	1EK9).	The	process	
displays	 the	 secreted	 substrate	 molecule	 (shown	 in	 yellow)	 binding	 to	 the	 ABC,	 which	 causes	 a	
conformational	 change	 in	 the	MFP	 leading	 to	 its	 interaction	with	 the	OMP.	 The	 secreted	 substrate	
molecule	is	then	subsequently	translocated	to	the	extracellular	milieu.	
	
		
1.3.2.2 Type	II	Secretion	System	(T2SS)	
Compared	 to	 the	 T1SSs,	 type	 II	 secretion	 systems	 (T2SSs)	 are	 considerably	 more	
complex	and	are	commonly	employed	in	Gram-negative	bacteria	such	as	Yersinia	spp	
and	Klebsiella	spp.	In	order	to	export	proteins	through	the	plasma	membrane	the	Sec	
or	Tat	pathways	 is	employed.	 	Once	 in	the	periplasm,	the	protein	 is	 trafficked	across	
the	 outer	membrane	 using	 the	 T2SS.	 	 T2SSs	 employ	 12	 to	 16	 proteins	 for	 enabling	
secretion	of	folded	proteins	through	the	outer	membrane.	Perhaps	surprisingly	though	
only	a	couple	of	these	are	actually	located	in	the	outer	membrane	[38,39,42,43].	The	
majority	 of	 the	 proteins	 are	 located	 in	 the	 plasma	membrane	 or	 in	 the	 periplasmic	
space	 (see	 Figure	 1.3).	 For	 the	 T2SS,	 the	 general	 secretory	 pathway	 (Gsp)	
nomenclature	is	used,	followed	by	a	capital	letter.		
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The	 cytoplasmic	 protein	 GspE	 is	 a	 hexameric	 ATPase,	 providing	 energy	 to	 drive	 the	
export	of	proteins	[38,40,41].	GspE	interacts	with	the	inner	membrane	platform.		This	
is	 composed	 of	 4	 core	 proteins	 (GspC,	 F,	 L	 and	M)	which	 anchor	 the	 ATPase	 to	 the	
pseudopilus	apparatus	[39,42-45].		The	pseudopilus	is	composed	of	5	proteins	termed	
pseudopilins.		The	pseudopilins	themselves	are	a	group	of	proteins	(GspG-K)	that	come	
together	to	form	a	large	multimeric	structure	called	the	pseudopilus.	The	base	of	the	
pseudopilus	 is	 in	 the	 periplasm	 and	 interacts	with	 the	 plasma	membrane.	 Based	 on	
evidence	from	several	experiments	it	has	been	hypothesised	that	the	pilus	may	grow	
in	 order	 to	 push	 secreted	 molecules	 through	 the	 outer	 membrane	 complex,	 or	
alternatively	 as	 a	 cork	 to	 close	 off	 the	 outer	membrane	 channel	when	 not	 required	
[38,46].		
The	 outer	 membrane	 complex	 of	 T2SS	 consists	 of	 two	 components,	 (i)	 the	 pore	
forming	protein	GspD,	which	exists	as	a	multimer	of	12-14	copies	forming	a	pore	in	the	
outer	 membrane,	 and	 (ii)	 a	 lipoprotein	 GspS	 known	 as	 the	 ‘’pilotin’’,	 stabilises	 the	
GspD	multimer	 in	 the	 outer	 membrane	 [44,45,47-49].	 The	 pore	 formed	 by	 GspD	 is	
about	 95	 Å	 in	 diameter,	 a	 size	 large	 enough	 for	 proteins	 to	 pass	 through	 the	 T2SS	
assembly	in	a	folded	state	[46,50,51].	
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Figure	1.3	Schematic	representation	of	the	Type	2	Secretion	System	(T2SS).	The	position	of	the	inner	
membrane	 (IM),	periplasm	 (PP),	outer	membrane	 (OM)	and	 the	major	 components	of	 the	T2SS	are	
shown.	The	cytoplasmic	hexameric	ATPase	GspE	 (shown	 in	blue)	provides	energy	 for	protein	export	
and	interacts	with	the	inner	membrane	platform	composed	of	GspF,	GspL,	GsM	and	GspC	(shown	in	
red,	 light	blue,	purple	and	dark	blue	 respectively).	 The	 inner	membrane	platform	anchors	 the	GspE	
hexamer	to	the	pseudopilin	(shown	in	yellow)	comprising	of	GspG-K	which	links	to	the	pore	forming	
multimeric	 protein	 GspD	 (shown	 in	 light	 orange)	 in	 the	 outer	membrane.	 GspS	 (shown	 in	 orange)	
stabilises	 the	GspD	multimer	 in	 the	OM.	 The	 protein	 (shown	 as	 orange,	 rounded	 rectangle)	 is	 first	
transported	 from	 bacterial	 cytoplasm	 to	 periplasm	 using	 the	 Sec	 pathway	 (shown	 in	 green)	 and	
trafficked	across	the	OM	using	the	T2SS	assembly.		
	
1.3.2.3 Type	III	Secretion	System	(T3SS)		
The	 type	 III	 secretion	 system	 (T3SS)	 is	 found	 in	Gram-negative	bacteria	 that	 interact	
with	both	plants	and	animal	hosts,	either	as	pathogens	or	symbionts	 [47-49,52].	The	
primary	function	of	the	T3SS	machinery	termed	as	the	‘’injectisome’’	is	the	delivery	of	
effector	 proteins	 across	 the	 bacterial	 and	 host	 membranes	 into	 the	 cytosol	 of	 host	
cells	 to	 hijack	 host	 cell	 functions,	 including	 immune	 and	 defence	 responses	 [50-52].	
This	thesis	is	based	on	the	T3SS	of	pathogenic	Yersinia	pestis	and	is	described	in	detail	
in	section	1.3.3.		
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1.3.2.4 Type	IV	Secretion	System	(T4SS)	
In	comparison	to	other	secretion	systems,	the	T4SS	(Figure 1.4)	is	unique	in	its	ability	
to	 transport	 a	 wide	 range	 of	 substrates	 such	 as	 single	 peptide	 molecules,	 protein-
protein	complexes	and	protein-DNA	complexes.		Furthermore,	the	T4SS	is	employed	in	
the	infection	of	a	wide	range	of	hosts	ranging	from	higher	eukaryotes	such	as	animal	
and	plant	cells,	to	yeast	and	prokaryotes	[52].	Many	bacteria	have	homologous	type	IV	
secretion	 systems,	 including	 the	 pathogens	Agrobacterium	 tumefaciens	 (VirB/D4),	
Helicobacter	 pylori	 (CAG/ComB)	 and	 Pseudomonas	 aeruginosa	(TraS/TraB)	[52,53].	
Although	T4SSs	have	garnered	attention	because	of	their	significance	in	pathogenesis,	
it	is	important	to	point	out	that	not	all	pathogenic	bacteria	have	a	T4SS.	
	
There	are	 several	 subclasses	of	T4SS,	however	 the	majority	of	 the	work	 to	date,	has	
focused	 on	 Agrobacterium	 tumefaciens.	 The	 VirB	 system	 from	A.	 tumefaciens	is	
capable	 of	 exporting	DNA-protein	 complex	 from	 its	 Ti	 plasmid	 into	 the	host	 [52,54].	
Here,	VirB4,	VirB11	and	VirD4	are	 cytoplasmic	ATPases	 that	 generate	 the	energy	 for	
the	system,	driving	complex	assembly	followed	by	substrate	translocation.	 	VirB1	is	a	
lytic	 transglycosylase	 responsible	 for	 making	 holes	 in	 the	 peptidoglycan	 layer	 thus	
allowing	 the	 formation	 of	 the	 protein	 channel	 [53,55].	 VirB6-10	 form	 a	 scaffold	
creating	 a	 translocation	 channel,	 connecting	 the	 plasma	 membrane	 to	 the	 outer	
membrane.	 	 This	 assembly	 enables	 the	 transport	 of	 the	 substrate	 directly	 from	 the	
cytoplasm	 to	 the	 extracellular	 milieu.	 	 The	 channel	 is	 a	 cylindrical	 structure	 with	 a	
diameter	and	length	of	185	Å	to	allow	for	the	exportation	of	folded	protein	molecules	
[54,56].  
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Figure	1.4	Schematic	representation	of	the	Type	4	Secretion	System	(T4SS).	The	inner	membrane	(IM),	
periplasm	 (PP),	 outer	 membrane	 (OM)	 and	 the	 major	 components	 of	 the	 T4SS	 are	 shown.	 The	
cytoplasmic	 proteins	 VirD4,	 VirB11	 and	 VirB4	 are	 ATPases	 providing	 energy	 for	 T4SS	 assembly	 and	
substrate	 translocation.	 VirB6-10	 form	 a	 scaffold,	 spanning	 the	 bacterial	 cytoplasm	 to	 the	
extracellular	milieu,	creating	a	translocation	channel	for	the	substrate.	VirB7	and	VirB9	together	form	
the	pore	in	the	OM	for	substrate	translocation.	VirB2	assembly	forms	the	pilus	connecting	the	IM	to	
the	OM.	VirB3	and	VirB5	interact	with	the	pilus.	VirB1	makes	holes	in	the	peptidoglycan	layer	allowing	
T4SS	protein	assembly.	 Substrate	 (shown	 in	orange,	 rounded	 rectangle)	 is	 translocated	either	using	
the	 Sec-pathway	 from	 cytoplasm	 to	 the	 PP	 and	 then	 the	 extracellular	 milieu	 or	 directly	 from	
cytoplasm	to	the	external	environment	using	the	T4SS.		
	
1.3.2.5 Type	V	Secretion	System	(T5SS)	
The	 type	 five	 secretion	 system	 (T5SS)	 (Figure	 1.5)	 is	 typically	 referred	 to	 as	 the	
autotransporter	system	and	is	characterised	by	the	requirement	of	SEC	machinery	and	
a	β-barrel	domain	[14,55,57-59].		The	process	of	transport	from	the	plasma	membrane	
to	 the	 outer	 membrane	 can	 be	 divided	 into	 three	 sub	 classes,	 monomeric	
autotransporter	 system	 (T5aSS),	 two	partner	 secretion	pathway	 (T5bSS)	and	 trimeric	
autotransporters	(T5cSS)	[14,56-59].	 	The	T5SS	serves	as	a	pathway	for	secretion	of	a	
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large	number	of	proteins	exceeding	the	number	of	proteins	secreted	by	the	T2SS.	Over	
500	 proteins	 are	 secreted	 through	 the	 T5aSS	 class	 alone.	 The	 majority	 of	 the	 T5SS	
secreted	 proteins	 that	 have	 been	 characterised	 to	 date	 are	 responsible	 for	 the	
virulence	of	animals	or	human	pathogenic	bacteria	[14,57-59].	
The	T5SS	proteins	are	produced	with	an	N-terminal	signal	peptide,	which	exports	them	
into	 the	 periplasm	 using	 the	 Sec	 pathway.	 The	 bacterial	 proteins	 secreted	 via	 the	
T5aSS	typically	comprise	an	N-terminal	passenger	domain	from	40	-	400	kDa	in	size	and	
a	conserved	C-terminal	domain	which	forms	a	β-barrel	[14,57-60].	The	β-barrel	is	able	
to	 insert	 into	 the	outer	membrane	and	 is	needed	 for	 translocation	of	 the	passenger	
domain	 into	the	extracellular	milieu.	 	 In	some	cases,	such	as	adhesins,	the	passenger	
domain	 remains	 attached	 to	 the	 β-barrel	 and	 the	 protein	 remains	 attached	 in	 the	
outer	membrane.	In	other	cases,	the	passenger	domain	is	cleaved	from	the	β-barrel	to	
form	a	toxin	or	hydrolytic	enzyme.	Recently,	detailed	structural	studies	have	suggested	
that	 the	 barrel	 is	 not	 capable	 of	 transporting	 the	 passenger	 domain	 by	 itself.	 It	 has	
been	 hypothesised	 that	 a	 helper	 protein,	 Omp85/YaeT	 enables	 the	 transportation	
across	 the	 outer	 membrane	 [57,59].	 Proteins	 secreted	 via	 the	 T5aSS	 include	 IgA	
protease	from	Neisseria	meningitidis	and	Pertactin	from	Bordetella	pertussis	[14,60].	
A	second	class	of	proteins	secreted	via	the	T5SS	is	called	T5bSS	proteins.	In	contrast	to	
T5aSS,	 the	 passenger	 and	 translocator	 functions	 in	 T5bSS	 are	 located	 on	 separate	
polypeptide	 chains.	 T5bSS	 contains	 a	 pair	 of	 proteins	 in	 which	 one	 of	 the	 proteins	
carries	 the	 β-barrel	 domain,	 and	 the	 other	 is	 the	 secreted	 protein	 (passenger	
polypeptide).	 This	 process	 is	 called	 two	 partner	 secretion	 (TPS)	 [57,61].	 The	
mechanism	of	 transport	 of	 the	 passenger	 polypeptide	 of	 the	 T5bSS	 is	 similar	 to	 the	
passenger	domain	transport	in	T5aSS.		T5bSS	(TPS)	secreted	proteins	include	adhesins	
such	as	HecA/HecB	of	the	plant	pathogen	Dickeya	dadantii	(Erwinia	chrysanthemii)	and	
cytolysins	such	as	ShlA/ShlB	of	Serratia	marcescens	[14,62].	
The	 third	 sub-class	 of	 T5SS	 proteins,	 called	 T5cSS	 are	 trimeric	 autotransporters,	 in	
which	a	single	β-barrel	is	formed	by	contributions	from	each	of	the	three	monomeric	
subunits.	 In	 contrast	 to	 the	 monomeric	 T5aSS,	 they	 are	 usually	 adhesins	 and	 don’t	
exhibit	enzymatic	 function.	However,	 the	method	of	 transportation	of	 the	passenger	
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domain	 is	 identical	 to	 that	 in	 T5aSS.	 An	 example	 of	 T5cSS	 protein	 is	 YadA,	
the	Yersinia	adhesin	A	of	Yersinia	enterocolitica	[61,63-68].	
	
	
Figure	 1.5	 Schematic	 representation	 of	 the	 Type	 5	 Secretion	 System	 (T5SS).	 Inner	membrane	 (IM),	
periplasm	 (PP),	 outer	 membrane	 (OM)	 and	 the	 major	 components	 of	 the	 T5SS	 are	 shown.	 The	
secretion	pathway	of	the	monomeric	autotransporter	system	(T5aSS)	 is	depicted	at	the	bottom	left,	
the	two-partner	system	(T5bSS)	is	displayed	in	the	centre,	and	the	trimeric	autotransporters	(T5cSS)	is	
shown	on	the	right.	The	four	functional	domains	of	the	proteins	are	shown:	the	signal	sequence,	the	
passenger	domain,	the	linker	region,	and	the	β-domain.	The	autotransporter	proteins	are	synthesised	
and	exported	through	the	cytoplasm	across	the	IM	via	the	Sec	machinery.	Once,	through	the	IM,	the	
signal	sequence	is	cleaved	and	the	β-domain	inserts	into	the	OM	in	a	β-barrel	structure	forming	a	pore	
in	the	OM.	The	passenger	domain	then	inserts	into	the	pore	and	is	tranlocated	across	the	OM	to	the	
extracellular	milieu.		
	
1.3.2.6 Type	VI	Secretion	System		
The	 type	 VI	 secretion	 system	 (T6SS)	 is	 the	 most	 recently	 identified	 Gram-negative	
bacterial	 secretion	 system.	 The	 name	 T6SS	 was	 first	 coined	 in	 2006,	 when	 it	 was	
identified	in	Vibrio	cholera	[62,69-71].	T6SS	is	highly	conserved	and	is	found	in	nearly	
25%	of	all	Gram-negative	bacteria	 such	as	Pseudomonas,	Escherichia,	Agrobacterium	
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and	 Helicobacter	 spp.	 [63-68,72].	 It	 is	 a	 large	 complex	 composed	 of	 13	 core	
components	that	span	from	the	cytoplasm,	to	the	extracellular	milieu	and	the	target	
cell.	 	These	proteins	collectively	assemble	a	structure	reminiscent	of	an	upside-down	
bacteriophage-like	structure	anchored	 to	 the	bacterial	 cell	envelope	 [69-71,73].	T6SS	
machinery	 is	 capable	 of	 delivering	 effector	 proteins	 directly	 into	 the	 host	 cell	
cytoplasm	in	a	single-step,	independent	of	the	Sec	and	Tat	pathways	[72,74].				
The	T6SS	core	components	can	be	grouped	into	the	base	plate	complex,	sheath,	tube	
and	spike.	In	both	V.	cholerea	and	P.	aeruginosa,	the	base	plate	complex	comprises	of	
TssE	(type	six	subunit	E),	TssF,	TssG,	TssJ,	TssK,	TssL,	TssM	and	TssA.	TssEFG	are	located	
in	the	cytosolic	side	of	the	bacterial	inner	membrane	and	in	close	proximity	to	the	tube	
complex	[73,75-77].	TssL	is	anchored	in	the	inner	bacterial	membrane,	TssM	is	bound	
to	 the	 inner	 membrane	 and	 extends	 outwards	 interacting	 with	 TssJ,	 an	 outer	
membrane	lipoprotein	[74,78].	The	roles	of	TssF,	TssG	and	TssA	are	unclear	although	
they	are	universally	conserved	[73,75-77].	The	formation	of	the	base	plate	assembly	is	
followed	by	 the	haemolysin	coregulated	protein	 (Hcp)	 tube	 formation.	The	Hcp	 tube	
undergoes	 polymerisation	 and	 emerges	 from	 the	 base	 plate	 complex	 spanning	 the	
bacterial	 cytosol	 to	 the	 extracellular	 milieu	 [78,79].	 Then	 the	 VipA/VipB	 sheath	
polymerises	 around	 the	 growing	 Hcp	 tube.	 TssK	 is	 an	 essential	 cytoplasmic	 protein,	
which	interacts	with	membrane	bound	TssJ-TssL-TssM	complex	as	well	as	the	tube	and	
sheath	components	of	the	T6SS	[73].	Analogous	to	phage,	a	conformational	change	in	
the	sheath	structure	causes	contraction.	This	propels	the	Hcp	tube	out	of	the	cell	and	
across	 the	 target	 cell	 membrane.	 This	 contraction	 event	 enables	 the	 delivery	 of	
effectors	 loaded	 onto	 the	 VgrG	 (valine-glycine	 repeat	 G)/PAAR	 (proline-alanine-
alanine-arginine	motif	containing	proteins)	spike	complex	or	the	distal	end	of	the	Hcp	
tube	[79,80].	The	contraction	process	disassembles	the	unsheathed	Hcp	tube;	parts	of	
the	 tube	 that	 are	 not	 expelled	 from	 the	 cell	 are	 recycled	 within	 the	 cytosol.	 	 The	
contracted	sheath	 is	remodelled	by	the	ATPase	activity	of	ClpV,	restoring	the	pool	of	
available	 sheath	 subunits.	 	 Sheath	 components	 VipA/VipB	 interact	 with	 ClpV	 that	 is	
associated	 with	 the	 baseplate	 components	 in	 the	 bacterial	 cytosol.	 The	 naked	
baseplate	 complex	 is	 then	 either	 recycled	 or	 disassembled,	 depending	 on	 the	
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requirement	 and	 activation	 state	 of	 the	 T6SS	 [7,73].	 The	 T6SS	 assembly	 is	 shown	 in	
Figure	 1.6.
	
	
Figure	1.6	Schematic	representation	of	the	Type	6	Secretion	System	(T6SS).	The	inner	membrane	(IM),	
periplasm	 (PP),	 outer	 membrane	 (OM)	 and	 the	 major	 components	 of	 the	 T6SS	 are	 shown.	 The	
components	 of	 the	 base	 plate	 complex:	 TssEFG	 are	 located	 on	 the	 cytosolic	 side	 of	 the	 IM,	 TssL	 is	
anchored	 in	 the	 IM,	 TssM	 is	 bound	 to	 the	 IM	and	extends	 to	 the	OM	and	 interacts	with	 TssJ,	 TssK	
interacts	 with	 membrane	 bound	 TssJLM	 complex,	 and	 sheath	 and	 tube	 components.	 The	 tube	 is	
formed	 of	Hcp	 polymer,	 emerging	 from	 the	 base	 plate	 spanning	 the	 cytoplasm	 to	 the	 extracellular	
milieu.	 The	 sheath	 is	 composed	 of	 VipA/VipB	 which	 polymerises	 around	 the	 growing	 Hcp	 tube.	
Conformation	change	in	sheath	components	causes	contraction	of	Hcp	tube	causing	the	propulsion	of	
the	spike	complex	of	VgrG/PAAR	 located	at	 the	 tip	of	 the	Hcp	tube	along	with	 the	 loaded	effectors	
into	the	target	cell	in	the	extracellular	milieu.	ATPase	ClpV	remodels	the	sheath,	recycles	the	tube	and	
drives	the	translocation	of	effectors	and	VgrG/PAAR	spike	complex	through	the	T6SS	machinery.	
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1.3.3 Type	Three	Secretion	System	in	Detail	
Pathogenic	 Yersinia	 species	 cause	 human	 diseases	 ranging	 from	 relatively	 mild	
intestinal	 disease	 for	 Yersinia	 enterocolitca	 [80-84]	 to	 bubonic	 plague	 for	 Yersinia	
pestis	 [7,85].	 Despite	 the	 differences	 in	 disease,	 virulence	 of	 the	 Yersinia	 species	 is	
caused	 by	 a	 conserved	 type	 three	 secretion	 system	 (T3SS),	 which	 is	 now	 a	 well-
established	model	 system	 for	 this	 form	of	 protein	 secretion.	 Although	 the	 T3SS	was	
first	 discovered	 in	 Yersinia	 pestis,	 it	 is	 a	 conserved	 virulence	 factor	 amongst	 other	
human	pathogens	 such	as	enteropathogenic	Escherichia	coli	 (EPEC),	Salmonella	 spp.,	
Pseudomonas	 aeruginosa,	 Shigella	 flexneri,	 and	 Chlamydia	 spp.	 [81-84,86].	 These	
pathogenic	 bacteria	 collectively	 cause	 numerous	 fatalities	 and	 significant	 healthcare	
costs	annually	[85,87-90].	
T3SS	 uses	 a	molecular	 syringe	 for	 the	 delivery	 of	 cytotoxic	 effectors	 into	 eukaryotic	
host	 cells.	 These	effectors	 influence	and	manipulate	diverse	 cellular	pathways	 in	 the	
eukaryotic	host	for	the	survival	and	proliferation	of	the	pathogen	by	either	repressing	
the	 inflammatory	 response	 or	 altering	 phagocytosis	 [83,86,90].	 Interfering	 with	 the	
delivery	of	effectors	could	have	substantial	consequences	on	disease	pathology.		Since	
this	virulence	mechanism	 is	conserved	 in	numerous	pathogenic	bacteria,	 it	makes	an	
attractive	target	for	novel	therapeutics.		
In	Yersinia	spp.,	the	genes	of	T3SS	are	 located	on	a	70	kb	virulence	plasmid,	and	the	
expression	of	genes	in	vitro	is	dependent	on	temperature	and	calcium	concentration,	a	
phenomenon	 called	 the	 low	 calcium	 response	 (LCR)	 [87-92].	 T3SS	 genes	 are	 not	
expressed	 at	 ambient	 temperature.	 However,	 upon	 increasing	 the	 temperature	 of	
Yersinia	 cultures	 from	 26°C	 to	 37°C	 in	 the	 presence	 of	millimolar	 concentrations	 of	
calcium,	 conditions	 representing	 the	mammalian	 host,	 T3SS	 genes	 are	 expressed	 at	
low	 levels	 and	 the	 molecular	 machinery	 known	 as	 the	 ‘’injectisome’’	 is	 assembled	
[90,92-94].	
The	 ‘’injectisome’’	 comprises	 several	 components	 that	 can	be	broken	down	 into	 the	
various	units:	 (i)	 the	basal	body	which	 is	 composed	of	 the	 inner	membrane	ring,	 the	
scaffold	proteins,	the	outer	membrane	ring,	the	export	apparatus,	the	ATPase	complex	
and	 the	 C	 ring;	 (ii)	 the	 needle	 which	 is	 an	 extension	 from	 the	 basal	 body	 into	 the	
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extracellular	milieu	and	(iii)	the	pore	complex	also	known	as	the	‘’translocon’’	which	is	
formed	in	the	membrane	of	the	target	(Figure	1.7).		
	
Figure	1.7	Schematic	representation	of	the	Type	3	Secretion	System	(T3SS).	The	inner	membrane	(IM),	
periplasm	 (PP),	 outer	membrane	 (OM),	 the	 host	 cell	membrane	 and	 the	major	 components	 of	 the	
T3SS	are	shown:	basal	body,	needle	and	pore	complex.	The	basal	body	comprises	of	YscC,	YscD,	YscJ	
which	form	a	platform	for	the	assembly	of	YscQ,	YscRSTUV	and	the	complex	YscNLK	of	which	YscN	is	
the	 ATPase	 powering	 the	 secretion	 of	 substrates.	 The	 needle	 comprises	 of	 YscI	 which	 forms	 a	 rod	
through	 which	 YscF	 is	 secreted	 and	 forms	 the	 needle.	 The	 pore	 complex	 is	 formed	 by	 the	
polymerisation	 of	 LcrV	 at	 the	 distal	 end	 of	 YscF	 forming	 a	 pentameric	 tip	 and	 complexes	 with	
translocators	 YopB	 and	 YopD	 which	 then	 insert	 into	 host	 cell	 membrane	 creating	 a	 pore	 or	
‘’translocon’’.	The	class	II	chaperone	LcrH	(shown	in	yellow)	is	depicted	as	binding	to	YopB	and	YopD	
before	being	channeled	across	 the	T3SS	assembly.	The	cargo	of	YopB/D	 is	 then	released	which	gets	
inserted	into	the	host	cell	membrane	forming	a	pore.		
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THE	BASAL	BODY	
Assembly	of	the	T3SS	is	driven	by	the	formation	of	the	basal	body	which	is	initiated	by	
the	 oligomerisation	 of	 YscC	 on	 the	 periplasmic	 side	 of	 the	 outer	 membrane	 and	 is	
termed	the	outer	membrane	ring	(OM)	[91,92,95,96]	Next,	a	ring	of	YscD	is	assembled	
in	the	inner	membrane	and	is	thought	to	connect	the	inner	and	outer	membrane	rings	
[92-94,97].	 YscD	 then	 binds	 to	 YscJ,	 which	 oligomerises	 to	 complete	 the	 inner	
membrane	 (MS)	 ring	 [92,93,95,96,98-104].	The	assembly	of	 these	 structures	 forms	a	
basic	 channel	 through	 the	 bacterial	 envelope,	 which	 serves	 as	 a	 platform	 for	 the	
assembly	of	the	remaining	injectisome	components.		
On	the	cytosolic	face	of	the	basal	body	is	the	C-ring.		This	is	composed	of	YscQ,	which	
colocalises	 with	 YscC	 in	 the	 outer	 membrane	 stabilising	 the	 whole	 assembly.		
Additionally,	a	complex	composed	of	YscN,	YscL	and	YscK	is	formed	and	interacts	with	
the	C-ring.	YscN	is	the	ATPase	that	powers	the	secretion	of	substrates	by	the	T3SS,	YscL	
is	 a	 negative	 regulator	 of	 ATPase	 activity,	 while	 the	 function	 of	 YscK	 is	 unknown	
[97,105].			
The	 next	 to	 follow	 is	 the	 assembly	 of	 the	 export	 apparatus	 composed	 of	 integral	
membrane	 proteins	 YscRSTUV	 [93,98-104,106-110]	 within	 the	 inner	 membrane,	
independently	 of	 the	 scaffold	 proteins.	 The	 pathways	 for	 assembly	 converge	 at	 this	
point	 with	 the	 recruitment	 of	 the	 export	 apparatus	 to	 YscJ	 in	 the	 MS	 ring	 of	 the	
scaffold	 [105,111,112].	 The	 formation	 of	 the	 fully	 functional	 basal	 body	 is	 achieved	
with	 the	 amalgamation	 of	 the	 scaffold,	 ATPase	 complex	 and	 export	 apparatus.	 The	
basal	body	is	now	capable	of	exporting	secretion	substrates.		
	
THE	NEEDLE	AND	THE	‘’EARLY	STAGE’’	
On	completion	of	the	basal	body,	YscI	integrates	into	the	inner	membrane	and	forms	
the	 rod	 that	 allows	 substrate	 transport	 across	 the	 inner	 membrane.	 	 This	 stage	 is	
referred	 to	 as	 the	 ‘’early’’	 stage	 because	 only	 ‘’early’’	 substrates	 are	 translocated.	
These	include	the	first	proteins	to	be	secreted:	YscIFPXO	and	YopR	[106-110,113-116].	
The	 needle	 protein	 YscF	 is	 secreted	 through	 the	 YscI	 rod	 into	 the	 periplasmic	 space	
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allowing	substrate	transport	across	the	inner	membrane	[111,112,117,118].	YscF	then	
undergoes	 polymerisation	 to	 form	 the	 needle,	 which	 extends	 ~41	 nm	 from	 the	
bacterium	Y.	pestis	or	~58	nm	from	Y.	enterocolitica.	The	needle	has	an	outer	diameter	
of	~6-7	nm	and	an	inner	diameter	of	~2-3	nm	[97,113-116].			
YscPXO	and	YopR	are	not	 shown	 in	 the	diagram	but	have	a	 regulatory	 role.	 	 Indeed,	
YscP	 is	 required	 to	 control	 the	 needle	 length	 while	 YopR	 is	 important	 in	 the	 early	
stages	of	needle	assembly,	though	its	exact	role	is	not	clear	[117,118].	Likewise,	YscX	
and	YscO	are	essential	for	the	secretion	of	early	substrates	but	are	not	secreted	from	
the	bacterium	until	needle	assembly	 is	complete	 [97,119].	 	YscY	 is	 thought	to	be	the	
chaperone	 for	 YscX	 secretion	 [2,106]	 and	 YscY	 has	 also	 been	 shown	 to	 bind	 to	
SycD/LcrH,	which	 is	 the	 chaperone	 for	 facilitating	 secretion	of	 the	middle	 substrates	
YopB	and	YopD.		The	role	of	the	chaperones	such	as	LcrH	is	covered	more	extensively	
below.		
THE	MIDDLE	STAGE	AND	TRANSLOCON	ASSEMBLY	
The	secretion	of	 translocators	LcrV,	YopB	and	D	 into	 the	extracellular	milieu	 initiates	
the	middle	stage.		LcrV	polymerises	at	the	distal	end	of	YscF	forming	a	pentameric	tip	
on	the	needle	complex	[119,120].		YopB	and	YopD	complex	with	LcrV	at	the	needle	tip	
and	are	inserted	into	the	host	cell	membrane	creating	a	pore.	 	This	 large	assembly	is	
termed	the	pore	complex	or	‘’translocon’’.	 	This	is	the	key	step	in	the	creation	of	the	
T3SS	 as	 organisms	 in	which	 the	 translocon	 formation	 is	 impeded	 are	 rendered	 non-
lethal	in	vivo	[120,121].	
Once	the	translocon	 is	 formed,	Yops	are	delivered	through	the	complex	and	the	 late	
stage,	 involving	 the	 delivery	 of	 effector	 proteins	 such	 as	 YopN	 and	 TyeA	 begins	
[121,122].	 	Here,	 immune	 supressing	 proteins	 and	molecules	 targeting	macrophages	
are	released	and	the	process	of	infection	begins	[122,123]	
	
	
	
35	
	
Table	 1.1	 Secretion	 Systems	 of	 Gram-negative	 bacteria	 describing	 their	 subunit	
composition,	functional	characteristics	and	citations.		
Secretion	
System	
Composition	of	subunits	 Functional	Characteristics	 Citations	
T1SS	 ATP	 Binding	 Cassette	 (ABC)	
transporters	 also	 known	 as	 Inner	
Membrane	 Component	 (IMC)	
located	 in	the	 inner	membrane.	e.g.	
AcrB	in	E.	coli		
	
	
ABC	 is	 an	 ATPase.	 It	 supplies	
energy	for	transport	of	variety	of	
substrates	 such	 as	 ions	 and	
macromolecules.		
	
	
	
AcrB	 -	
[123,124],	
PDB:	4CDI	
	
Membrane	 Fusion	 Protein	 (MFP)	
located	in	the	periplasm.	e.g.	AcrA	in	
E.	coli.	
	
	
MFP	 interacts	 with	 the	 OMP	 to	
complete	 the	 channel	 to	 the	
external	 milieu	 for	 export	 of	
various	compounds.	
AcrA	 -	
[124,125],	
PDB:	2F1M	
	
	
Outer	 Membrane	 Pore	 forming	
protein	 (OMP)	 is	 anchored	 in	 the	
outer	 membrane	 by	 a	 β-barrel	
structure.	e.g.	TolC	in	E.	coli	
	
OMP	 forms	 an	 exit	 duct	 for	
diverse	 molecules	 like	 protein	
toxins	and	antibacterial	drugs.	
	
	
TolC	 -	
[125,126],	
PDB:	2XMN	
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Secretion	
System	
Composition	 Function	 Citations	
T2SS	 Inner	 Membrane	 (IM)	
platform	comprising	 four	 core	
proteins:	 GspC,	 GspF,	 GspL	
and	 GspM	 tightly	 associated	
with	 cytoplasmic	 hexameric	
ATPase	GspE.	
	
GspE	 is	 an	 ATPase,	 provides	
energy	to	drive	export	of	proteins	
and	 interacts	 with	 IM	 platform.	
GspC,	F,	L	and	M	anchor	GspE	to	
the	pseudopilus	apparatus.		
	
GspE	 -	 [126,127],	
PDB:	4KSR.		
GspC	 -	 [127,128],	
PDB:	3OSS.		
GspF	 -	 [128-130],	
PDB:	 3C1Q.	 GspL	 -	
[129-131],	 PDB:	
2W7V,	2BH1.	GspM	
-	 [131,132],	 PDB:	
1UV7.	
	
Periplasmic	 pseudopilus,	 a	
large	 multimeric	 structure	
composed	 of	 the	 major	
pseudopilin	 subunit	GspG	 and	
minor	 pseudopilin	 subunits	
GspI,	GspJ,	GspK	and	GspH.		
	
	
The	base	of	pseudopilus	 is	 in	 the	
periplasm	 and	 interacts	 with	 the	
plasma	 membrane.	 Pilus	 may	
grow	 in	 order	 to	 push	 secreted	
molecules	 through	 the	 OM	
complex	or	block	the	OM	channel	
when	not	required.	
	
GspG	 -	 [132,133],	
PDB:	3G20.	
GspH	 -	 [133,134],	
PDB:	4DQ9.	
Gsp	 I/J/K	 -	
[134,135],	 PDB:	
3CI0.	
	
	
Outer	 Membrane	 (OM)	
complex	 consists	 of	 a	
dodecameric	 secretin	 GspD	
and	 a	 lipoprotein	 GspS	
(pilotin).	
	
GspD	 forms	 a	 large	 pore	 in	 the	
OM	 for	 passage	 of	 folded	
proteins	 and	 GspS	 stabilizes	 the	
GspD	multimer	in	the	OM.	
GspD	 -	 [135,136],	
PDB:	3EZJ.		
GspS	 -	 [136,137],	
PDB:	3SOL.	
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Secretion	
System	
Composition	 Function	 Citations	
T3SS	 Basal	body	
Scaffold	proteins:	YscC,	
YscD,	YscJ	
Export	 apparatus	
proteins:	 YscR,	 YscS,	
YscT,	YscU,	YscV.	
Cytoplasmic	
components:	 YscQ	 (C-
ring)	 and	 YscN,	 YscL,	
YscK	(ATPase	complex).	
	
YscC	forms	a	ring	in	the	OM,	acting	as	scaffold.	
YscD	 &	 YscJ	 form	 a	 ring	 in	 the	 IM	 creating	 a	
scaffold.	
YscRST	promote	polymerization	of	YscV.	YscU	is	
essential	 for	 substrate	 specificity.	 YscN	 is	 the	
ATPase	for	substrate	secretion	by	T3SS.	YscN	is	
a	negative	regulator	of	ATPase	activity.		
	
	
YscD	 -	
[137,138],	
PDB:	4D9V	
YscU	 -	
[138,139],	
PD:	2V5G	
	
	
The	needle	
YscI,	 YscF,	 YscP,	 YscX,	
YscO	and	YopR	
YscI	 forms	 the	 rod,	
followed	 by	 secretion	
of	YscF	which	forms	the	
needle	
	
	
YscI	 forms	 the	 rod	 to	 allow	 substrate	 passage	
across	 the	 IM.	 YscF	 undergoes	 polymerization	
to	 form	 the	 needle	 for	 translocation	 of	
substrates.	 YscP	 regulates	 the	 length	 of	 the	
needle.	 YscX	 and	 YscO	 are	 required	 for	 early	
substrate	secretion.		
	
YscF	 -	
[139,140],	
PDB:2P58	
YscO	 -	 PDB:	
4MH6	
YopR	 -	
[140,141],	
PDB:	1Z21	
Pore	complex	
LcrV	 (needle	 tip	
complex)	
YopB/YopD	 (translocon	
pore)	
	
LcrV	assists	YopB/YopD	for	insertion	in	the	host	
cell	membrane.	 YopB/YopD	 create	 a	 pore	 into	
the	 host	 cell	 membrane	 and	 form	 the	
translocon	for	delivery	of	virulent	proteins.		
	
LcrV	 -	
[141,142],	
PDB:	1R6F	
YopD	 -	
[53,142],	
PDB:	4AM9	
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Secretion	
System	
Composition	 Function	 Citations	
T4SS	 Inner	 Membrane	 (IM)	
complex	 is	 composed	 of	
three	 hexameric	 ATPases	
(VirD4,	 VirB4	 and	 VirB11)	
located	 at	 the	 cytoplasmic	
side	of	the	IM,	together	with	
VirB3,	VirB6	and	VirB8.		
VirD4,	 VirB4	 and	 VirB11	
ATPAses	 provide	 energy	 for	
substrate	 transport	 and	 T4SS	
biogenesis.	VirB11	assists	VirB4	
in	 pilus	 biogenesis	 and	
polymerization.	 VirB8	 helps	 in	
the	assembly	of	the	pili.		
	
	
VirB4	 -	 [53,143],	 PDB:	
4AG5.	
VirB11	 -	 [143,144],	
PDB:	 2GZA.	 VirB8	 -	
[144,145],	PDB:	4AKZ.		
Outer	 membrane	 (OM)	
complex	 comprises	 of	 VirB7,	
VirB9	and	VirB10	with	VirB10	
extending	from	the	IM	to	the	
OM.	
	
	
VirB7	and	VirB9	together	from	a	
pore	 in	 the	 OM	 for	 substrate	
translocation.	VirB10	forms	part	
of	 a	 scaffold	 around	 the	
translocation	 channel	 for	
substrate.	
VirB7/VirB9/VirB10	 -	
[145,146],	PDB:	3JQO.	
VirB9/VirB10	 -	
[74,146],	PDB:	3ZBJ	
Conjugative	 pilus	 is	
composed	 of	 VirB2	 and	
VirB5.	 
VirB2	and	VirB5	form	the	major	
and	minor	 subunit	 of	 the	 pilus	
respectively,	connecting	 the	 IM	
to	the	OM.		
	
	
39	
	
					
Secretion	
System	
Composition	 Function	 Citations	
T6SS	 Baseplate	 complex	 comprising	
TssE	 (type	 six	 subunit	 E),	 TssF,	
TssG,	TssJ,	TssK,	TssL,	TssM,	TssA	
and	ClpV	(ATPase).	TssEFG,	TssK,	
TssL,	 ClpV	 are	 located	 on	 the	
cytosolic	 side	 of	 bacterial	 IM,	
TssM	 is	 bound	 to	 the	 IM	 and	
extends	 onto	 the	 OM	 where	 it	
connects	to	TssJ.			
	
TssM	 is	 bound	 to	 the	 IM	 and	 extends	
outwards	 interacting	 with	 TssJ.	 TssK	
interacts	with	membrane	bound	TssJLM	
complex,	 the	 tube	 and	 sheath	
components.	 ClpV	 is	 an	 ATPase,	
provides	 energy	 for	
assembly/disassembly	 of	 the	 sheath	
and	baseplate	components.	
	
	
TssJ/TssM	 -	
[74,147],	
PDB:	3RX9	
	TssL	 -	
[147,148],	
PDB:	3U66	
ClpV	 -	
[148,149],	
PDB:	3ZRJ	
Sheath	 component:	 VipA/VipB	
(TssB/TssC)	
Interacts	with	ClpV	 in	bacterial	 cytosol,	
causes	 contraction	 of	 the	 growing	 Hcp	
tube	 and	 propels	 the	 spike	 complex	
loaded	with	effectors.	
VipA/VipB	 -	
[79,149],	
PDB:	3J9G.	
Tube	 component	 is	 haemolysin	
coregulated	 protein	 (Hcp)	
hexamer	 (Hcp1),	 connecting	 the	
IM	with	the	OM.		
	
Virulence	 factor,	 transporter	 of	
effectors	and	chaperone.		
Hcp1	 -	
[79,150],	
PDB:	4W64.		
Spike	complex	is	made	of	PAAR-
VgrG	protein	complex	and	in	the	
OM.	 
Transportation	 of	 effectors	 into	 the	
extracellular	milieu,	killing	of	target	cell.	
	
	 	
PAAR-VgrG	
-	 [150,151],	
PDB:	4JIV	
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1.3.3.1 The	role	of	Chaperones	in	the	T3SS	
For	 efficient	 export	 of	 both	 hydrophobic	 translocators	 and	 effector	 proteins	 specific	
chaperones	are	required.	They	act	as	 ‘’bodyguards’’	preventing	their	substrates	 from	
generating	premature	or	non-specific	interactions	with	other	proteins	in	the	bacterial	
cytosol	 prior	 to	 export.	 Moreover,	 they	 can	 maintain	 their	 substrates	 in	 a	 partially	
folded	 state	 in	 order	 to	 enable	 their	 passage	 through	 the	 narrow	 channel	 of	 the	
injectisome	and	may	also	play	a	role	in	secretion	process	[151-154].	Interestingly,	the	
T3SS	chaperones	 lack	the	ability	 to	bind	and	hydrolyse	ATP	unlike	classic	chaperones	
like	DnaK	or	GroEL.	T3SS	chaperones	are	divided	into	three	sub-groups	based	on	their	
binding	 partners	 and	 their	modes	 of	 interaction:	 class	 I	 chaperones	 interacting	with	
effector	 proteins,	 class	 II	 chaperones	 interacting	 with	 the	 translocators	 and	 class	 III	
chaperones	interacting	with	T3SS	needle	components	[152-155].		
	
1.3.3.2 Class	I	Chaperones	
Class	 I	 chaperones	 are	 relatively	 small	 (~10-15	 kDa),	 acidic	 (pI	 4-5)	 and	 generally	
display	a	homodimeric	structure	with	a	conserved	α-β	fold	(Figure	1.8).	They	interact	
with	their	cognate	effector	protein	through	a	chaperone-binding	domain	(CBD),	which	
is	located	within	the	first	100	amino	acids	of	the	effector	protein.	This	is	downstream	
from	 the	 short	 amino	 terminal	 export	 signal.	 They	 are	 classified	 into	 two	 categories	
based	 on	 their	 interaction	 with	 their	 effectors:	 class	 IA	 chaperone	 bind	 a	 single	
effector,	whereas	class	IB	chaperones	bind	multiple	effectors.		
Class	1A	chaperones:	 The	majority	of	 the	 structures	 solved	 to	date	 fall	 into	class	 IA.	
The	examples	 for	 class	 IA	 chaperones	 are	 SycE	 [155,156],	 SycH	 [156,157],	 SycN-YscB	
(see	 Figure	 1.8a)	 [157-159],	 SycT	 (see	 Figure	 1.8b)	 [158-160]	 from	 Yersinia	 spp.	 and		
CesT	[160,161]	from	enteropathogenic	E.	coli	(EPEC).		
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Figure	 1.8	 Ribbon	 representation	 of	 the	 crystal	 structure	 of	 class	 IA	 chaperones	 of	 the	 T3SS:	 (a)	
heterodimer	SycN-YscB	from	Yersinia	pestis	(red/magenta,	PDB	code	1XKP),	(b)	homodimer	SycT	(the	
monomeric	units	are	coloured	magenta	and	red	respectively,	PDB	code	2BHO).	Figure	was	prepared	
using	PyMOL.	
	
	
The	 class	 I	 chaperones	 show	 low	 sequence	 similarity,	 but	 possess	 a	 conserved	 3D	
structure	 and	 a	 common	mode	 of	 binding.	 Each	 of	 these	 dimeric	 chaperones	 use	 a	
similar	 fold,	 where	 the	 monomer	 comprises	 of	 three	 α-helices	 and	 a	 five-stranded	
antiparallel	 β	 sheet	 arranged	 in	 the	 order	 of	 α-β-β-β-α-β-β-α,	where	 the	 helices	 are	
positioned	on	one	face	of	the	β	sheet.	The	central	α	helix	and	the	loop	and	β	strand,	
which	immediately	follows,	are	responsible	for	dimerization.	This	covers	a	hydrophobic	
surface	area	of	generally	around	2500	Å2	[156,161-163].	The	CBD	of	effector	proteins	
wrap	 around	 chaperone	 homodimers	 in	 an	 extended,	 horseshoe	 like	 conformation	
with	some	α-helical	secondary	structure	organisation	[156,160,162-164].	The	presence	
of	hydrophobic	surfaces	on	the	chaperone	homodimers	are	responsible	for	the	binding	
of	the	cognate	effector	protein	[156,160,162,164].	A	good	example	of	this	interaction	
is	SycH	and	its	effector	YscM2.		Here	the	stable	YscM2(33-50)	fragment	wraps	around	the	
homodimeric	 SycH	 in	 an	 extended	 fashion.	 YscM2(33-50)	 interacts	 with	 SycH	 via	 a	
structured	 α	 helix	 and	 β	 strand	 that	 dock	 with	 the	 β	 sheet	 and	 helix	 of	 the	 SycH	
[156,157]	(see	Figure	1.9).	
(a)	 (b)	
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Figure	 1.9	Ribbon	 representation	of	 the	 crystal	 structure	of	Yersinia	pestis	T3SS	Class	 IA	 chaperone	
SycH	in	complex	with	a	stable	fragment	of	its	cognate	effector	protein	YscM2(33-50)	(PDB	code	1TTW).	
The	monomeric	 units	 of	 SycH	 are	 shown	 in	 red	 and	magenta	 respectively.	 The	 effector	 YscM2(33-50)	
fragment	is	shown	in	green.	Figure	was	prepared	using	PyMOL.		
	
Interestingly	there	are	deviations	from	the	homdimeric	structure	described	above.	For	
example,	the	crystal	structure	of	class	IA	chaperone	SycN-YscB	is	unique	amongst	the	
class	 I	 chaperones	 because	 it	 is	 a	 heterodimer	 [157,161]	 (see	 Figure	 1.11a).	 Here,	
although	the	topology	of	each	monomer	is	conserved,	the	heterodimeric	nature	of	the	
assembly	 leads	 to	 an	 asymmetry	 that	 does	 not	 exist	 in	 homodimeric	 class	 IA	
chaperones.	 Even	 though	 the	α2	helix	of	YscB	 lies	parallel	 to	 the	dimer	 interface,	 as	
observed	 in	 the	homodimers,	 the	corresponding	helix	 in	SycN	 is	 tilted	and	 induces	a	
shift	of	β4	and	β5	of	YscB.	This	asymmetry	in	the	dimer	interface	has	a	direct	influence	
on	the	specific	binding	of	YscB	to	its	effector,	YopN	[152,161]	(see		Figure	1.10).		YopN	
contains	an	N-terminal	secretion	signal	followed	by	a	chaperone-binding	domain	(CBD)	
where	 its	 two	 chaperones,	 SycN	and	 YscB,	 bind.	 The	 YopN	CBD	wraps	 around	 SycN-
YscB	chaperone	keeping	YopN	partially	unfolded	and	secretion	competent	[152,165].			
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	Figure	 1.10	Ribbon	 representation	of	 the	 crystal	 structure	 of	Yersinia	 pestis	T3SS	macromeolecular	
assembly	of	effector	YopN	in	complex	with	its	heterodimeric	class	IA	chaperone	SycN-YscB	(PDB	code	
1XKP).	SycN,	YscB	and	YopN	are	shown	in	red,	magenta	and	green	respectively.	Figure	was	prepared	
using	PyMOL.			
	
Class	1B	Chaperones:	As	stated	previously,	class	IB	chaperones	contrast	to	the	Class	1A	
by	binding	to	multiple	diverse	effectors.	For	example,	Spa15	from	Shigella	flexneri	and	
InvB	 from	 Salmonella	 enterica	 (see	 Figure	 1.11a	 and	 Figure	 1.11b,	 respectively).	
Interestingly,	 in	 spite	 of	 possessing	 the	 ability	 to	 bind	 to	 various	 effectors,	 the	
monomers	of	each	chaperone	share	the	same	overall	fold	as	the	class	IA	chaperones.	
However,	the	main	difference	lies	with	the	orientation	of	the	dimers.	In	particular,	the	
α2	 helices	 that	 form	 the	 dimeric	 interface	 have	 a	 different	 orientation,	 leading	 to	 a	
dimer	 in	which	 the	 subunits	 are	 rotated	 about	 30°	 with	 respect	 to	 each	 other.	 The	
residues	that	cause	this	differing	shape	and	orientation	of	the	α2	helix	are	conserved	
among	other	putative	 class	 IB	 chaperones	and	 thus	distinguish	 class	 IB	 from	class	 IA	
chaperones.	 	 The	 change	 in	 dimeric	 shape	 also	 changes	 the	 orientation	 of	 the	
hydrophobic	 pockets	 that	 bind	 the	 effectors.	 	 The	 effectors	 still	 wrap	 around	
chaperone	 homodimers	 in	 the	 extended,	 horseshoe-like	 conformation,	 but	 the	
rotation	of	the	assembly	causes	a	longer	wrapping	linker.	Moreover,	the	residues	that	
form	 the	 hydrophobic	 binding	 regions	 are	more	 highly	 conserved,	 enabling	 differing	
effectors	to	bind.	This	suggests	that	the	chaperones	of	the	1B	class	are	more	general	
chaperones	than	the	more	specific	class	1A	[142,165-169].	
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Figure	1.11	Ribbon	representation	of	the	crystal	structure	of	class	IB	chaperones	of	the	T3SS:	(a)	Spa15	
from	 Shigella	 flexneri	 (monomers	 coloured	 red	 and	magenta	 respectively,	 PDB	 code	 1RY9)	 and	 (b)	
InvB	from	Salmonella	enterica	(monomers	shown	in	red	and	magenta	respectively,	PDB	code	2FM8).	
Figure	was	prepared	using	PyMOL.		
	
1.3.3.3 Class	II	&	III	Chaperones	
Both	 class	 II	 &	 class	 III	 chaperones	 are	 small,	 acidic	 and	 slightly	 larger	 than	 class	 I	
chaperones	(~15-20	kDa).	Both	bind	to	parts	of	the	secretion	apparatus	that	is	formed	
outside	 the	 bacteria.	 The	 class	 II	 chaperones	 bind	 to	 and	 stabilise	 the	 translocon	
forming	translocator	proteins	(for	example,	YopB	and	YopD	in	Yersinia	spp.,	PopB	and	
PopD	 in	 Pseudomonas	 aeruginosa	 and	 IpaB	 and	 IpaC	 in	 Shigella	 spp.,	 respectively).	
Similarly,	the	class	III	T3S	chaperones	bind	to	the	needle	component	preventing	their	
premature	association	or	aggregation	within	the	bacterial	cytoplasm	(for	example	YscF	
in	 Yersinia	 spp.	 and	 PscF	 in	 Pseudomonas	 aeruginosa).	 Importantly,	 the	 translocon	
pore	and	needle	complexes	can	only	form	if	their	respective	chaperones	are	present	in	
the	bacterial	cytosol	 [142,166-171].	 If	 the	chaperones	are	knocked	out,	no	needle	or	
pore	formation	occurs,	thus	rendering	the	bacteria	non-infective.		
Interestingly,	 class	 II	 and	 class	 III	 chaperones,	 although	 binding	 to	 molecules	 that	
perform	completely	different	functions,	have	remarkably	similar	structures.	These	are	
formed	from	multiple	copies	of	a	motif	called	the	tetratricopetide	repeat	(TPR).	TPRs	
are	short	34	amino	acid	motifs	that	adopt	a	αhelix-turn-αhelix	conformation	and	stack	
onto	 each	 other	 to	 form	 elongated	 structures	 [170-172].	 The	 X-ray	 structure	 of	 a	
domain	containing	three	TPRs	from	protein	phosphatase	5	discovered	the	helix-turn-
helix	arrangement,	with	adjacent	TPR	motifs	packing	in	a	parallel	fashion,	resulting	in	a	
(a)	 (b)	
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spiral	of	 repeating	anti-parallel	alpha-helices.	The	two	helices	are	denoted	as	A	Helix	
and	B	Helix	(Figure	1.12).	The	packing	angle	between	the	two	helices	is	~24°	within	a	
single	TPR	and	produces	a	right-handed	super	helical	shape.	Two	protein	surfaces	are	
generated:	mainly	residues	on	helices	A	contribute	to	the	 inner	concave	surface,	and	
the	other	surface	presents	residues	from	both	helices	A	and	B.	There	can	be	between	3	
and	16	direct	 repeats	 in	a	given	protein	domain	 [170,172].	 Individual	TPR	motifs	are	
not	 stable	and	must	be	arrayed	 in	 tandem	 to	 fold	 correctly.	 TPR	containing	proteins	
are	widespread	in	prokaryotic	and	eukaryotic	organisms	and	are	involved	in	a	variety	
of	 biological	 processes,	 such	 as	 cell	 cycle	 regulation,	 transcriptional	 control,	
mitochondrial	 and	 peroxisomal	 protein	 transport,	 neurogenesis	 and	 protein	 folding	
[142,166-170].		
	
	
	
	
Figure	1.12	Consensus	sequence	of	TPR.	The	consensus	TPR	motif	(yellow)	and	solvating	helix	(green)	
sequence	 are	 displayed	 with	 the	 corresponding	 sequence	 underneath,	 ‘n’	 denotes	 the	 number	 of	
consensus	 TPRs.	 The	 highly	 conserved	 residues	 are	 highlighted	 in	 yellow	 (>50%	 conservation	 of	 an	
identical	 residue)	 and	 pink	 (50%	 of	 similar	 residue	 type).	 The	 consensus	 sequence	was	 taken	 from	
SMART	(a	Simple	Modular	Architecture	Research	Tool)	database	with	accession	no.	SM00028.	 
	
Excitingly,	 crystal	 structures	 for	 both	 Class	 II	 and	 Class	 III	 chaperones	were	 recently	
solved	as	follows:	
	
	
	
			A	LT	L	NN	IG	TI	Y		YA	RED	YDQALNYYEQALSLSRAV		AEAKQNLGNAKQKQG	
	A	Helix	 B	Helix	 Solvating	Helix	
1	 13	 17	
	n	
30	 34	
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1. Class	 II	 Chaperones:	 SycD	 from	 Yersinia	 enterocolitica,	 IpgC	 from	 Shigella	
flexneri	 and	 PcrH	 from	 Pseudomonas	 aeruginosa	 [139,142,166-169,173]	 (	
Figure	1.13).	
	
	Figure	1.13	Ribbon	representation	of	crystal	structures	of	homodimeric	T3SS	class	II	chaperones:	(a)	
SycD(21-163)	 from	 Yersinia	 enterocolitica	 (PDB	 code	 2VGX),	 (b)	 IpgC	 from	 Shigella	 flexneri	 (PDB	 code	
3GYZ)	and	(c)	PcrH(21-160)	from	Pseudomonas	aeruginosa	(PDB	code	2XCC).	The	monomers	are	shown	in	
red	and	magenta	respectively	in	each	of	the	above	structures.	Figure	was	prepared	using	PyMOL.				
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2. Class	 III	 Chaperones:	 YscG	 from	 Yersinia	 enterocolitica	 and	 PscG	 from	
Pseudomonas	aeruginosa[139,167,168,173]	(Figure	1.14).	
Figure	 1.14	 Ribbon	 representation	 of	 the	 crystal	 structure	 of	 T3SS	 class	 III	 chaperones:	 (a)	 YscG	
(coloured	green)	 in	 complex	with	YscE	 (coloured	blue)	 from	Yersinia	enterocolitica	 (PDB	code	2P58)	
and	 (b)	 PscG	 (coloured	 green)	 in	 complex	with	PscE	 (coloured	blue)	 from	Pseudomonas	aeruginosa	
(PDB	code	2UWJ).	Figure	was	prepared	using	PyMOL.		
	
The	structures	 reveal	 that	each	class	of	 chaperone	possess	a	TPR	domain	of	3.5	TPR	
motifs.	These	form	a	basket-like	molecule	that	has	concave	and	convex	sides.	In	each	
case	 their	 secretion	 apparatus	 cargo	 is	 bound	 to	 the	 concave	 face	 of	 the	molecule.	
However,	 the	mode	 of	 binding	within	 this	 concave	 face	 and	 oligomeric	 structure	 of	
each	 chaperone	 is	 very	 different	 for	 both	 classes.	 Class	 II	 chaperones	 form	
homodimers	 that	 bind	 to	 extended	 peptides	 of	 the	 translocator	 proteins.	 	Whereas	
Class	 III	 chaperones	 form	heterodimers	with	 a	 further	protein	 and	bind	a	 structured	
helical	 segment	of	 their	 needle	 cargo.	 	 This	might	 be	due	 to	 the	 class	 II	 chaperones	
being	 required	 to	 bind	 two	 types	 of	 cargo	 protein	 and	 the	 class	 III	 chaperones	 only	
being	required	to	bind	one	cargo	protein.	To	dissect	the	structures	in	more	detail	each	
class	is	discussed	separately	in	detail	below.	
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1.3.3.4 Structure	and	biophysical	characterisation	of	Class	II	Chaperones	
Oligomeric	 Structure:	 	 Although	 class	 II	 chaperones	 are	 generally	 homodimers	 their	
exact	mode	of	dimerization	 is	somewhat	ambiguous.	The	crystal	structures	provide	a	
number	 of	 possible	 conformations	 depending	 on	 the	 protein	 and	 construct	 used	
(Figure	1.15	and	Figure	1.16).	For	N-terminally	shortened	SycD	(21–163)	and	IpgC	(10–
151),	 further	 mutational	 analysis	 suggested	 that	 the	 head-to-head	 dimer	 was	 the	
relevant	unit	 (Figure	1.15).	 In	 the	 case	of	 SycD,	 crystal	 structures	 show	 two	possible	
head-to-head	 conformations	 (Figure	 1.15a&b).	 In	 contrast,	 the	 relevant	 unit	 of	 full-
length	 IpgC	 (1–151)	 seems	 to	 be	 a	 back-to-head	 conformation	 (Figure	 1.15d).	 N-
terminally	shortened	PcrH	(21–160)	crystal	structures	show	two	dimer	structures	that	
might	be	stable	in	solution,	an	asymmetric	back-to-back	dimer	and	a	symmetric	head-
to-head	dimer	(Figure	1.15	(e)	&	(f)).	
To	 investigate	 the	 physiological	 role	 of	 class	 II	 chaperone	 dimerization,	 in	 vivo	
experiments	 were	 carried	 out	 in	 Yersinia	 and	 in	 Shigella,	 respectively.	 Here,	 the	
mutated	 monomeric	 mutant	 showed	 characteristics	 typical	 of	 a	 null	 mutant.	 These	
consisted	of	a	lack	of	translocator	secretion	and	an	inability	to	invade	mammalian	cells	
[166-168,174].	 Yet	 studies	 on	 AcrH	 and	 PcrH	 have	 shown	 that	 translocator	 binding	
disrupts	their	dimeric	structures	and	produces	1:1	chaperone-translocator	complexes	
[166,174-176].		
Such	structural	ambiguity	suggests	certain	flexibility	in	the	topology	of	the	translocator	
chaperones,	 which	would	 seem	 to	 be	 of	 importance	 to	 their	 function.	 This	 appears	
logical	given	the	modular	TPR	units	that	 form	their	structure.	However,	 there	 is	 little	
information	and	no	biophysical	studies	to	have	specifically	investigated	whether	this	is	
the	case.	These	questions	form	the	basis	of	this	thesis	and	will	be	elaborated	in	Section	
1.4	–	Thesis	Aims.	
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Figure	1.15	Ribbon	representation	of	 the	crystal	structures	of	class	 II	 chaperones:	 (a)	&	 (b)	head-to-
head	confirmations	of	dimeric	obtained	without	YopD	peptide	SycD21-163.	Chains	A	and	B	of	SycD21-163	
are	 coloured	 blue	 and	 red,	 respectively.	 Structures	 (a)	 and	 (b)	were	 produced	 from	 2VGX.pdb	 and	
2VGY.pdb,	respectively.	Leucine	65	is	represented	by	green	spheres	and	was	mutated	to	glutamic	acid	
to	obtain	monomeric	protein.	LcrH	differs	from	SycD	in	only	two	positions	(N136D	and	P138T).	These	
amino	acids	are	shown	as	space	 fill	 spheres	 in	each	of	 the	monomeric	units.	 (c)	&	 (d)	Two	differing	
conformations	of	dimeric	 IpgC10-151	 (c)	and	dimeric	 IpgC1-151	 (d).	Chains	A	and	B	of	 IpgC	are	coloured	
cyan	 and	 orange,	 respectively.	 Structures	 (c)	 and	 (d)	were	 produced	 from	 3GZ1.pdb	 and	 3KS2.pdb,	
respectively.	 (e)	&	 (f)	Two	differing	conformations	of	dimeric	PcrH21-160.	Chains	A	and	B	of	PcrH21-160	
are	coloured	dark	and	green	respectively.	Structures	(e)	and	(f)	were	both	produced	from	2XCC.pdb.	
Figures	(a)	to	(f)	were	prepared	using	PyMOL.				
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Cargo	 Binding:	 Although	 biochemical	 studies	 have	 implicated	 more	 than	 one	
interaction	 between	 chaperone	 and	 translocators,	 structures	 of	 IpgC	with	 IpaB	 (51–
72),	PcrH	(21–160)	with	PopD	(47–56),	and	SycD	(21-163)	with	YopD	(56–	65)	show	a	
common	main	interaction	where	an	extended	peptide	from	each	translocator	binds	to	
the	same	concave	face	of	its	cognate	TPR	domain	(1:1	ratio)	[142,166,175,176]	(Figure	
1.16).	Thus,	the	structures	suggest	that	the	chaperone	can	only	bind	one	translocator	
at	any	given	time.		
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A	good	example	to	illustrate	the	chaperone-translocator	binding	is	the	crystal	structure	
of	SycD	in	complex	with	a	peptide	of	the	N-terminal	region	of	the	minor	translocator	
protein	 YopD	 (Figure	 1.16	 c).	 The	N-terminal	 YopD	hexapeptide	 58PELIKP63	 has	 three	
hydrophobic	residues	(58PELIKP63)	that	dock	into	three	specific	conserved	hydrophobic	
clefts	found	along	the	concave	face	of	the	chaperone.	The	clefts	are	lined	by	aromatic	
and	 aliphatic	 residues	mainly	 from	 the	 A	 helices	 of	 the	 first	 and	 second	 TPR	motifs	
[142,167].	The	same	type	of	interaction	and	conserved	residues	were	found	in	Shigella	
and	 Pseudomonas	 where	 the	 major	 translocator	 IpaB	 (58PELKAP63)	 and	 the	 minor	
translocator	PopD	(49VELNAP54)	bind	to	IpgC	and	PcrH,	respectively	[167].		The	binding	
mode	 is	 shown	 in	 Figure	 1.16	 and	 the	 sequence	 conservation	 of	 the	 chaperones	 is	
shown	 in	 Figure	 1.17.	 Interestingly,	 Lunelli	 et	 al.	 performed	 Isothermal	 Titration	
Calorimetry	(ITC)	experiments	to	obtain	a	Kd	for	the	interaction	of	PELKAP	peptide	with	
IpgC	and	various	 constructs	of	 IpgC	 in	which	 the	peptide-binding	 site	was	disrupted.	
PELKAP	bound	to	IpgC	with	a	Kd	of	625	±	11	µM,	whereas	the	IpaB51-72	peptide,	used	in	
the	co-crystallization	bound	to	IpgC	with	a	Kd	of	72	±	8	µM.	The	mutated	IpgC	showed	
no	binding	to	the	peptide,	was	unable	to	complement	the	deletion	of	ipgC	in	epithelial	
cell	 invasion	 and	 failed	 to	 allow	 secretion	 of	 translocator	 IpaB.	 Additionally,	 they	
assayed	 the	 KD	 of	 peptides	 encoding	 the	 putative	 chaperone-binding	motif	 of	 YopB	
(VQLPAP)	and	YopD	(PELIKP)	to	SycD.	These	still	showed	an	interaction,	but	with	a	very	
weak	Kd	of	455	±	19	µM	and	1,370	±	38	µM	respectively	[167,173].	Thus	although	the	
peptide	 binding	 interfaces	 shown	 in	 the	 crystal	 structures	 are	 important,	 the	 ITC	
results	suggest	a	further	interaction	site	on	the	chaperone	is	probable.	
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Figure	 1.17	 Structure	 based	 sequence	 alignment	 of	 T3SS	 Class	 II	 chaperones.	 	 IpgC	 from	 Shigella	
flexneri,	 PcrH	 from	Pseudomonas	 aeruginosa,	 SycD	 from	Yersinia	 enterocolitica,	 fl-LcrH	 and	 tr-LcrH	
from	Yersinia	pestis	(residues	are	shown	in	red).	Residues	forming	the	TPR	helices	are	highlighted	in	
yellow.	 C-terminal	 solvating	 helix	 forming	 residues	 are	 highlighted	 in	 green.	 Residues	 involved	 in	
hydrophobic	and	van	der	Waal’s	interaction	with	the	class	II	chaperone’s	corresponding	translocator	
extended	peptides	are	highlighted	in	red.	Amino	acids	involved	in	salt	bridge	formation	by	interaction	
with	 side	 chain	 residues	 of	 corresponding	 translocator	 peptides	 are	 highlighted	 in	 light	 blue.	 The	
difference	between	SycD	and	LcrH	(fl-LcrH	and	tr-LcrH)	is	in	only	two	positions:	N136D	coloured	dark	
blue	and	P138T	coloured	purple.			
	
1.3.3.5 Structure	and	biophysical	characterisation	of	Class	III	Chaperones	
As	stated	earlier,	although	the	class	III	chaperones	possess	a	TPR	domain	like	the	class	
II	chaperones,	they	don’t	form	homodimers	and	don’t	bind	their	cargo	as	an	extended	
peptide.	 	 Instead	they	 interact	with	an	additional	protein	to	 form	a	heterodimer	and	
interact	with	their	cargo	through	a	structured	αhelix-turn-loop	arrangement.		
Oligomeric	 State:	 In	 both	 reported	 structures,	 the	 class	 III	 TPR	 chaperone	 domain	
binds	a	small	2	α-helical	protein	at	its	N-terminus.	In	Pseudomonas	the	TPR	chaperone	
PscG	binds	PscE	and	 in	 Yersinia	 the	TPR	 chaperone	YscG	binds	YscE	 (Figure	1.19).	 In	
both	 structures	 the	 interaction	 between	 these	 proteins	 is	 very	 similar,	 unlike	 the	
numerous	 different	 homodimers	 of	 the	 Class	 II	 chaperones.	 The	 two	 helices	 of	
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PscE/YscE	interact	through	hydrophobic	interactions	with	the	first	two	N-terminal	TPR	
containing	helices	of	PscG/YscG.	Protein	sequence	alignment	of	YscG,	PscG	and	other	
related	proteins	showed	that	these	hydrophobic	residues	are	conserved	(Figure	1.18).	
In	 the	 case	 of	 YscE/G,	 the	 total	 buried	 surface	 area	 of	 the	 interaction	 is	 1548	 Å2.	
Moreover,	the	positioning	of	PscE/YscE	in	the	complex	means	that	it	makes	very	little	
direct	 contact	 with	 the	 chaperones	 cargo,	 PscF/YscF	 (Figure	 1.19).	 The	 total	 buried	
surface	 area	 between	 YscF	 and	 YscE	 in	 the	 complex	 is	merely	 276	Å2.	 Thus	 it	would	
seem	that	the	role	of	PscE/YscE	 is	most	 likely	to	be	that	of	stabilising	PscG/YscG	 in	a	
form	that	can	readily	accept	its	cargo.	The	fact	that	YscE	null	mutant	strains	of	Yersinia	
do	not	accumulate	YscG	and	 that	PscE	null	mutant	 strains	of	Pseudomonas	 are	non-
cytotoxic	support	this	hypothesis	[139,173,177].		
	
Figure	1.18	Structure	based	sequence	alignment	of	T3SS	class	 III	chaperones	sharing	homology	from	
diverse	pathogens.	PscG	 from	Pseudomonas	aeruginosa	 (nosocomial	 infections),	YscG	 from	Yersinia	
pestis	 (bubonic	 plague),	 YscG	 from	 Vibrio	 parahaemolyticus	 (gastrointestinal	 illness),	 LscG	 from	
Photorhabdus	 luminescens	 (insect	 pathogen),	 and	 YscG	 from	 Aeromonas	 hydrophila	 (respiratory	
illness	 in	humans,	 reptiles,	and	birds).	Residues	 showing	100	%	conservation	are	highlighted	 in	 red.	
PscG	 homologs	 share	 high	 conservation	 within	 residues	 that	 interact	 with	 PscE	 (purple)	 and	 PscF	
(orange).	
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Cargo	 Binding:	 The	 main	 binding	 site	 of	 the	 heterodimer	 is	 located	 on	 the	 hydrophobic	
concave	groove	of	the	TPR	domains	of	PscG/YscG.	PscG/YscG	acts	as	a	scaffold	to	organise	
the	assembly	of	PscE/YscE	and	PscF/YscF	into	the	heterotrimeric	complex.	In	both	cases,	the	
concave	surface	of	PscG/YscG	formed	by	TPR	containing	α-helices	(H1,	H3	and	H5)	and	a	C-
terminal	 α-helix	 (H7),	 display	 a	 highly	 hydrophobic	 platform,	which	 grasps	 the	 C-terminal	
helix	of	PscF/YscF.	[139,173,177-180].	In	YscEFG	complex,	the	C-terminal	residues	of	YscF50-
87	 adopt	 a	α-helical	 hairpin	 conformation	within	 the	 TPR	 groove.	 The	 total	 buried	 surface	
area	between	YscF	and	YscG	in	the	complex	is	2724	Å2.	Thus,	the	complex	that	YscG	makes	
with	YscF	is	far	more	extensive	than	those	made	by	the	class	II	chaperones	with	their	cargo.	
In	 synergy	with	 the	 structure	 of	 YscEFG,	 the	 interaction	 of	 PscF	mirrors	 that	 of	 YscF,	 but	
differs	at	the	N-terminus.	Here	instead	of	the	hairpin-helix	conformation,	the	PscF	shows	an	
extended	 peptide.	 	 One	 explanation	 for	 the	 difference	 is	 the	 PscF	 construct	 used	 was	
truncated	 whereas	 the	 YscF	 was	 full	 length.	 Interestingly,	 further	 experimentation	
concluded	 that	 the	 N-terminal	 section	 of	 YscF	 (1-49)	 could	 not	 be	 resolved	
crystallographically	as	it	was	unstructured.		
	
Figure	1.19	Crystal	structures	of	the	heterotrimeric	complex	comprising	the	class	III	chaperones:	(a)	YscEFG	
complex	comprising	the	heterodimer	chaperone	of	YscE/YscG	(coloured	blue/red)	and	needle	protein	YscF50-
87	 (coloured	 green).	 (b)	 PscEFG	 complex	 showing	 the	 heterodimer	 chaperone	 of	 PscE/PscG	 (coloured	
blue/red)	and	needle	protein	PscF54-84	(coloured	green).	Figures	were	prepared	using	PyMOL.	
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1.4 Thesis	Aims	
Given	the	crucial	 role	of	 the	class	 II	 translocator	chaperones,	this	study	aims	 to	investigate	
their	 conformational	 stability	 and	 the	 thermodynamic	 importance	 of	 the	 homodimeric	
interface.	 To	 accomplish	 these	 aims	 the	class	 II	 chaperone	 LcrH	 from	Yersinia	 pestis	was	
chosen	as	a	model	 system.	 LcrH	 is	 identical	 to	SycD	 from	Y.	enterocolitica,	 except	 for	 two	
minor	amino	acid	substitutions,	(Figure	1.15	and	Figure	1.17).	
Initially	 we	will	 investigate	the	 oligomeric	 states	 of	 different	 constructs	 of	 LcrH	 and	 their	
secondary	 structure	 characteristics.	 These	will	be	 achieved	 by:	 (i)	 constructing	 the	 LcrH	
genes	-	full	length	LcrH	(fl-LcrH),	truncated	LcrH	(tr-LcrH)	and	monomeric	L65E	LcrH	(tr-LcrH	
L65E),	(ii)	carrying	out	molecular	cloning	of	constructed	LcrH	genes	into	suitable	expression	
vectors	for	protein	expression	followed	by	purification	strategies	and	(iii)	 initial	biophysical	
characterisation	of	 LcrH	protein	constructs.	The	oligomeric	 states	of	 these	proteins	will	be	
studied	 by	 analytical	 size	 exclusion	 chromatography	 (SEC)	 and	 their	 secondary	 structure	
characterised	through	far-UV	circular	dichroism	(CD).	
Furthermore	 we	will	 examine	 the	 monomer-dimer	 equilibrium	 and	 oligomeric	 state	 of	
various	 LcrH	 protein	 constructs	which	 will	be	 undertaken	 by	 the	 use	 of	 analytical	 ultra-
centrifugation	 (AUC),	 analytical	 size	 exclusion	 chromatography	 (SEC)	 and	 dynamic	 light	
scattering	(DLS).	In	addition	I	intend	to	explore	the	thermodynamic	stability	and	flexibility	of	
LcrH	 proteins	 through	 equilibrium	 chemical	 denaturations	 (monitored	 by	 far-UV	 CD	 and	
fluorescence	spectroscopy).	
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Chapter	2 Materials	and	Methods	
2.1 Molecular	Biology	Methods	
In	this	study,	three	different	constructs	of	LcrH	–	full	length	LcrH	(fl-LcrH,	168	amino	acids),	
truncated	LcrH	(tr-LcrH,	amino	acids	21-163,	143	residues)	and	mutant	L65E	LcrH	(sequence	
identical	 to	 tr-LcrH,	 except	 at	 amino	 acid	 position	 65	 where	 leucine	 was	 mutated	 to	
glutamate)	was	produced.		The	techniques	used	for	their	gene	construction	and	cloning	are	
described	as	follows.	
	
2.1.1 fl-LcrH	gene	synthesis	
The	fl-LcrH	gene	was	synthesized	using	the	steps	outlined	below:		
2.1.1.1 Recursive	PCR	
The	 full	 length	LcrH	 (fl-LcrH)	 gene	was	 initially	 synthesized	using	a	 recursive	PCR	method.	
This	 required	the	design	of	eight	coding	and	non-coding	overlapping	oligonucleotides	 that	
spanned	the	entire	sequence	of	the	LcrH	gene	(Figure	2.1).	The	overlapping	regions	 in	the	
oligonucleotides	were	20	base	pairs	in	length	and	engineered	to	give	melting	temperatures	
(Tm)	 in	 the	 range	 54	 –	 64	 °C.	 Computer	 based	 sequence	 analysis	 using	 ClustalW	multiple	
sequence	alignment	of	the	entire	gene	sequence	with	the	sequence	of	the	overlap	regions	
was	 performed.	 The	 sequence	 alignment	 showed	 them	 to	 be	 unique	 and	 unlikely	 to	 give	
non-specific	priming.	The	designed	sequences	were	synthesised	by	VH	Bio	Limited,	UK	and	
supplied	in	lyophilised	form.	They	were	dissolved	in	ddH2O	to	give	a	stock	concentration	of	
50	µM.		
	
	
Figure	2.1:	 Schematic	 showing	 the	 recursive	oligonucleotides	 required	 for	 synthesis	of	 the	 LcrH	gene.	The	
gene	is	represented	as	a	blue	box,	the	coding	oligonucleotides	represented	as	black	lines	and	the	non-coding	
oligonucleotides	 represented	 as	 red	 lines.	 Note	 that	 each	 oligonucleotide	 overlapped	 with	 each	 of	 its	
neighbours	by	20	bases.		
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To	perform	the	recursive	PCR	the	overlapping	oligonucleotides	(0.5	µM	final	concentration)	
were	 added	 to	 10	 x	 reaction	 buffer	 (5	 μL,	 Stratagene),	 dNTPs	 (0.2	 mM	 of	 each	 final	
concentration),	sterile	deionised	distilled	water	and	Pfu	Turbo	DNA	polymerase	(1	μL	of	2.5	
U	 μL-1	 –Stratagene)	 to	 give	 a	 total	 reaction	 volume	 of	 50	 µL	 in	 a	 sterile	 PCR	 tube.	 The	
recursive	 PCR	 was	 carried	 out	 starting	 with	 95	 °C	 of	 initial	 denaturation	 for	 2	 minutes,	
followed	 by	 a	 cycle	 repeated	 25	 times:	 denaturation	 at	 95	 °C	 for	 30	 seconds,	 annealing	
temperature	 of	 52	 °C	 for	 30	 seconds,	 elongation	 at	 72	 °C	 for	 30	 seconds,	 and	 finally	 10	
minutes	of	extension	at	72	°C	in	a	thermal	cycler.	2.1.1.1.1 Agarose	Gel	Electrophoresis	
0.75	g	of	Molecular	Biology	grade	agarose	(Fisher,	UK)	was	added	to	50	ml	of	1	x	TBE	buffer	
(Tris-Borate-EDTA	buffer	-	90	mM	Boric	acid,	2	mM	EDTA,	90	mM	Tris-HCl,	pH	8.0)	in	a	100	
ml	 conical	 flask.	 The	 mixture	 in	 the	 conical	 flask	 was	 then	 heated	 in	 the	 laboratory’s	
microwave	oven	to	prepare	a	1.5	%	w/v	agarose	gel.	Ethidium	bromide	was	then	added	to	
the	molten	agarose	(final	concentration	0.5	µg	ml-1).	The	complete	mix	was	added	to	the	gel	
mould	and	left	to	set.	DNA	samples	were	prepared	by	adding	1	µL	of	6x	gel	loading	buffer	
(0.25%	Bromophenol	Blue,	0.25%	Xylene	cyanol	FF,	15%	Ficoll)	to	5	µL	of	DNA	preparation.	
The	 gel	 loading	 buffer	 contains	 bromophenol	 blue	 dye,	 which	 helps	 increase	 the	 DNA	
sample’s	density	allowing	it	to	fall	 into	the	well	of	the	gel	and	provides	a	visible	marker	to	
monitor	the	progress	of	electrophoresis.	Once	the	gel	was	set,	it	was	submerged	in	1	x	TBE	
buffer	and	loaded	with	DNA	samples	and	100	bp	DNA	ladder	(0.5	µg	of	100	bp	DNA	ladder	
diluted	in	loading	buffer	–	NEB)	for	detecting	the	band	of	500	bp	LcrH	gene.	The	100	bp	DNA	
ladder	 contains	 standard	 molecular	 size	 marker	 ranging	 from	 100-1,517	 bp.	 Agarose	 gel	
electrophoresis	 was	 performed	 in	 an	 electrophoresis	 tank	 (BIORAD,	 UK)	 by	 applying	 a	
current	of	35	mA	and	voltage	of	70	volts.	DNA	 is	negatively	charged	at	pH	8.0,	hence	 the	
application	 of	 an	 electric	 current	 caused	 migration	 of	 DNA	 towards	 the	 anode.	 DNA	
fragments	migrate	through	the	matrix	of	agarose	gel	at	rates	that	are	inversely	proportional	
to	the	log10	of	the	molecular	weight	of	DNA.		
2.1.1.2 Polymerase	Chain	Reaction	(PCR)	
In	order	to	extract	a	full	length	LcrH	gene	(fl-LcrH)	with	restriction	sites	for	further	cloning,	a	
conventional	 PCR	 was	 performed	 using	 the	 recursive	 PCR	 product	 as	 template.	
Oligonucleotides	 were	 designed	 to	 match	 the	 termini	 of	 fl-LcrH	 (coding	 and	 non-coding	
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strands)	with	melting	temperatures	(Tm)	of	≈	70	°C.	The	coding	oligonucleotide	incorporated	
a	 BamHI	 and	 the	 non-coding	 oligonucleotide	 incorporated	HindIII	 restriction	 site	 at	 their	
ends.	The	reverse	oligonucleotide	also	incorporated	a	stop	codon	after	the	gene	sequence,	
but	 before	 the	 HindIII	 restriction	 site.	 The	 designed	 sequences	 were	 synthesized	 by	
Integrated	DNA	Technologies,	Belgium	and	supplied	in	lyophilised	form.	They	were	dissolved	
in	ddH20	to	give	a	stock	concentration	of	50	µM.	
To	perform	the	PCR	the	oligonucleotides	(0.5	µM	final	concentration	of	each)	were	added	to	
the	recursive	PCR	product	(2	μL),	10	x	reaction	buffer	(5	μL,	Stratagene),	dNTPs	(0.2	mM	of	
each	final	concentration),	sterile	deionised	distilled	water	and	Pfu	Turbo	DNA	polymerase	(1	
μL	of	2.5	U	μL-1	–Stratagene)	to	give	a	total	reaction	volume	of	50	µL	in	a	sterile	PCR	tube.	
The	PCR	was	carried	out	starting	with	95	°C	of	initial	denaturation	for	2	minutes,	followed	by	
a	cycle	repeated	25	times:	denaturation	at	95	°C	for	30	seconds,	annealing	temperature	of	
52	°C	for	30	seconds,	elongation	at	72	°C	for	30	seconds,	and	finally	10	minutes	of	extension	
at	72	 °C	 in	a	 thermal	cycler.	As	before,	on	completion	of	 the	PCR,	 the	entire	PCR	product	
was	 run	on	a	1.5	%	agarose	 gel	 to	 confirm	 the	 success	of	 the	 reaction	 (Section	2.1.1.1.1)	
showed	a	clear	band	of	DNA	at	~	500	base	pairs.	 	The	correct	sized	DNA	was	excised	from	
the	gel	and	purified	(Section	2.1.3.2).		
	
2.1.2 Insertion	of	synthesised	LcrH	gene	into	a	cloning	vector	
The	 newly	 synthesized	 fl-LcrH	gene	was	 first	 incorporated	 into	 a	 cloning	 vector	 using	 the	
following	strategy.	
2.1.2.1 Cloning	of	l-LcrH	gene	into	TOPO	TA	cloning	vector	2.1.2.1.1 Poly-A	tailing	with	Taq	polymerase		
1	 unit	 of	 Taq	 polymerase	 was	 added	 to	 the	 PCR	 reaction	 from	 Section	 2.1.1.2	 and	 was	
incubated	for	8-10	minutes	(no	cycle)	at	72°C	in	a	thermal	cycler.	This	 introduced	a	poly-A	
tail	 (‘A’	 overhangs)	 of	 the	 3’	 end	 of	 DNA	 which	 complements	 the	 ‘T’-overhangs	 already	
present	 in	the	pCR®2.1-TOPO®	vector	(InvitrogenTM).	This	enables	the	 incorporation	of	the	
PCR	product	into	the	cloning	vector	for	which	the	map	is	shown	in	Figure	2.2.	
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Figure	2.2	pCR2.1-TOPO	cloning	vector	contains	a	number	of	features	for	efficient	subcloning.	The	vector	is	
supplied	as	a	linearized	vector	containing	T	overhangs	for	direct	ligation	of	Taq-amplified	PCR	products.	The	
T7	 promoter	 and	 M13	 forward	 and	 reverse	 primer	 sites	 are	 present	 for	 in	 vitro	 RNA	 transcription	 and	
sequencing.	EcoR	I	sites	flank	the	PCR	product	insertion	site	for	easy	excision	of	inserts.	The	presence	of	lac	
promoter	and	operator	allows	for	easy	blue/white	colony	screening	on	X-Gal-IPTG	agar	plates.	Kanamycin	
and	ampicillin	resistant	sites	 in	the	vector	allow	for	the	choice	of	selection	in	E.	coli.	 	The	vector	map	was	
produced	using	SnapGene	Viewer	1.5.3.		
	2.1.2.1.2 Ligation	for	TOPO	TA	cloning	
The	ligation	reaction	was	performed	using	3	µL	of	the	poly-A	extended	fl-LcrH	PCR	product,	
2	µL	of	pCR®2.1-TOPO®	vector,	1	µL	of	T4	DNA	ligase	(NEB,	UK),	1	µL	of	T4	DNA	ligase	10	x	
reaction	buffer,	3	µL	of	sterile	deionised	distilled	water	to	give	total	reaction	volume	of	10	
µL.	The	reaction	mixture	was	incubated	at	14	°C	for	4	hours.	2.1.2.1.3 Transformation	of	Ligated	fl-LcrH	in	chemically	competent	cells	
The	chemically	competent	cells	used	for	the	transformation	of	the	fl-LcrH	gene	cloned	in	the	
TOPO	TA	cloning	vector	was	One	Shot®	TOP10	E.	coli	cells	(InvitrogenTM).		
One	Shot®	TOP10	Genotype:		
F-	mcrA	Δ(	mrr-hsdRMS-mcrBC)	Φ80lacZΔM15	Δ	lacX74	recA1	araD139	Δ(araleu)7697	galU		
galK	rpsL	(StrR)	endA1	nupG	
2	µL	of	the	ligation	mixture	was	added	to	50	µL	of	One	Shot®	TOP10	E.	coli	cells	in	a	sterile	
microcentrifuge	 tube	 and	 allowed	 to	 incubate	 on	 ice	 for	 30	 minutes.	 	 The	 mixture	 was	
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incubated	at	42	°C	in	a	water	bath	for	30	seconds	and	placed	on	ice	for	2	minutes.	250	µL	of	
LB	media	was	added	to	the	transformed	cells	and	incubated	on	a	shaker	(250	RPM)	at	37	°C	
for	one	hour.		After	incubation,	the	cells	were	centrifuged	at	6,000	RPM	for	2	minutes;	the	
supernatant	was	discarded	 leaving	approximately	100	µL	of	LB	media.	 	The	cell	pellet	was	
resuspended	and	plated	on	LB	agar	plate	containing	25	µg/mL	of	Kanamycin,	20	µg/ml	of	X-
Gal	and	0.2	mg/ml	of	IPTG	for	blue/white	colony	screening.		The	plate	was	left	to	incubate	
at	37	 °C	overnight	and	checked	 the	next	morning.	 	White	colonies	 represented	 the	E.	coli	
cells	that	contained	the	fl-LcrH	gene	incorporated	into	the	TOPO	TA	cloning	vector.	2.1.2.1.4 DNA	extraction	and	purification		
Representative	white	colonies	were	picked	using	sterile	toothpicks,	and	used	to	inoculate	5	
ml	of	sterile	LB	broth	containing	50	µg/ml	of	Kanamycin.		This	was	incubated	at	37	°C	for	14-
16	hours	on	a	shaker	(250	RPM).		Small-scale	isolation	of	plasmid	DNA	from	these	bacterial	
colonies	 was	 then	 performed	 (known	 as	 minipreparation	 of	 plasmid	 DNA	 (plasmid	
miniprep)).		This	process	is	based	on	the	alkaline	lysis	method	for	extraction	of	plasmid	DNA	
from	 a	 relatively	 small	 volume	 of	 bacteria	 and	 was	 performed	 using	 a	 QIAprep	 Spin	
Miniprep	Kit	(QIAGEN	Ltd.).		The	plasmid	miniprep	was	carried	out	using	the	manufacturer’s	
instructions.		2.1.2.1.5 Estimation	of	DNA	concentration	
Plasmid	 DNA	 samples	 obtained	 from	 the	 plasmid	 miniprep	 method	 were	 diluted	 using	
ddH2O	 for	 measurement	 of	 DNA	 concentration.	 	 A	 Shimadzu	 UV-1601	 UV-VIS	 Scanning	
spectrophotometer	was	baselined	using	ddH2O	as	blank	sample.	100	µL	of	the	diluted	DNA	
sample	was	added	to	a	quartz	cuvette	and	a	spectrum	was	measured	from	350	to	220	nm.	
Three	 differing	 dilutions	 for	 a	 given	DNA	 sample	were	 prepared	 and	 an	 average	 of	 three	
measured	spectra	was	taken	for	ensuring	accurate	DNA	concentration	measurement.		DNA	
absorbs	at	260	nm,	hence	this	wavelength	was	used	to	determine	the	amount	of	DNA.	The	
following	Equation	2.1	was	used	to	measure	the	concentration	of	DNA:	
Equation	2.1	 𝑫𝑵𝑨 𝒄𝒐𝒏𝒄𝒆𝒏𝒕𝒓𝒂𝒕𝒊𝒐𝒏 = 𝑨𝟐𝟔𝟎 𝒏𝒎 ×𝒅𝒊𝒍𝒖𝒕𝒊𝒐𝒏 𝒇𝒂𝒄𝒕𝒐𝒓×𝒄𝒐𝒏𝒗𝒆𝒓𝒔𝒊𝒐𝒏 𝒇𝒂𝒄𝒕𝒐𝒓	
where,	 A260nm	 denotes	 the	 absorbance	 at	 260	 nm;	 conversion	 factor	 is	 50	 since	 an	
absorbance	 at	 260	 nm	 of	 1.0	 corresponds	 to	 50	 ng	 ml-1	 of	 double	 stranded	 DNA,	 the	
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resultant	DNA	concentration	 is	measured	 in	ng	ml-1.	A260nm	 to	A280nm	 ratio	of	1.6	or	above	
indicated	pure,	contamination	free	DNA	sample.		2.1.2.1.6 Analytical	Restriction	Digestion	with	EcoRI	
The	fl-LcrH	gene	would	be	 incorporated	between	EcoRI	sites	 in	the	pCR®2.1-TOPO®	vector	
on	 successful	 ligation	 (the	 EcoRI	 sites	 flank	 the	 PCR	 product	 insertion	 site	 in	 the	 vector).	
Hence,	 the	 purified	 plasmid	 miniprep	 DNA	 samples	 were	 digested	 with	 EcoRI	 restriction	
enzyme	to	confirm	positive	clones.	The	digestion	was	carried	out	using	8	µL	of	plasmid	DNA,	
0.5	µL	of	EcoRI	restriction	enzyme	(NEB,	UK),	0.5	µL	of	sterile	deionised	distilled	water,	and	1	
µL	 of	 NEB	 buffer	 2	 to	 give	 a	 total	 reaction	 volume	 of	 10	 µL.	 The	 reaction	 mixture	 was	
incubated	at	37	°C	for	3	hours.	The	digested	bands	were	visualized	on	a	1.5	%	agarose	gel	
(Section	 2.1.1.1.1).	 Presumptive	 positive	 clones	 were	 sent	 for	 DNA	 sequencing	 (Section	
2.1.2.1.7)	and	sequenced	using	M13	reverse	primer.		2.1.2.1.7 DNA	sequencing	
DNA	samples	each	with	a	volume	of	15	µL	of	miniprep	DNA	at	a	concentration	of	100	ng	µL-1	
were	 prepared	 in	 labelled	 microcentrifuge	 tube	 and	 sent	 with	 the	 correct	 sequencing	
primer.	 DNA	 sequencing	 was	 carried	 out	 by	 Lark	 Technologies,	 Essex,	 UK	 (now	 Beckman	
Coulter	Genomics	Ltd).	The	resultant	DNA	chromatograms	were	viewed	and	analyzed	using	
ChromasPro	software	version	1.34	(Technelysium	Pty	Ltd.).		
2.1.3 Insertion	of	synthesised	fl-LcrH	gene	into	an	expression	vector	
Two	 expression	 vectors	 were	 used	 for	 expressing	 fl-LcrH.	 	 These	 were	 pProEX-HTb	
(Invitrogen)	and	pTrc-GST	(designed	vector	obtained	from	Prof.	A.R.	Fersht	and	based	on	the	
pRSETA	 vector,	 Life	 Technologies).	 	 These	 are	 shown	 in	 Figure	 2.3.	 The	 fl-LcrH	 gene	was	
inserted	into	these	vectors	between	the	restriction	sites	BamHI	and	HindIII.	
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Figure	2.3:	pProEX-HTb	(a)	and	pTrc-GST	(b)	vectors.	The	vectors	contain	a	number	of	features	including,	an	
ampicillin	resistance	gene	(shown	in	green	colour)	that	permits	the	selection	of	cells	carrying	the	expression	
vector	and	multiple	cloning	site	 (MCS)	shown	 in	orange.	 	The	Trc	promoter	sequence	contains	part	of	 the	
tryptophan	promoter,	part	of	the	lactose	promoter	and	the	lactose	repressor	gene,	thus	allowing	high	level	
of	expression	when	induced	with	isopropyl	β-D-1-thiogalactopyranoside	(IPTG).	Vector	maps	were	produced	
using	SnapGene	viewer	version	1.5.2.	
	
2.1.3.1 Restriction	digest	of	fl-LcrH	gene	
Fl-LcrH	 in	the	TOPO	vector	and	each	expression	vector	were	digested	separately	using	the	
restriction	 enzymes	 BamHI	 and	 HindIII.	 	 Due	 to	 the	 star	 activity	 of	 BamH1	 a	 sequential	
restriction	 digestion	was	 carried	 out.	 	 16	 µL	 of	 gel	 purified	DNA	 (PCR	 product	 or	 plasmid	
vector	 DNA),	 2	 µL	 of	 NEB	 buffer	 2	 (NEB),	 1	 µL	 of	 HindIII	 restriction	 enzyme	 (NEB),	 and	
incubated	for	3	hours	at	37	°C.	The	HindIII	was	then	heat	deactivation	by	incubating	at	65	°C	
for	20	minutes	and	subsequently	placed	on	ice.	0.4	µL	of	NaCl	(5mM	stock	solution	NEB),	0.2	
µL	of	BSA	(1	x	final	concentration	from	100	X	stock	solution,	NEB),	1	µL	of	BamHI	restriction	
enzyme	 (NEB),	 0.4	 µL	 of	 sterile	 ddH2O	was	 added	 to	 the	 reaction	mixture	 to	 give	 a	 total	
volume	of	20	µL	and	incubated	for	3	hours	at	37	°C.		BamHI	was	deactivated	by	heating	the	
reaction	mixture	at	65	°C	for	20	minutes.		The	digested	DNA	samples	were	visualized	on	1.5	
%	 agarose	 gel	 (Section	 2.1.1.1.1)	 and	 DNA	 bands	 of	 correct	 size	 were	 excised	 and	 gel	
purified	as	below.		
	
(b)	(a)	
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2.1.3.2 Purification	of	DNA	from	an	Agarose	Gel	
The	correct	sized	DNA	band	visualized	on	agarose	gel	was	excised	and	placed	in	a	PCR	tube	
(the	PCR	tube	was	punctured	with	a	hole	at	the	bottom	and	filled	with	glass	wool),	and	was	
placed	into	a	microcentrifuge	tube.		The	lid	of	the	microcentrifuge	tube	was	punctured	and	
the	 PCR	 tube	 containing	 the	 excised	 gel	 was	 inserted	 to	 fit	 tightly	 at	 the	 top.	 	 This	 was	
centrifuged	for	10	minutes	at	13,000	RPM	to	separate	the	DNA	from	the	gel.	 	The	gel	was	
held	 on	 the	 glass	 wool	 with	 the	 DNA	 in	 solution	 collected	 at	 the	 bottom	 of	 the	
microcentrifuge	tube.		This	DNA	was	then	purified	from	this	solution	via	DNA	precipitation	
using	the	Pellet	Paint	Co-Precipitant	(Novagen)	as	per	the	manufacturer’s	instructions.		The	
DNA	was	then	re-solubilised	in	20	µL	of	sterile	ddH2O.	
2.1.3.3 Ligation	
The	gel	purified	digested	 insert	and	vector	were	 ligated	 in	a	ratio	of	3:1	 (insert:	vector)	 in	
terms	of	 volume.	 	 The	 ligation	 reaction	was	performed	by	adding	6	µL	of	 the	gel	purified	
insert,	2	µL	of	the	digested	vector	DNA,	0.5	µL	of	sterile	ddH2O,	1	µL	of	T4	DNA	ligase	10	x	
reaction	buffer	(NEB,	UK),	0.5	µL	of	T4	DNA	ligase	(NEB,	UK)	to	give	a	total	reaction	volume	
of	 10	 µL.	 	 The	 reaction	 mixture	 was	 incubated	 at	 4	 °C	 for	 14-16	 hours.	 	 The	 ligase	 was	
deactivated	by	incubating	the	reaction	mixture	at	65	°C	for	20	minutes	
2.1.3.4 	Transformation	using	Electro-competent	cells	
The	 ligation	 mixture	 was	 transformed	 in	 electrocompetent	 XL1-Blue	 E.	 coli	 cells	 (Agilent	
Technologies).	 	 The	 XL1-Blue	 strain	 of	 E.	 coli	 allows	 blue-white	 colour	 screening	 for	
recombinant	 plasmids,	 is	 an	 excellent	 host	 strain	 for	 routine	 cloning	 applications	 using	
plasmid	or	lambda	vectors	and	helps	in	preparation	of	high	quality	plasmid	DNA.		
XL1-Blue	Genotype:		
recA1	endA1	gyrA96	thi-1	hsdR17	supE44	relA1	lac	[F´	proAB	lacIq	Z∆M15	Tn10	(Tetr)]		
(Genes	listed	signify	mutant	alleles.	Genes	on	the	F´	episome,	however,	are	wild	type	unless	
indicated	otherwise).	
In	order	to	perform	transformation,	1	µL	of	the	ligation	mixture	was	added	to	30	µL	of	XL1-	
Blue	 cells	 (in	 10	 %	 glycerol),	 mixed	 well	 and	 added	 to	 0.2	 cm	 electroporation	 cuvette	
(BIORAD).		The	cuvette	was	placed	into	the	chamber	slide	and	electroporated	using	the	Bio-
Rad	MicropulserTM.	 	 A	 pre-programmed	 electroporation	 setting	 called	 EC2	 (voltage	 of	 2.5	
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kV)	was	used,	as	this	was	the	manufacturer’s	recommended	setting.		A	voltage	delivery	time	
of	approximately	5	milliseconds	after	pulsing	was	an	 indicator	of	efficient	electroporation.		
Once	 pulsed,	 1	 ml	 of	 LB	 broth	 was	 immediately	 added	 to	 the	 sample	 and	 the	 mixture	
incubated	at	37	°C	for	1	hr.	The	culture	produced	from	the	transformation	was	plated	out	(≈	
50	 µL)	 onto	 LB-Agar	 plates	 containing	 ampicillin	 (100	 µg	 ml-1	 final	 concentration)	 and	
incubated	 overnight	 at	 37	 °C.	 Single	 bacterial	 colonies	 were	 picked	 the	 following	 day,	
inoculated	 in	5	ml	LB	broth	containing	100	µg	ml-1	ampicillin	and	 incubated	at	37	 °C	on	a	
shaker	(250	RPM)	for	14-16	hours.		
2.1.3.5 Confirmation	of	DNA	Clones	
To	 determine	whether	 the	 ligation	 had	 been	 successful,	 the	 isolated	DNA	was	 restriction	
digested	(Section	2.1.3.1,	except	the	reaction	volume	was	10	µL)	and	run	on	a	1.5	%	agarose	
gel	(Section	2.1.1.1.1).		A	positive	result	showed	a	DNA	band	that	corresponded	to	the	size	
of	the	LcrH	gene	(500	bases).	The	DNA	that	produced	positive	restriction	digests	were	then	
sent	for	DNA	sequencing	(Section	2.1.2.1.7).	
	
2.1.4 Synthesis	&	 insertion	of	 truncated	LcrH	 (tr-LcrH)	 gene	 in	 into	pTrc-
GST	vector	
The	shortened	version,	tr-LcrH	was	synthesized	by	performing	a	conventional	PCR	using	fl-
LcrH	 in	 pProEXHTb	 vector	 as	 a	 template.	 Oligonucleotides	 were	 designed	 to	 match	 the	
termini	of	tr-LcrH	(coding	and	non-coding	strands)	with	melting	temperatures	(Tm)	of	67–74	
°C.	 The	 coding	 oligonucleotide	 incorporated	 a	BamHI	 and	 the	 non-coding	 oligonucleotide	
incorporated	 HindIII	 restriction	 site	 at	 their	 ends.	 The	 reverse	 oligonucleotide	 also	
incorporated	a	stop	codon	after	the	gene	sequence,	but	before	the	HindIII	 restriction	site.	
The	designed	sequences	were	synthesized	by	Integrated	DNA	Technologies	Inc.	and	supplied	
in	 lyophilised	 form.	They	were	dissolved	 in	ddH20	to	give	a	stock	concentration	of	50	µM.	
The	PCR	reaction	was	performed	and	success	confirmed	as	described	in	Section	2.1.1.2.	
The	correctly	sized	tr-LcrH	PCR	product	was	then	incorporated	into	the	pTrc-GST	vector	by	a	
simple	 restriction	 digest	 of	 vector	 and	 gene,	 followed	 by	 DNA	 extraction,	 ligation	 and	
transformation	 (Section	 2.1.2.1.3).	 The	 success	 was	 confirmed	 with	 analytical	 restriction	
digest	and	DNA	sequencing	(Section	2.1.3.5).	
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2.1.5 Synthesis	of	LE65	mutant	of	tr-LcrH	
In	 order	 to	 create	 the	 monomeric	 L65E	 LcrH	 construct,	 site	 directed	 mutagenesis	 was	
performed	on	the	pTrc-GST	expression	vector	containing	the	tr-LcrH	gene.	A	point	mutation	
was	 carried	 out	 in	 the	 tr-LcrH	 gene,	 where	 the	 65th	 amino	 acid	 Leucine	 was	mutated	 to	
Glutamic	acid.	 	Oligonucleotides	 for	 the	coding	and	non-coding	 strand	 spanning	 the	point	
mutation	site	in	tr-LcrH	were	synthesized	(Integrated	DNA	Technologies,	Inc.)	with	Tm	of	78	
°C.	 	 Site	 directed	 mutagenesis	 PCR	 was	 performed	 using	 the	 QuikChange®	 Site-Directed	
Mutagenesis	 Kit	 (Stratagene).	 	 The	 formula	 commonly	 used	 for	 estimating	 the	 Tm	 for	 the	
oligonucleotides	 is	 shown	 in	 Equation	 2.2	 (QuikChange®	 Site-Directed	 Mutagenesis	 kit	
instruction	manual)		
Equation	2.2	 𝑇! = 81.5+ 0.41 % 𝐺𝐶 − 675𝑁 −% 𝑚𝑖𝑠𝑚𝑎𝑡𝑐ℎ	
For	 calculating	 Tm:	N	 is	 the	 primer	 length	 in	 bases,	 values	 for	%	GC	 and	%	mismatch	 are	
whole	numbers.	
2.1.5.1 Site	Directed	Mutagenesis	
Site	 directed	mutagenesis	was	 carried	 out	 using	 1.25	 µL	 each	 of	 oligonucleotides	 for	 the	
coding	 and	non-coding	 strand	 (125	ng	 each),	 2	µL	 of	 template	 (10	ng	of	 tr-LcrH-pTrc-GST	
plasmid	vector),	5	µL	of	10	x	reaction	buffer	(Stratagene),	1	µL	of	dNTPs	(10mM	mix),	38.5	
µL	of	ddH2O	and	1	μL	of	Pfu	 turbo	DNA	polymerase	(2.5	U/μL	–Stratagene)	to	give	a	total	
reaction	volume	of	50	µL	in	a	sterile	PCR	tube.		
The	 mutagenesis	 PCR	 was	 performed	 starting	 with	 95	 °C	 of	 initial	 denaturation	 for	 30	
seconds,	 followed	 by	 a	 cycle	 repeated	 18	 times:	 denaturation	 at	 95	 °C	 for	 30	 seconds,	
annealing	temperature	of	55	°C	for	30	seconds,	elongation	at	68	°C	for	5	minutes	30	seconds	
(1	minute	per	kb	of	plasmid	length)	and	finally	5	minutes	of	extension	at	68	°C	in	a	thermal	
cycler.	1	µL	of	DpnI	 restriction	enzyme	(10	U/µL)	was	added	to	 the	reaction	mixture	after	
the	completion	of	PCR,	thoroughly	mixed,	spun	down	in	a	microcentrifuge	tube	for	1	minute	
and	 incubated	 at	 37	 °C	 for	 1	 hour.	 This	 DNA	 was	 used	 to	 transform	 XL1-Blue	
electrocompetent	cells	(Section	2.1.3.4).	Colonies	were	picked	for	growing	bacterial	cultures	
overnight,	 followed	 by	 isolation	 and	 purification	 of	 plasmid	 DNA	 (Section	 2.1.3.2).	 The	
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plasmid	 DNA	 samples	 were	 subjected	 to	 analytical	 restriction	 digestion	 with	 BamHI	 and	
HindIII	(Section	2.1.3.1)	except	that	the	reaction	volume	was	10	µL.	The	restriction	digestion	
was	analysed	on	a	1.5	%	agarose	gel.	DNA	samples	showing	 the	correct	sized	bands	were	
selected,	sent	for	DNA	sequencing	(Section	2.1.2.1.7)	and	sequencing	was	carried	out	using	
pTrc-His	reverse	primer.		
	
2.2 Protein	Production	and	Purification	
LcrH	proteins	 fl-LcrH,	 tr-LcrH	and	monomeric	L65E	LcrH	were	produced	using	the	protocol	
described	below.		
2.2.1	Protein	Production		
BL21	C41	(DE3)	Electrocompetent	strain	of	E.	coli	cells	were	transformed	(Section	2.1.2.1.3)	
with	 expression	 plasmid	 vectors	 pTrc-GST	 and	 pProEX-HTb,	 both	 carrying	 the	 LcrH	 gene	
respectively.	 BL21	 C41(DE3)	 cells	 are	 E.	 coli	 strains	 that	 are	 effective	 in	 expressing	 toxic	
proteins	 from	 all	 classes	 of	 organisms,	 including	 bacteria,	 yeast,	 plant,	 viruses,	 and	
mammals.	The	C41	strains	contain	genetic	mutations	phenotypically	selected	for	conferring	
tolerance	 to	 toxic	proteins.	The	strain	C41	 (DE3)	was	derived	 from	BL21	 (DE3).	This	 strain	
has	 a	mutation	 that	 reduces	 the	 level	 of	 T7	 RNAP	 activity,	 thereby	 preventing	 cell	 death	
associated	with	overexpression	of	many	recombinant	toxic	proteins	[178-181].		
BL21	C41	(DE3)	Genotype:	F	–	ompT	hsdSB	(rB
–	mB–)	gal	dcm	(DE3)	
Single	 colonies	 containing	 the	 LcrH	 gene	were	 picked	 and	 grown	 in	 10	ml	 of	 LB	medium	
containing	final	concentration	of	50	µg/ml	ampicillin	overnight	at	37	°C	on	a	shaker.		The	10	
ml	overnight	grown	bacterial	culture	was	used	to	inoculate	1L	of	2	x	YT	+	ampicillin	in	a	2L	
flask	and	was	grown	at	37	°C	with	constant	shaking	at	200	RPM	until	the	absorption	of	the	
cells	at	600	nm	(A600)	reached	0.6	–	1.0	(≈	3	–	4	hours).		The	absorption	was	monitored	using	
a	 UV-2401PC	 UV-Vis	 recording	 spectrophotometer.	 	 Isopropyl-thio-β-D-galactopyranoside	
(IPTG)	 (Melford	 Laboratories	 Ltd.,	 UK)	 was	 added	 to	 a	 final	 concentration	 of	 0.1	 mM	 to	
induce	 protein	 expression.	 	 The	 temperature	 was	 lowered	 to	 18	 °C	 for	 improving	 the	
stability	 and	 solubility	 of	 the	 protein	 undergoing	 expression	 and	 placed	 on	 the	 shaker	
overnight	 (200	 RPM).	 	 The	 cells	 were	 harvested	 after	 16-18	 hours	 post	 induction	 in	 a	
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Beckman	Avanti	J-30I	centrifuge	and	using	the	JLA	9.1000	rotor	for	10	minutes	at	4,000	x	g	
at	4	°C.		
2.2.1.1 Cell	Lysis	for	Protein	Extraction	2.2.1.1.1 Cell	Lysis	by	Sonication	
The	harvested	bacterial	cell	pellet	was	resuspended	in	40	ml	of	ice-cold	1x	PBS	containing	10	
%	glycerol.		The	cells	were	lysed	by	sonication	using	a	Sonics	Vibracell	Ultrasonic	Processor	
(Sonics	&	Materials	Inc.).		The	mixture	was	retained	on	ice,	whilst	6	cycles	of	15	seconds	on,	
45	seconds	off,	with	an	output	of	30	volts	were	applied,	until	the	cell	mixture	became	non-
viscous	and	darker	in	colour.		The	cell	debris	was	then	removed	by	centrifugation	at	33,000	
x	g	in	Beckman	Avanti	J-30I	centrifuge,	in	a	JA-30.50	rotor	for	1	hour	at	4	°C.		2.2.1.1.2 Cell	Lysis	by	Homogenisation	
The	suspension	of	harvested	bacterial	cells	in	ice	cold	1X	PBS	with	10	%	glycerol,	5	mM	DTT	
was	 filtered	 through	 a	 sieve	 and	 poured	 into	 the	 inlet	 of	 high	 pressure	 homogenizer	
Emulsiflex-C3	(Avestin	Inc.,	Canada).		The	cell	lysis	was	carried	out	under	pressure	of	20,000	
lb/in2	with	nitrogen	gas	according	to	the	manufacturer’s	instructions.		The	cells	were	lysed	
by	 two	 passages	 through	 the	 Emulsiflex-C3	 until	 the	 lysate	 became	 non-viscous	 and	
homogenous.	 	 The	cell	 lysate	was	 then	centrifuged	at	33,000	x	 g	 for	1	hour	at	4	 °C	using	
Beckman-Coulter	JA-30.50	rotor.		
	
2.2.1.2 Purification	by	Affinity	Chromatography		
The	supernatant	protein	extracted	after	cell	lysis	and	subsequent	centrifugation	was	filtered	
through	a	0.2	µm	syringe	filter	(Sartorius	Stedim	Biotech	GmbH,	Germany)	and	subjected	to	
affinity	purification.	 	Affinity	purification	of	LcrH	proteins	was	carried	out	by	two	methods	
depending	on	the	expression	plasmid	used	for	protein	production	 i.e.	pProEX	HTb	plasmid	
containing	 the	 fl-LcrH	 gene	 produced	 a	 hexahistidine	 tagged	 protein	 whereas	 pTrc-GST	
plasmid	produced	GST	tagged	proteins:		
1)	Ni2+	affinity	chromatography	–	pProEX	HTb	plasmid	containing	the	fl-LcrH	gene	produced	
a	hexahistidine-tagged	fl-LcrH	protein.	His-tagged	fl-LcrH	protein	was	purified	by	using	Ni2+	
charged	 column	 packed	with	 Iminodiacetic	 acid	 agarose	 resin	 (Sigma,	 UK).	 The	 resin	was	
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charged	with	Ni2+	by	passing	2	column	volumes	of	100	mM	NiSO4	and	the	unbound	NiSO4	
was	removed	with	a	column	volume	of	1x	PBS.	
2)	GST-affinity	chromatography	was	used	to	purify	fl-LcrH,	tr-LcrH	and	monomeric	L65E	LcrH	
proteins	 produced	 from	 pTrc-GST	 vector	 containing	 the	 respective	 genes.	 	 GST-tagged	
proteins	were	purified	by	using	a	column	packed	with	glutathione	agarose	resin	called	Super	
Glu	–	Glutathione	Superflow	(Generon,	UK).	
2.2.1.3 		Buffer	Solutions	
All	 buffer	 solutions	 were	 made	 with	 deionised	 distilled	 H2O	 (resistance	 of	 18.2	 Ω)	 and	
vacuum	 filtered	 using	 0.2	 µm	membrane	 filter	 (Whatman)	 prior	 to	 usage.	 The	 names	 of	
buffers	and	their	respective	compositions	are	shown	in	Table	2.1.		
Table	2.1:	Buffer	solutions	and	their	compositions	
Name	of	buffer	 Buffer	composition		
His-tag	Wash	
buffer	
	
1x	PBS	(137	mM	NaCl,	10	mM	phosphate,	2.7	mM	KCl),	pH	7.4	
	 	 	
His-tag	Elution	
buffer	
	 50	mM	phosphate,	150	mM	NaCl,	
250	mM	Imidazole,	pH	7.0	
	 	 	
GST	Wash	buffer	 	 20	mM	phosphate,	150	mM	NaCl,	pH	7.2,	5	mM	DTT	
	 	 	
GST	Elution	
buffer	
	 20	mM	phosphate,	150	mM	NaCl,	10	mM	reduced	glutathione,	pH	
7.2,	5mM	DTT	
2.2.1.4 Ni2+	Affinity	chromatography	and	cleavage	of	His-tagged	proteins	
The	filtered	supernatant	was	loaded	onto	a	Ni2+	affinity	column	pre-equilibrated	with	his-tag	
wash	buffer.	After	passing	the	supernatant	protein	through	the	Ni2+	affinity	column	(column	
volume	=	10	ml),	it	was	washed	with	20	column	volumes	of	his-tag	wash	buffer.	The	protein	
was	eluted	with	his-tag	elution	buffer.	After	elution,	the	column	was	washed	with	2	column	
volumes	of	6	M	GdmHCl	to	unfold	any	residual	protein	bound	to	the	column.	The	column	
70	
	
	 	
was	then	washed	with	5	column	volumes	of	ddH2O,	followed	by	2	column	volumes	of	20	%	
ethanol	and	stored	at	4	°C.		The	eluted	protein	was	cleaved	overnight	at	25	°C	by	addition	of	
TEV	protease	to	remove	the	fused	N-terminal	His-tag.	The	affinity	purification	and	cleavage	
of	LcrH	was	monitored	by	visualisation	on	SDS-PAGE	(Section	2.2.2.2).	
2.2.1.5 GST	Affinity	purification	and	cleavage	of	GST-tagged	proteins	
The	filtered	supernatant	was	loaded	onto	the	GST	affinity	column	(column	volume	=	10	ml)	
and	washed	with	 20	 column	 volumes	 of	GST	wash	 buffer.	 LcrH	 –	GST	 fusion	 protein	was	
cleaved	on	 the	 resin	overnight	at	25	 °C	by	addition	of	 thrombin	protease	 (GE	Healthcare,	
UK).	The	cleaved	LcrH	was	eluted	as	a	flow	through	in	the	GST	wash	buffer.	The	bound	GST-
tag	was	removed	from	the	column	by	the	addition	of	GST	elution	buffer.	The	column	was	
subsequently	washed	with	two	column	volumes	of	6	M	GdmHCl	to	unfold	and	remove	any	
residual	proteins	bound	to	the	column.	The	column	was	immediately	washed	with	5	column	
volumes	of	ddH2O,	followed	by	2	column	volumes	of	20	%	ethanol	and	stored	at	4	°C.	
2.2.1.6 Purification	using	Size	Exclusion	Chromatography	by	AKTA	FPLC	
The	 final	 step	 in	 the	 purification	 used	 size	 exclusion	 chromatography	 using	 AKTA	 FPLC	
system	(GE	Healthcare)	by	loading	the	cleaved	LcrH	protein	fractions	onto	a	HiLoadTM	16/60	
SuperdexTM	200	gel	filtration	column	(GE	Healthcare,	UK)	with	a	bed	volume	of	120	ml.	The	
column	was	equilibrated	with	180	ml	of	50	mM	phosphate	buffer,	5	mM	DTT,	pH	7.0.	The	
cleaved	 LcrH	 protein	 fractions	 were	 concentrated	 using	 Amicon®	 Ultra	 Centrifugal	 Filter	
units	(Millipore)	and	filtered	through	0.2	µm	syringe	filter	(Sartorius	Stedim	Biotech	GmbH,	
Germany).	 The	protein	 samples	 (under	10	ml	 volume)	were	 loaded	onto	 the	 gel	 filtration	
column	with	 a	 50	ml	 superloop	 (GE	 Healthcare).	 1	 column	 volume	 of	 50	mM	 phosphate	
buffer,	5	mM	DTT,	pH	7.0	was	applied	to	the	column	at	a	flow	rate	of	1	ml/min.	Fractions	
were	collected	in	2.5	ml	aliquots,	in	30	mm	tubes.	
	
2.2.2 Protein	Purity	
Mass	 spectrometry	 (Section	 2.2.2.1)	 and	 SDS-PAGE	 (Section	 2.2.2.2)	 of	 the	 proteins	
confirmed	both	the	size	and	checked	the	purity,	respectively.	In	all	cases	the	purity	of	LcrH	
proteins	was	greater	than	95	%.	The	nucleic	acid	contamination	of	the	protein	was	checked	
by	the	280/260	nm	ratio.	A	ratio	of	1.6	or	above	indicated	no	contamination.		
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2.2.2.1 Mass	Spectrometry		
Sample	and	Matrix	preparation		
A	fresh	saturated	matrix	solution	for	MALDI-ToF	was	prepared	in	a	microcentrifuge	tube	by	
dissolving	Sinapinic	acid	(Formula	weight	=	224.21)	in	50	%	acetonitrile,	0.1	%	TFA	in	ddH2O.		
The	 mixture	 was	 vortexed	 for	 1	 minute	 and	 centrifuged	 for	 20	 seconds	 to	 remove	 any	
undissolved	matrix	from	the	solution	and	the	clean	top	matrix	was	used.	Protein	samples	of	
30	 µM	 concentration	 were	 given	 ZipTip®	 (Millipore)	 treatment	 as	 per	 manufacturer’s	
instructions.	 Sample	 and	 matrix	 solutions	 were	 mixed	 in	 the	 ratio	 of	 1:	 4	 in	 a	
microcentrifuge	tube.	0.5	µL	of	the	mixture	was	immediately	loaded	onto	a	MALDI	plate	and	
allowed	to	dry	at	room	temperature	prior	to	insertion	into	the	mass	spectrometer.		
Mass	 spectra	 were	 recorded	 on	 a	 Micromass	 TofSpec	 mass	 spectrometer	 (Micromass,	
Manchester,	UK),	equipped	with	nitrogen	UV	laser	(337	nm	with	a	4	nm	pulse	width).	
2.2.2.2 	SDS-Polyacrylamide	Gel	Electrophoresis		
All	 solutions	were	made	 as	 described	 in	 the	 laboratory	manual	 [181,182].	 SDS-PAGE	was	
carried	 out	 according	 to	 standard	 protocols	 using	 the	 Laemmli	 system	 [182,183]. LcrH	
protein	samples	were	resuspended	in	SDS	loading	buffer	(50	mM	Tris-HCl,	pH	6.8,	100	mM	
DTT,	2%	SDS,	0.1%	bromophenol	blue,	10%	glycerol),	boiled	for	10	minutes	and	loaded	on	
an	18%	SDS-PAGE	gel	for	analysis.		
	
2.2.3 Determination	of	Protein	Concentration		
Protein	concentration	was	determined	spectrophotometrically,	using	the	UV-2401PC-UV-Vis	
recording	spectrophotometer,	according	to	Equation	2.3.	
Equation	2.3	
𝐶 = 𝐴!"# − 𝐴!"#𝜀𝑙  𝑥 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟	
Where	C	 is	 the	protein	concentration	 in	M.	Ax	 is	 the	absorbance	at	x wavelength.	𝜀	 is	 the	
molar	extinction	coefficient,	and	𝑙	is	the	cuvette	path	length	in	cm.		
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The	molar	extinction	coefficient	at	280	nm	wavelength,	𝜺280 nm is	calculated	by	Equation	2.4	
[183,184]:	
Equation	2.4	  𝜺!"# !"  =  (# Trp) (5500)  +  (# Tyr) (1490)  +  (# Cys) (125)	
Where	‘#	Trp’	refers	to	the	number	of	tryptophan	residues,	‘#	Tyr’	refers	to	the	number	of	
tyrosine	residues	and	‘#	Cys’	refers	to	the	number	of	cysteine	residues	in	the	protein.		The	
molar	extinction	coefficient	(𝜺!"# !") for	the	LcrH	proteins	are	as	follows;	for	fl-LcrH,	12,420	
M-1	cm-1,	tr-LcrH	and	mutant	L65E	LcrH,	10,805	M-1	cm-1.		
	
2.2.4 	Storage	of	Purified	Protein	
The	LcrH	proteins	were	dialysed	into	50	mM	Tris,	pH	8.0,	5	mM	DTT	overnight	at	4	°C.	They	
were	then	concentrated	using	centrifugal	concentrators	(Millipore)	to	≈	100-200	µM	and	1	
ml	aliquots	in	micro-centrifuge	tubes	were	rapidly	frozen	using	liquid	nitrogen.	The	samples	
were	then	stored	at	-80	°C.			
	
2.3 Biophysical	Characterization	of	LcrH	proteins	
In	all	experiments,	50	mM	phosphate,	pH	7.0,	5	mM	DTT	buffer	was	used.	The	molarity	of	
the	 stock	 solutions	of	urea	was	determined	using	 a	 refractometer	 (model	NAR-1T,	Atago,	
Tokyo).	
2.3.1 Multimeric	 state	 of	 LcrH	 proteins	 using	 Analytical	 Size	 Exclusion	
Chromatography	(SEC)		
In	order	to	determine	the	multimeric	state	of	LcrH	proteins,	analytical	SEC	was	performed	
on	an	AKTA	FPLC	system	(GE	Healthcare).	 	This	was	done	by	 injecting	100	µL	of	protein	at	
concentrations	from	3	µM	to	100	µM	in	50	mM	Phosphate	buffer,	pH	7.0,	5	mM	DTT	onto	a	
SuperdexTM	 75	 10/30	 column	 and	 SuperdexTM	 200	 10/30	 column	 (GE	 Healthcare).	 	 The	
column	was	pre-equilibrated	with	LcrH	buffer	before	injection	of	protein	samples.	1	column	
volume	of	50	mM	Phosphate	buffer,	pH	7.0,	5	mM	DTT,	was	applied	at	a	 flow	rate	of	0.5	
ml/min.	 	 For	 the	 SEC	 experiments	 involving	 urea	 denatured	 protein	 samples,	 the	 column	
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and	 protein	 sample	 was	 pre-equilibrated	 for	 4	 hours	 and	 run	 with	 the	 required	
concentration	of	urea.		
2.3.2 Analytical	Ultracentrifugation	(AUC)	
Two	 types	 of	 sedimentation	 experiment	 can	 be	 performed	 using	 an	 analytical	
ultracentrifuge;	 sedimentation	 equilibrium	 and	 sedimentation	 velocity.	 Sedimentation	
velocity	experiments	involve	spinning	molecules	at	a	high	speed	and	looking	at	the	rate	at	
which	the	molecules	move	in	response	to	the	centrifugal	force	that	is	generated.	From	the	
rate	at	which	 the	molecules	move,	a	sedimentation	coefficient	can	be	determined	 (as	 the	
centrifugal	 force	 is	 known).	 Information	 regarding	 the	 shape	 and	 sometimes	
aggregation/oligomerisation	 state	 can	 be	 determined,	 although	 the	 latter	 parameter	 is	
more	 easily	 determined	 by	 sedimentation	 equilibrium	 experiments.	 In	 contrast,	
sedimentation	equilibrium	experiments	 involve	spinning	molecules	at	moderate	speeds	so	
that	 centrifugal	 force	 causes	 the	 protein	 to	 sediment	 gradually,	 creating	 a	 concentration	
gradient	 across	 the	 cell,	 whilst	 diffusive	 forces	 act	 to	 oppose	 the	 sedimentation	 forces.	
Eventually	 these	 two	 forces	 are	 in	 equilibrium	 and	 so	 no	 net	 movement	 of	 the	
concentration	gradient	is	observed.	This	gradient	can	then	be	measured	and	from	knowing	
how	this	concentration	gradient	is	affected	by	changing	rotor	speed,	molecular	masses	(and	
hence	oligomerization	states)	can	be	determined.	Masses	can	be	determined	accurately	as,	
at	 equilibrium,	 the	 concentration	 distribution	 is	 only	 dependent	 on	 the	 mass	 of	 the	
sedimenting	species	and	not	on	its	shape	(unlike	for	sedimentation	velocity	experiments).	If	
a	species	is	self-associating,	dissociation	constants	can	often	be	obtained	if	they	are	in	the	
range	measurable	by	 the	 instrument	 (usually	between	1	μM	–	0.5	mM,	depending	on	 the	
absorbance	 of	 the	 molecule	 in	 question).	 All	 experiments	 performed	 on	 this	 system	 are	
sedimentation	equilibrium	experiments	as	this	is	the	method	used	when	an	accurate,	shape-
independent	molecular	weight	is	required.	
Aimee	 Boyle	 from	 School	 of	 Chemistry,	 University	 of	 Bristol	 performed	 sedimentation	
equilibrium	experiments	on	the	analytical	ultracentrifuge.		The	experiments	were	conducted	
using	a	Beckman-Optima	XL-I	 analytical	 centrifuge	 fitted	with	an	An-60	Ti	 rotor.	 Solutions	
were	prepared	at	40	µM	protein	concentration	in	50	mM	Phosphate	buffer,	pH	7.0,	5	mM	
DTT.	Data	was	recorded	at	25	°C	using	speeds	in	the	range	17,000	–	30,000	rpm.		Datasets	
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were	 initially	 fitted	to	a	single,	 ideal	species	model	using	the	program	Ultrascan	[184,185]	
which	employed	the	Equation	2.5.		
	
Equation	2.5	 C 𝑥 = 𝑒𝑥𝑝 !" ! !! !! !! ⊽ ∗ !  !!!!!!! ! ! + B	
Where	 C(x)	 is	 the	 concentration	 of	 peptide	 as	 a	 function	 of	 radial	 position	 (M),	 A	 is	 the	
measured	 absorbance	 of	 the	 sample,	 M	 is	 the	 molar	 mass	 of	 the	 species	 (Da),	 ω	 is	 the	
angular	 velocity	 of	 the	 rotor	 (rad	 s-1),	 ν	 is	 the	 partial	 specific	 volume	 of	 the	 protein	 in	
question	 (ml	g-1),	D	 is	 the	solvent	density	 (g	ml-1),	x2	 is	 the	 radial	position	 (cm2),	xr2	 is	 the	
reference	radial	position	(cm2),	R	 is	 the	gas	constant	 (J	mol-1	K-1),	T	 is	 the	temperature	(K)	
and	B	is	a	baseline	offset	which	compensates	for	any	non-ideality	in	the	data	acquisition	or	
the	cells.		
The	partial	 specific	 volume	of	 the	peptide	 (0.7341	cm3	g-1)	 and	 the	density	of	 the	 solvent	
(1.0042	 g	 cm-3)	 were	 calculated	 using	 Sednterp.	 A	 monomer-dimer	 equilibrium	 model	
(Equation	2.6)	was	used	to	determine	the	KD	of	the	species.	A	fit	was	deemed	appropriate	if	
the	 residuals	 from	 the	 fit	were	 randomly	 scattered	and	had	an	 absorbance	 close	 to	 zero.	
Any	trends	in	the	residuals	indicated	a	different	model	was	required.		
The	 monomer-dimer	 equilibrium	 model	 was	 used	 for	 determining	 the	 dimerization	
dissociation	 constant	 KD	 after	 performing	equilibrium	 sedimentation	 is	 shown	 in	 Equation	
2.6.	
Equation	2.6	𝐶! =  𝐶! 𝑅!  exp [𝑀𝜑 𝑅! − 𝑅!! + ( 2𝐾! ∗𝑀 )[𝐶! 𝑅! ]!exp [2𝑀𝜑 𝑟! − 𝑟!! ]	
Where	𝐶! 	is	the	total	protein	concentration,	𝑅!	is	the	reference	radius	(cm),	𝑅	is	the	radius	
(cm)	 and	 𝐶! 𝑅! 	 is	 the	 monomer	 concentration	 at	 𝑅!,	 𝑀	 is	 the	 molecular	 weight	 of	
monomer,	𝜑	 =	!! !! ⊽ ∗ !!!" ,	 ω	 is	 the	 angular	 velocity	 of	 the	 rotor	 (rad	 s-1),	ν	 is	 the	 partial	
specific	volume	of	the	protein	in	question	(ml	g-1),	D	is	the	solvent	density	(g	ml-1),	R	is	the	
gas	constant	(J	mol-1	K-1)	and	T	is	the	absolute	temperature	(K).	
75	
	
	 	
The	protein	concentration	(𝐶!)	versus	radius	(𝑟)	plots	were	analysed	to	determine	𝐾!	of	the	
species	 according	 to	 the	 above	 theoretical	 Equation	 2.6	 for	monomer-dimer	 equilibrium.	
Least	 squares	 curve	 fitting	 was	 performed	 using	 the	 Ultrascan	 software.	 Errors	 were	
obtained	by	Monto	Carlo	analysis	and	given	with	5	%	confidence	limit.		
	
2.3.3 Dynamic	Light	Scattering	(DLS)	
Dynamic	 light	 scattering	 (DLS),	 also	 known	 as	 quasi-elastic	 light	 scattering	 (QELS)	 and	
photon	correlation	spectroscopy	(PCS),	 is	a	non-invasive,	well-established	technique	 in	the	
field	of	protein	crystallography.	DLS	is	used	to	measure	hydrodynamic	sizes,	polydispersities	
and	 aggregation	 effects	 of	 protein	 samples	 in	 solution	 [185,186].	 Apart	 from	proteins,	 its	
applications	 include	 emulsions,	 micelles,	 polymers,	 nanoparticles	 or	 colloids.	 It	 measures	
the	 size	 and	 size	 distribution	 of	 molecules	 in	 the	 submicron	 region,	 and	 with	 the	 latest	
technology	lower	than	1nm.	In	DLS,	a	laser	beam	illuminates	the	sample	and	the	Brownian	
motion	of	particles	or	molecules	in	suspension	scatters	the	laser	light	at	different	intensities.	
Analysis	of	these	intensity	fluctuations	yield	the	velocity	of	the	Brownian	motion	and	hence	
the	particle	size	using	the	Stokes-Einstein	relationship	[186,187]	(Equation	2.7).		
Equation	2.7	 𝑅! = 𝑘!𝑇6𝜋𝜂𝐷 
 
Where,	𝑅! 	is	the	hydrodynamic	radius,	𝑘!	is	Boltzmann	constant,	𝑇	is	temperature,	𝜂	is	the	
solvent	 viscosity	 and	 𝐷	 is	 the	 translational	 diffusion	 coefficient	 (obtained	 through	 the	
velocity	of	Brownian	motion	by	DLS).		
DLS	 measurements	 were	 carried	 out	 using	 Zetasizer	 Nano	 S	 instrument	 (Malvern	
Instruments	 Ltd).	 Protein	 samples	 were	 prepared	 at	 concentrations	 of	 50	 µM	 in	 50	 mM	
phosphate	 buffer,	 pH	 7.0,	 5	mM	 DTT.	 For	 experiments	 involving	 urea	 denatured	 protein	
samples,	 the	 protein	 sample	was	 pre-equilibrated	 for	 4	 hours	 and	 run	with	 the	 required	
concentration	of	urea.	All	 samples	were	spun	at	10,000	rpm	for	10	minutes	before	 taking	
measurements.	 The	 results	 were	 analyzed	 by	 Zetasizer	 software	 version	 6.12	 (Malvern	
Instruments	Ltd).		
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2.4 Secondary	and	Tertiary	Structure	Characterization		
2.4.1 Circular	Dichroism	(CD)	Spectroscopy	
Circular	 Dichroism	 (CD)	 Spectroscopy	 is	 a	 spectroscopic	 technique	 where	 the	 CD	 of	
molecules	is	measured	over	a	range	of	wavelengths.	CD	is	the	difference	in	the	absorption	
of	 left	 and	 right	 handed	 circularly	 polarised	 light	 in	 chiral	 (structurally	 asymmetrical)	
molecules	 and	occurs	when	a	molecule	 contains	one	or	more	 chiral	 chromophores	 (light-
absorbing	groups).	Depending	on	the	CD	instrument,	the	data	are	recorded	as	either	as	the	
difference	 in	 absorbance	 of	 right-	 and	 left-handed	 circularly	 polarised	 light,	 △ 𝐴 (𝜆) =𝐴! 𝜆 − 𝐴!(𝜆),	or	as	ellipticity,	θobs	in	degrees	or	millidegrees.	Data	in	both	formats	can	be	
converted	 to	 molar	 values,	 that	 is,	 to	 the	 differential	 molar	 circular	 dichroic	 extinction	
coefficient,	△ε = εL – εR and	to	the	molar	ellipticity,	[θ].	△ε and	[θ]	are	related	by	Equation	
2.8.	
Equation	2.8																																																	 𝜽 =  𝟑𝟑𝟎𝟎   𝚫𝛆	
It	should	be	noted	that	the	concentration	standards	are	different	for	 𝜃 	and	Δε.	Δε	 is	the	
differential	absorbance	of	a	1	mol/l	solution	 in	a	1	cm	cell	 ,	whereas	 𝜃 	 is	 the	rotation	 in	
degrees	of	a	1	dmol/cm3	solution	and	a	path	length	of	1	cm.		
The	principle	of	CD	involves	a	monochromatic	beam	of	light	passing	through	a	Photo	Elastic	
Modulator	 (PEM)	 that	 converts	 the	 linear	 polarised	 light	 into	 alternating	 left	 and	 right	
handed	polarised	light.	The	two	polarisations	are	differently	absorbed	by	the	chiral	sample,	
and	 the	 detector	 called	 Photo	Multiplier	 Tube	 (PMT)	 [187-189],	 detects	 this	 difference	 in	
absorption	and	conveys	the	CD	signal.	Along	with	the	CD	signal,	the	CD	spectropolarimeter	
also	records	the	High	Tension	(HT)	voltage	of	the	detector.	This	HT	voltage	is	a	measure	of	
the	amount	of	voltage	the	detector	is	using	and	is	dependent	on	the	amount	of	light	striking	
the	 detector	 (more	 light	 –	 lower	 HT	 voltage).	 Furthermore,	 HT	 voltage	 is	 roughly	
proportional	to	the	absorbance	of	the	sample.	If	the	HT	voltage	goes	above	~800	Volts	the	
noise	will	become	disproportionate	to	the	sample	signal	and	the	output	will	be	completely	
unreliable	(Jasco	J-715	Spectropolarimeter	Operating	Manual).		
CD	spectroscopy	is	widely	used	to	study	a	range	of	chiral	molecules,	but	its	most	important	
application	is	in	the	study	of	large	biological	molecules.	Largely,	it	is	used	for	analysis	of	the	
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secondary	 structure	 or	 conformation	 of	 proteins,	 as	 secondary	 structure	 is	 sensitive	 to	
environment,	temperature	or	pH.	CD	can	be	used	to	monitor	secondary	structural	changes	
with	environmental	 conditions	or	 interaction	with	other	molecules.	 Structural,	 kinetic	and	
thermodynamic	information	about	proteins	can	be	derived	from	CD	spectroscopy	[188-190].		
Far-UV	(spectral	region	190-250	nm)	CD	was	used	to	probe	the	secondary	structure	of	the	
LcrH	 protein	 at	 different	 protein	 concentrations	 and	 denaturant	 concentrations.	 Spectra	
were	acquired	on	either	a	Jasco	J-715	CD	Spectropolarimeter	(JASCO,	UK)	or	a	ChirascanTM	
CD	 Spectrometer	 (Applied	 Photophysics	 Ltd,	 UK).	 All	 far-UV	 CD	 spectra	 were	 acquired	 in	
LcrH	 buffer,	 at	 25	 °C.	 The	 following	 pathlengths	were	 used:	 10	 or	 5	mm	 pathlengths	 for	
protein	concentrations	at	3	µM;	1,	2	or	5	mm	path	lengths	for	proteins	concentrations	at	6,	
12	 and	 25	 µM	 and	 1	 mm	 path	 length	 for	 protein	 concentrations	 at	 50	 µM	 and	 80	 µM.	
Spectra	 were	 recorded	 from	 200	 to	 300	 nm.	 To	 compare	 data,	 and	 thus	 correct	 for	
pathlength	 and	 concentration,	 all	 ellipticities	were	 converted	 to	molar	 ellipticity	 (degrees	
cm2	dmol-1),	shown	in	Equation	2.9.	
Equation	2.9	
Ѳ !"#$% = 100 ×Ѳ!"# 𝑑 ×𝑚 	
Where,	 Ѳ 𝒎𝒐𝒍𝒂𝒓	 is	 molar	 ellipticty	 in	 deg	 cm2	 dmol-1,	 Ѳ𝒐𝒃𝒔	 is	 the	 observed	 CD	 signal	 in	
millideg,	d	is	the	cuvette	path	length	in	cm	and	m	is	molar	concentration	of	protein.		
2.4.2 Fluorescence	Spectroscopy		
Fluorescence	is	a	phenomenon	where	a	molecular	system	absorbs,	then	emits	light.	During	
absorption,	 high	 energy	 (short	 wavelength)	 light	 excites	 the	 system,	 promoting	 electron	
within	the	molecule	to	move	from	the	ground	state,	to	the	excited	state	[190,191].	Emission	
is	 observed	when	 the	 excited	 electron	 returns	 from	 the	 excited	 state	 back	 to	 the	 ground	
state.	 As	 some	 energy	 is	 always	 lost	 by	 non-radiative	 processes,	 such	 as	 vibrational	
transitions,	the	energy	of	the	emitted	light	 is	always	 lower	than	that	of	the	absorbed	light	
[191,192].	The	energies	and	relative	intensities	of	the	fluorescence	signals	give	an	indication	
about	 the	 structure	 and	 environment	 of	 the	 fluorophores	 (substances	 that	 exhibit	
fluorescence).		
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Fluorescence	 spectrophotometer	 also	 called	 Spectrofluorimeter	or	 Fluorimeter	 is	 a	device	
for	measurement	of	 fluorescence	of	proteins	 that	contain	 intrinsic	 fluorophores	 (naturally	
occurring	 fluorophores)	 such	 as	 tryptophan,	 tyrosine	 and	 phenylalanines.	 A	 typical	
fluorescence	spectrophotometer	contains	a	sample	holder,	incident	photon	source	(a	xenon	
lamp),	 monochromators	 for	 selecting	 particular	 incident	 wavelengths,	 focussing	 optics,	
photon-collecting	detector	and	a	control	software	unit.	The	detector	is	usually	set	at	90°	to	
the	 light	 source.	 A	 fluorescence	 emission	 spectrum	 is	 recorded	 when	 the	 excitation	
wavelength	is	held	constant	and	the	emission	beam	is	scanned	as	a	function	of	wavelength.	
A	 fluorescence	 spectrophotometer	 detects	 the	 changes	 in	 fluorescence	 intensity,	 which	
enables	the	study	of	the	tertiary	structural	changes	of	proteins	or	binding	of	two	molecules.		
For	example,	the	wavelength	of	tryptophan	fluorescence	can	be	used	to	determine	whether	
a	tryptophan	is	 in	an	aqueous	environment	(longer	wavelength)	or	buried	deep	within	the	
protein	(shorter	wavelength)	[192,193].		
All	 measurements	 were	 performed	 in	 a	 thermostatted	 cuvetter	 holder	 at	 25	 °C	 using	 a	
Varian	 Cary	 Eclipse	 Fluorescence	 Spectrophotometer	 (Agilent	 Technologies).	 Tyrosine	
fluorescence	 was	 employed	 due	 the	 lack	 of	 Tryptophan	 residues	 in	 LcrH.	 The	 excitation	
wavelength	 was	 274	 nm	 and	 band	 passes	 for	 excitation	 and	 emission	 was	 5	 nm.	 The	
fluorescent	emission	of	the	LcrH	protein	was	measured	from	294	to	400	nm.	The	λmax	of	303	
nm	(emission	wavelength	for	tyrosine)	was	used	in	analysis	unless	otherwise	stated.		
2.5 Equilibrium	Studies	for	measuring	Thermodynamic	Stability	
2.5.1 General	Background	
The	 thermodynamic	 stability	 of	 proteins	 can	 be	 investigated	 by	 performing	 unfolding	
studies	 under	 equilibrium	 conditions.	 These	 experiments	 involve	 unfolding	 the	protein	 by	
varying	 one	 parameter	 (concentration	 of	 chemical	 denaturant,	 temperature,	 pH	 and	
pressure)	 and	 utilising	 a	 probe	 (fluorescence	 and	 circular	 dichroism)	 to	 measure	 the	
equilibrium	produced.	In	this	study,	chemical	denaturations	were	performed	using	urea	and	
circular	dichroism	(Section	2.4.1)	was	used	to	monitor	the	changes	in	secondary	structure.	
Fluorescence	 spectroscopy	 (Section	 2.4.2)	 was	 used	 to	 measure	 the	 changes	 in	 tertiary	
structure.	The	far	UV	spectra	from	200	to	300	nm	monitored	the	secondary	structure	of	the	
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protein.	 LcrH	 proteins	 are	 alpha	 helical	 containing	 three	 TPRs	 in	 each	 monomer,	 thus	
depicted	in	a	negative	peak	at	222	nm.		
2.5.2 Equipment	and	General	Procedures	
All	 experiments,	 unless	 otherwise	 stated,	were	 carried	 out	 at	 25	 °C	 in	 50	mM	Phosphate	
buffer,	pH	7.0,	5	mM	DTT.	All	stock	solutions	of	urea	were	made	using	volumetric	flasks,	and	
the	urea	solutions	were	flash	frozen	and	stored	at	-20	°C	to	prevent	degradation.	All	protein	
solutions	 were	 filtered	 0.2µm	 syringe	 filter	 prior	 to	 addition	 to	 denaturant	 solutions.	
GdmHCl	and	urea	solutions	were	checked	by	a	refractometer	(model	NAR-1T,	Atago,	Tokyo),	
using	Equation	2.10	and	Equation	2.11	respectively	[168,193].		
	
Equation	2.10	 𝑀𝑜𝑙𝑎𝑟𝑖𝑡𝑦 = 57.1 ∆𝑁 + 38.7 (∆𝑁)! − 91.6 (∆𝑁)!	
Equation	2.11	 𝑀𝑜𝑙𝑎𝑟𝑖𝑡𝑦 = 117.7 ∆𝑁 + 29.7 (∆𝑁)! + 185.5 (∆𝑁)!	
	
Where,	∆𝑵	is	the	difference	in	refractive	index	between	the	denaturant	solution	and	50	mM	
Phosphate	buffer,	pH	7.0,	5	mM	DTT.	
	
2.5.3 Preparation	of	Samples	for	Equilibrium	Chemical	Denaturation		
A	stock	solution	of	GdmHCl	(≈	8	M)	or	urea	(≈	10	M)	was	diluted	with	ddH2O	(resistance	of	
18.2	 Ω)	 to	 obtain	 a	 large	 range	 of	 denaturant	 concentrations	 using	 a	 Hamilton	Microlab	
dispenser	 (Hamilton	 Company).	 The	 protein	 and	 denaturant	 stock	 solutions	were	 filtered	
through	0.2	µm	syringe	filter.	Cuvettes	of	differing	path	lengths	were	used	depending	on	the	
protein	 concentration	 for	 the	 denaturation	 experiment.	 Smaller	 path	 length	 cuvette	 was	
used	 to	 scan	higher	 protein	 concentration	 samples	 to	prevent	 saturation	of	 the	detector.	
The	preparation	of	samples	for	different	protein	concentrations	and	the	use	of	cuvettes	of	
suitable	path	lengths	have	been	described	as	follows.		
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2.5.3.1 Sample	preparation	for	LcrH	protein	concentrations	1	to	12	µM	
Experiments	involving	denaturation	of	protein	samples	from	1	to	12	µM,	a	9	x	stock	solution	
of	protein	 (9	to	108	µM)	and	buffer	 (450	mM	Phosphate	buffer,	pH	7.0,	45	mM	DTT)	was	
prepared.	 100	 µL	 of	 this	 9	 x	 stock	 solution	 was	 added	 to	 800	 µL	 of	 denaturant	 sample	
resulting	 in	 a	 1	 x	 concentration	 of	 proteins	 ranging	 from	 1	 to	 12	 µM.	 Cuvettes	 of	 path	
lengths	10	mm	(for	1	µM	LcrH),	5	mm	(for	3	µM	and	6	µM	LcrH)	and	2	mm	(for	12	µM)	were	
used	for	performing	far-UV	CD	scans.	
2.5.3.2 Sample	preparation	for	LcrH	protein	concentrations	25	to	80	µM		
A	6x	stock	solution	of	protein	 (150	to	480	µM)	and	buffer	 (300	mM	Phosphate	buffer,	pH	
7.0,	30	mM	DTT)	was	prepared	for	conducting	experiments	involving	protein	samples	from	
25	 to	80	µM.	50	µL	of	 this	 6	 x	 stock	 solution	was	added	 to	250	µL	of	denaturant	 sample	
resulting	 in	a	1x	concentration	of	proteins	ranging	 from	25	to	80	µM.	The	 final	conditions	
were	50	mM	Phosphate	buffer	pH	7.0,	5	mM	DTT.	1	mm	path	 length	cuvette	was	used	to	
perform	far-UV	CD	scans	for	LcrH	protein	with	concentrations	25	to	80	µM.		
The	protein/denaturant	solutions	were	pre-equilibrated	at	25	°C	for	a	minimum	of	4	hours	
prior	 to	performing	experiments	on	 the	CD.	 Scans	were	 taken	 in	a	 thermostatted	cuvette	
holder	at	25	°C ±	0.2	°C	and	between	210	nm	and	250	nm	at	a	scan	rate	of	1	nm	s-1.	The	
largest	 difference	 in	 signal	 between	native	 and	denatured	 LcrH	was	 observed	 at	 222	nm,	
and	this	wavelength	was	used	to	monitor	unfolding.	For	easy	comparison	of	differing	data	
sets,	the	CD	signal	at	222	nm	(λobs)	was	converted	to	relative	spectroscopic	signal	(λrel)	using	
Equation	2.12.	
Equation	2.12	 𝜆!"# = 𝜆!"# − 𝜆!𝜆! − 𝜆! 	
	
Where	λobs	is	the	observed	CD	signal,	λN	is	the	signal	of	the	native	state	and	λD	is	the	signal	of	
the	denatured	state.		
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Chapter	3 Gene	 Construction,	 Purification	 Strategy	 and	 Initial	
Biophysical	Characterisation	of	LcrH	proteins	
3.1 Introduction	
This	 chapter	 describes	 the	 following:	 (i)	 gene	 construction	 of	 full	 length	 LcrH	 (fl-LcrH),	
truncated	LcrH	(tr-LcrH)	and	monomeric	L65E	LcrH,	(ii)	purification	strategies	of	these	three	
constructs	 and	 (iii)	 initial	 biophysical	 characterisation	 -	 oligomeric	 state,	 conditions	 under	
which	 these	 oligomeric	 states	 were	 maintained	 (i.e.	 abrogation	 of	 any	 aggregation)	 and	
secondary	structure	characterisation.		
	
3.2 Experimental	approaches	
Genes	were	constructed	using	PCR	and	site	directed	mutagenesis.	Protein	purification	was	
carried	 out	 using	 affinity	 and	 size	 exclusion	 chromatography.	 SDS-PAGE	 gels	 and	 Mass	
Spectrometry	 followed	 protein	 purification.	 Once	 purified,	 analytical	 size	 exclusion	
chromatography	was	used	to	determine	oligomeric	state	and	conditions	under	which	these	
oligomeric	states	were	maintained.	Finally,	protein	secondary	structure	was	analysed	using	
far-UV	circular	dichroism	(CD).			
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3.3 Results	
3.3.1 Full	length	LcrH	(fl-LcrH)	gene	construction	
The	fl-LcrH	gene	sequence	was	obtained	from	NCBI	Reference	Sequence:	NC_009595.1	
showing	507	bp	region	from	55032	to	55538.	The	translated	protein	sequence	of	full	length	
LcrH,	comprising	of	168	amino	acids,	is	shown	in	Figure	3.1.		
	
	
	
	
 
1.......10 ........20 ........30 ........40 ........50 ........60  
MQQETTDTQE YQLAMESFLK GGGTIAMLNE ISSDTLEQLY SLAFNQYQSG KYEDAHKVFQ  
 
........70 ........80 ........90 .......100 .......110 .......120  
ALCVLDHYDS RFFLGLGACR QAMGQYDLAI HSYSYGAIMD IKEPRFPFHA AECLLQKGEL  
 
.......130 .......140 .......150 .......160 .....168 
AEAESGLFLA QELIADKTEF KELSTRVSSM LEAIKLKKEM EHECVDNP 
 
Figure	3.1:	Full	length	LcrH	(fl-LcrH)	(a)	gene	NCBI	Reference	Sequence:	NC_009595.1	showing	507	bp	region	
from	 a	 Yersinia	 pestis	 CA88-4125	 plasmid	 pCD1	 and	 (b)	 fl-LcrH	 protein	 sequence	 with	 accession	 no.	
AAA27642	in	FASTA	format.		Sequences	are	numbered	in	red	and	amino	acids	are	shown	in	black.	
	
The	fl-LcrH	gene	was	constructed	using	recursive	PCR	(2.1.1.1)	where	eight	coding	and	non-
coding	 oligonucleotides	 spanning	 the	 entire	 length	 of	 the	 gene	 were	 used.	 Each	
oligonucleotide	 overlapped	 with	 its	 neighbour	 by	 20	 bases	 (Figure	 2.1).	 The	 resultant	
recursive	PCR	product	was	 run	on	1%	agarose	gel	 (2.1.1.1.1)	and	 showed	a	 range	of	DNA	
sizes	from	~100	–	500	bp	(Figure	3.2a).	This	is	expected	and	is	caused	by	recombination	and	
extension	 of	 oligonucleotides	 by	 different	 amounts.	 In	 order	 to	 obtain	 a	 full	 length	 LcrH	
(a)	
(b)	
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gene	from	the	recursive	PCR	mixture,	a	conventional	PCR	was	performed	using	the	recursive	
PCR	 product	 as	 the	 template	 and	 PCR	 primers	 encoding	 the	 5’	 and	 3’	 of	 the	 gene	 with	
additional	restriction	sites	(BamHI	and	HindIII	at	the	5’	and	3’	end,	respectively)	(Figure	3.3).	
Figure	3.2b	showed	that	the	PCR	yielded	DNA	bands	of	~500	bp	which	corresponds	to	the	
correct	size	of	fl-LcrH	gene	(504	bp).	The	PCR	product	was	then	gel	purified	(section	2.1.3.2)	
and	inserted	into	pProEX	HTb	(section	2.1.3)	and	pTrc-GST	(section	2.1.4)	vector	for	protein	
expression.	 DNA	 sequencing	 of	 the	 genes	 within	 the	 pProEX	 HTb	 and	 pTrc-GST	 vectors	
confirmed	correct	gene	sequence	had	been	synthesised.	
								 	
Figure	3.2	(a)	1%	agarose	gel	of	recursive	PCR	of	fl-LcrH	gene.	Lane	1	-	recursive	PCR	product	of	fl-LcrH	gene	
showing	a	range	of	DNA	sizes	ranging	from	~100	to	500	bp,	lane	2	-	1	Kb	DNA	ladder.	(b)	1.5%	agarose	gel	
showing	PCR	product	of	fl-LcrH	gene.	Lanes	1&2	contain	the	PCR	product	of	fl-LcrH	gene	showing	DNA	bands	
of	~500	bp.	Lane	3:	100	bp	DNA	ladder.	
	
Figure	3.3	Schematic	showing	the	incorporated	restriction	sites	of	BamHI	and	HindIII	at	the	5’	and	3’	termini	
respectively	of	the	full	length	LcrH	gene	using	conventional	PCR.		
	
3.3.2 Production	and	purification	of	full	length	LcrH	(fl-LcrH)		
The	pProEX	HTb	vector	(section	2.1.3)	expressed	the	fl-LcrH	as	a	fusion	protein	with	an	N-
terminal	 hexahistidine	 tagged	 protein.	 Protein	 expression	 was	 carried	 out	 in	 the	 E.	 coli	
(a)	 (b)	
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expression	 strain	 BL21	 C41	 (DE3).	 The	 conditions	 that	 gave	 the	 greatest	 soluble	 protein	
were	found	to	be	growth	at	37	°C	until	an	OD600nm	of	0.6	was	reached	and	then	 induction	
with	0.1	mM	IPTG	at	27	°C	for	14-16	hours.	The	fl-LcrH	protein	expression	at	different	time	
points	is	shown	in	Figure	3.4.		
	
	
Figure	3.4:	15	%	SDS-PAGE	gel	showing	the	production	of	his-tagged	fl-LcrH	protein	at	different	time	points.	
Lanes	1,	2,	3	and	4	are	lysed	bacterial	cell	pellets	after	induction	with	1mM	IPTG	at	time	t	=	0	hrs,	t	=	2	hrs,	t	
=	4	hrs	and	t	=	16	hrs	respectively.	Lane	5	–	protein	ladder.	The	protein	production	was	induced	with	IPTG	at	
16	°C	and	bacterial	cells	were	grown	overnight	before	harvesting	for	proteins.		
Native	 Purification:	 Fl-LcrH	 was	 extracted	 from	 the	 bacterial	 cells	 (Section	 2.2.1.1)	 and	
subjected	to	affinity	chromatography	using	Ni2+	column	(Section	2.2.1.4).	The	his-tagged	fl-
LcrH	 protein	was	 eluted	 (Figure	 3.5a)	 and	 the	 his-tag	 cleaved	 using	 TEV	 protease	 (Figure	
3.5b).	Fl-LcrH	has	a	molecular	weight	of	19	KDa	and	on	the	SDS-PAGE	gel	in	Figure	3.5b,	the	
cleaved	fl-LcrH	is	observed	as	band	of	≈	20	KDa.	However,	there	was	a	significant	proportion	
of	fl-LcrH	found	to	be	present	in	the	insoluble	pellet	after	sonication	(inclusion	bodies).		
Denatured	 Purification:	 The	 insoluble	 pellet	 (I)	 was	 re-suspended	 in	 a	 denaturing	 lysis	
buffer	(1x	PBS,	pH	7.0,	6	M	GdmHCl,	10	%	glycerol,	5	mM	DTT),	sonicated	on	ice,	centrifuged	
and	the	resultant	supernatant	was	subjected	to	affinity	chromatography	using	a	Ni2+	column	
pre-equilibrated	with	5	column	volumes	of	 lysis	buffer.	The	Ni2+	column	was	then	washed	
with	reducing	concentrations	of	GdmHCl	to	gradually	fold	the	bound	proteins	on	the	column	
before	 finally	washing	with	 1	 x	 PBS,	 pH	7.0,	 10	%	 glycerol	 to	 completely	 remove	 the	 any	
trace	 of	 GdmHCl.	 The	 his-tagged	 fl-LcrH	was	 then	 eluted	 using	 the	 his-tag	 elution	 buffer	
(section	2.2.1.2)	and	the	his-tag	from	the	protein	was	cleaved	by	TEV	protease	(Figure	3.5b).		
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Purification	 of	 fl-LcrH:	 Both	 natively	 purified	 and	 denatured	 purified	 cleaved	 fl-LcrH	 was	
then	subjected	to	size	exclusion	chromatography	to	remove	residual	TEV	protease	and	other	
protein	 impurities	(section	2.2.1.6).	Figure	3.5(c)	shows	the	size	exclusion	chromatography	
(SEC)	profile	of	fl-LcrH	purification.	The	inset	in	Figure	3.5(c)	shows	the	SDS-PAGE	gel	of	the	
protein	 fractions	eluted	 from	 the	 SEC	of	 fl-LcrH.	 In	 the	 SDS-PAGE	gel,	 lane	2	 contains	 the	
protein	fraction	loaded	onto	the	SEC,	lanes	3-5	show	higher	molecular	weight	impurities	and	
lane	6	onwards	 fl-LcrH	band	~19	 kDa	 can	be	observed.	 Lanes	6	&	7	 showed	 considerable	
amount	of	higher	molecular	weight	proteins	co-eluting	with	fl-LcrH.	The	SDS-PAGE	gel	lanes	
8-11	 contained	 relatively	 higher	 purity	 of	 fl-LcrH	 protein.	 Thus,	 it	 became	 clear	 that	 the	
purified	 fl-LcrH	 samples	 obtained	 after	 the	 final	 SEC	 contained	 higher	 molecular	 weight	
impurities.	Therefore,	to	increase	purity	to	95	%	an	additional	wash	step	was	introduced	in	
the	 nickel	 column	 step.	 Here,	 the	 columns	 were	 washed	 with	 1x	 PBS	 containing	 low	
concentration	of	imidazole	(5	mM)	before	elution	with	his-tag	elution	buffer.	However,	the	
co-elution	 of	 higher	 molecular	 weight	 impurities	 could	 not	 be	 completely	 avoided.	 Both	
purification	 strategies	 are	 summarised	 in	 Figure	3.5	and	achieved	more	 than	90	%	purity.	
Protein	fractions	corresponding	to	the	lanes	8-11	in	the	inset	Figure	3.5	(c)	were	pooled	and	
concentrated	as	more	than	90	%	purity	was	achieved.		
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Figure	3.5	15%	SDS	PAGE	gel	showing	(a)	elution	profile	of	his-tagged	fl-LcrH.	Lanes	 from	left	 left	 to	right,	
Lane	1	–	supernatant	containing	soluble	protein	(s),	lane	2	–	supernatant	from	re-solubilized	inclusion	bodies	
(I),	lane	3	–	eluted	fl-LcrH	from	soluble	supernatant	(s),	lane	4	–	eluted	fl-LcrH	from	re-solubilized	inclusion	
bodies	(I),	lane	5	–	flow	through	(f/t)	from	(s),	lane	6	–	flow	through	(f/t)	from	(I),	lane	7	–	protein	ladder.	(b)	
Cleavage	 of	 his-tag	 from	 fl-LcrH	 (combined	 elutions	 from	 soluble	 supernatant	 and	 re-solubilised	 inclusion	
bodies)	 using	 TEV	protease,	 lane	1-	protein	 ladder,	 lane	2	 –	uncleaved	his-tagged	 fl-LcrH,	 lanes	3	 and	4	 –	
cleaved	fl-LcrH.	(c)	Size	exclusion	chromatography	profile	of	cleaved	fl-LcrH,	the	chromatogram	showing	the	
elution	of	fl-LcrH	and	the	15	%	SDS-PAGE	gel	(inset)	showing	the	eluted	protein	fractions.	Lanes	from	left	to	
right,	 lane	 1	&	 12–	protein	 ladder,	 lane	 2	 –	 cleaved	 fl-LcrH	 sample	 loaded	on	 the	 FPLC,	 lane	 3-11:	 eluted	
protein	 fraction	 from	 SEC.	 The	 protein	 fractions	 loaded	 onto	 the	 SDS-PAGE	 gel	 are	 shown	 as	 the	
corresponding	lane	numbers	on	the	SEC	chromatogram.		
(a)	 (b)	
(c)	
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In	order	to	attain	higher	levels	of	protein	purity,	the	fl-LcrH	gene	was	inserted	in	pTrc-GST	
expression	 vector	 (section	 2.1.3).	 The	 pTrc-GST	 vector	 produces	 the	 fl-LcrH	 as	 an	 N-
terminally	GST	tagged	fusion	protein	(section	2.2.1.5).	As	before	the	vector	was	transformed	
in	BL21	C41(DE3)	expression	strain	of	E.	coli	and	grown	in	an	identical	manner	to	that	used	
for	producing	his-tagged	fl-LcrH	mentioned	 i.e.	bacterial	growth	at	37	°C	until	 reaching	an	
O.D600	 nm	 of	 0.6.	 	However,	 expression	was	 induced	with	 0.1	mM	 IPTG	at	 16	 °C	 for	 14-16	
hours.	 The	 fl-LcrH	 protein	 was	 then	 extracted	 from	 bacterial	 cells	 (section	 2.2.1.1)	 and	
subjected	 to	 affinity	 purification	 by	 passing	 it	 through	 a	 column	 containing	 glutathione	
agarose	 resin	 pre-equilibrated	with	GST	wash	 buffer	 (section	 2.2.1.3).	 Thrombin	 protease	
was	added	to	the	resin	bound	with	the	GST-fl-LcrH	fusion	protein	for	cleavage	on	column	in	
order	to	separate	the	GST	tag	from	fl-LcrH	protein.	The	fl-LcrH	eluted	from	the	column	as	a	
flow	 through	 while	 the	 GST	 tag	 remained	 bound	 to	 the	 glutathione	 agarose	 resin.	 The	
protein	production	and	purification	of	GST-tagged	fl-LcrH	followed	by	thrombin	cleavage	is	
shown	in	Figure	3.6.		
	
	
Figure	 3.6	 (a)	 18	 %	 SDS-PAGE	 showing	 the	 protein	 production	 and	 elution	 profile	 of	 GST-tagged	 fl-LcrH	
protein.	Lanes	from	left	to	right:	lane	1	-	lysed	cells,	lane	2	–	supernatant	protein,	lanes	3	&	4	–	GST-fusion	fl-
LcrH	protein	bound	to	the	glutathione	agarose	resin,	lanes	5	&	6	–	cleaved	GST	tag	bound	to	the	glutathione	
agarose	resin,	lanes	7	&	8	–	fl-LcrH	protein,	lane	9	–	protein	marker.	The	GST	tag	was	cleaved	using	thrombin	
protease	to	achieve	fl-LcrH	protein	of	≈	19	kDa.	(b)	Chromatogram	showing	size	exclusion	profile	of	fl-LcrH	
using	 S200	 16/60	 column.	 The	 fl-LcrH	 protein	 fractions	 from	 60	 –	 110	ml	were	 pooled	 and	 concentrated	
further.		
	
(a)	
(a)	 (b)	
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The	 fl-LcrH	 protein	 bands	 of	 ≈	 19	 kDa	 can	 be	 clearly	 observed	 in	 the	 18	%	 SDS-PAGE	 gel	
(Figure	3.6a)	after	cleavage	with	thrombin	protease.	The	affinity	purified	fl-LcrH	protein	was	
further	 concentrated	 and	 subjected	 to	 size	 exclusion	 chromatography	 for	 removal	 of	
thrombin	 (Figure	 3.6b).	 The	 fl-LcrH	 protein	 obtained	 using	 the	 GST-tagged	 fl-LcrH	 fusion	
method	 was	 easier	 to	 purify,	 provided	 a	 greater	 yield	 and	 was	 of	 higher	 purity	 in	
comparison	to	his-tagged	fl-LcrH	(>	95	%	vs.	<	90	%,	respectively).		
	
3.3.3 Truncated	LcrH	(tr-LcrH)	
After	the	successful	expression	and	purification	of	fl-LcrH,	it	proved	to	be	relatively	unstable	
and	 prone	 to	 aggregation	 on	 concentrating	 (discussed	 more	 fully	 later	 in	 this	 chapter).	
Moreover,	 soon	after	we	had	purified	 fl-LcrH	 the	 crystal	 structure	of	 SycD	was	published.	
This	is	the	same	protein	as	LcrH	but	found	in	Yersina	enterocolitica.		The	sequence	identity	
of	both	proteins	is	extremely	high	with	only	two	variant	amino	acid	positions	(position	136	
and	138	–	Figure	3.7	a).	 Importantly,	 the	paper	showed	that	 the	construct	used	 to	obtain	
crystals	was	a	shortened	version	of	SycD	(tr-SycD)	that	was	more	stable	and	 less	prone	to	
aggregation.	 	 This	 shortened	 construct	 spanned	 from	position	21	 to	 163.	 	 The	N-terminal	
deletion	removed	a	mostly	unstructured	region,	whereas	the	C-terminal	deletion	removed	a	
solvent	exposed	cysteine.	 It	was	therefore	decided	that	we	should	also	obtain	a	truncated	
LcrH	(tr-LcrH).		
 
Sequence      1........10........20........30........40........50........60 
SycD         MQQETTDTQEYQLAMESFLKGGGTIAMLNEISSDTLEQLYSLAFNQYQSGKYEDAHKVFQ 
tr-SycD      --------------------GGGTIAMLNEISSDTLEQLYSLAFNQYQSGKYEDAHKVFQ 
fl-LcrH      MQQETTDTQEYQLAMESFLKGGGTIAMLNEISSDTLEQLYSLAFNQYQSGKYEDAHKVFQ 
tr-LcrH      --------------------GGGTIAMLNEISSDTLEQLYSLAFNQYQSGKYEDAHKVFQ 
                                    
 
Sequence     .........70........80........90........100.......110.......120 
SycD         ALCVLDHYDSRFFLGLGACRQAMGQYDLAIHSYSYGAIMDIKEPRFPFHAAECLLQKGEL 
tr-SycD      ALCVLDHYDSRFFLGLGACRQAMGQYDLAIHSYSYGAIMDIKEPRFPFHAAECLLQKGEL 
fl-LcrH      ALCVLDHYDSRFFLGLGACRQAMGQYDLAIHSYSYGAIMDIKEPRFPFHAAECLLQKGEL 
tr-LcrH      ALCVLDHYDSRFFLGLGACRQAMGQYDLAIHSYSYGAIMDIKEPRFPFHAAECLLQKGEL 
 
              
Sequence     .........130.......140.......150.......160....... 
SycD         AEAESGLFLAQELIANKPEFKELSTRVSSMLEAIKLKKEMEHECVDNP 
tr-SycD      AEAESGLFLAQELIANKPEFKELSTRVSSMLEAIKLKKEMEHE----- 
fl-LcrH      AEAESGLFLAQELIADKTEFKELSTRVSSMLEAIKLKKEMEHECVDNP 
tr-LcrH      AEAESGLFLAQELIADKTEFKELSTRVSSMLEAIKLKKEMEHE----- 
 
(a)	
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Figure	 3.7:	 (a)	 Multiple	 sequence	 alignment	 of	 protein	 sequences	 of	 SycD	 and	 tr-SycD	 from	 Yersinia	
enterocolitica	(both	shown	in	black)	with	fl-LcrH	and	tr-LcrH	(both	shown	in	dark	red)	from	Yersinia	pestis.	
Asparagine	‘N’	in	SycD	and	tr-SycD	is	aspartic	acid	‘D’	both	in	fl-LcrH	and	tr-LcrH	and	is	highlighted	in	yellow.	
Proline	‘P’	in	SycD	and	tr-SycD	is	Threonine	‘T’	both	in	fl-LcrH	and	tr-LcrH	and	is	highlighted	in	turquoise.	The	
65th	Leucine	residue	is	highlighted	in	green	and	was	changed	to	Glutamic	acid	to	obtain	monomeric	tr-SycD	
and	L65E	 tr-LcrH.	Amino	acid	sequence	numbers	are	shown	 in	 red.	This	 figure	was	generated	by	ClustalW	
multiple	alignment	software.	(b)	Ribbon	representation	of	head-to-head	conformation	of	dimeric	SycD21-163	
(tr-SycD)	 from	Yersinia	enterocolitica	which	 is	99	%	 identical	 to	tr-LcrH	from	Yersinia	pestis.	 tr-LcrH	differs	
from	SycD	in	only	two	positions	(N136D	and	P138T).	Asparagine	and	Proline	at	amino	acid	positions	136	and	
138	are	shown	in	yellow	and	blue	spheres	respectively.	The	65th	leucine	residue	is	shown	in	green	spheres	
and	 was	mutated	 to	 glutamic	 acid	 to	 obtain	 the	monomeric	 L65E	 LcrH.	 Chains	 A	 and	 B	 of	 SycD21-163	 are	
coloured	cyan	and	red	respectively.	Figure	was	prepared	using	PyMOL.	
	
The	tr-LcrH	gene	was	constructed	by	PCR	with	the	fl-LcrH	gene	as	template	and	a	forward	
primer	starting	at	the	DNA	codons	of	the	21st	amino	acid	and	a	reverse	primer	starting	from	
DNA	 codons	 of	 the	 163rd	 amino	 acid	 (Figure	 3.8).	 Both	 primers	 possessed	 a	 BamHI	 and	
HindIII	 restriction	 sites,	 respectively	 for	 insertion	 into	 the	 pTrc-GST	 expression	 vector	
(Section	2.1.4).	
(b)	
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Figure	3.8	Schematic	representing	the	construction	of	tr-LcrH	through	PCR	using	fl-LcrH	as	template,	forward	
primer	spanning	the	DNA	encoding	21st	amino	acid	with	BamHI	restriction	site,	reverse	primer	spanning	the	
DNA	 encoding	 the	 163rd	 amino	 acid	 which	 also	 included	 a	 stop	 codon	 and	 HindIII	 restriction	 site.	 The	
resultant	PCR	product	obtained	 is	shown	as	the	shortened	tr-LcrH	spanning	amino	acids	 from	position	21-
163.	
	
The	pTrc-GST	vector	inserted	with	tr-LcrH	gene	was	transformed	into	XL-1	Blue	strain	of	E.	
coli	 (section	 2.1.3.4)	 followed	 by	 isolation	 of	 DNA	 from	 individual	 colonies.	 This	 was	
followed	by	restriction	digestion	of	the	isolated	DNA	using	BamHI	and	HindIII	(section	2.1.4)	
in	order	to	screen	the	colonies	that	yielded	DNA	containing	correctly	sized	insert.	Those	with	
a	DNA	size	of	~430	base	pairs	(Figure	3.9)	were	sent	for	DNA	sequencing.	DNA	sequencing	
confirmed	that	tr-LcrH	gene	was	successfully	cloned	 in	pTrc-GST	vector	 (section	2.1.2.1.7).
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Figure	 3.9	 1.5	 %	 agarose	 gel	 showing	 restriction	 digestion	 of	 tr-LcrH	 gene	 from	 pTrc-GST	 vector.	 Lane	 1	
shows	100	bp	DNA	ladder.	Lanes	2,	3,	4,	7,	9	and	10	show	DNA	band	of	~430	bp	corresponding	to	correct	size	
of	tr-LcrH	gene.	
	
3.3.4 Expression	&	Purification	of	Truncated	LcrH	(tr-LcrH)	
As	before	the	pTrc-GST	vector	containing	the	tr-LcrH	gene	was	transformed	into	BL21	C41	
(DE3)	 expression	 strain	 of	E.	 coli	 to	 produce	GST-tagged	 tr-LcrH	 protein.	 The	 protocol	 for	
GST-tagged	tr-LcrH	protein	production	was	identical	to	that	used	for	the	production	of	GST-
tagged	fl-LcrH	production	(Section	2.1.4).	The	protein	production	and	elution	profile	of	GST-
tagged	tr-LcrH	is	shown	in	Figure	3.10(a).	The	GST-tag	was	cleaved	off	the	tr-LcrH	protein	by	
using	thrombin	protease	giving	a	band	of	≈	16	kDa	shown	in	Figure	3.10b.		
	
Figure	3.10	18	%	SDS-PAGE	gel	 showing	 (a)	protein	production	of	GST-tagged	tr-LcrH:	Lane	1	–	 lysed	cells,	
lane	2	–	supernatant	protein,	 lane	3	–	protein	marker,	 lane	4	–	flow	through,	 lane	5	–	wash,	 lanes	6	&	7	–	
GST-tagged	 tr-LcrH	 bound	 to	 glutathione	 agarose	 resin,	 lane	 8	 –	 protein	marker.	 (b)	 Cleavage	 of	 GST	 tag	
from	tr-LcrH	using	thrombin	protease.	Lane	1	–	GST-tagged	tr-LcrH	bound	to	the	glutathione	agarose	resin,	
lanes	2-4	–	thrombin	protease	 induced	cleavage	for	separation	of	GST	tag	from	tr-LcrH	on	the	glutathione	
agarose	resin,	lane	5	–	protein	marker.		
(a)	 (b)	
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The	tr-LcrH	protein	was	concentrated	and	further	subjected	to	purification	by	size	exclusion	
chromatography	 (Section	 2.2.1.6),	 which	 ensured	 the	 removal	 of	 thrombin	 protease	 and	
enabled	 to	 achieve	 more	 than	 95	 %	 purity.	 The	 protein	 samples	 eluted	 from	 the	 size	
exclusion	chromatography	we	loaded	on	an	18	%	SDS-PAGE	gel	(Section	2.2.2.2)	to	check	for	
the	level	of	purity,	shown	in	Figure	3.11.		The	tr-LcrH	protein	samples	eluted	from	the	size	
exclusion	chromatography	column	showed	bands	of	≈	16	kDa	more	than	95	%	purity.	Thus,	
tr-LcrH	was	successfully	produced	and	purified.	
	
	
	
	
	
	
	
Figure	3.11:	 (a)	 Size	exclusion	 chromatography	profile	of	 tr-LcrH	using	S200	16/60	 column.	 	 (b)	18	%	SDS-
PAGE	gel	 showing	 tr-LcrH	protein	 samples	purified	by	 size	exclusion	chromatography.	 Lanes	1	 to	8	are	 tr-
LcrH	SEC	fractions	from	70	ml	until	110	ml	with	each	fraction	of	5	ml	volume.			
	
3.3.5 Construction	of	L65E	tr-LcrH	
The	study	that	described	the	crystal	structure	of	SycD	(and	thus	obviously	LcrH)	also	showed	
that	a	single	amino	acid	mutation	could	render	the	SycD	dimer	monomeric	[168,194].	This	
mutation	 was	 L65E	 (Figure	 3.7).	 It	 was,	 therefore,	 important	 that	 we	 also	 obtained	 this	
monomeric	version	of	LcrH.	To	obtain	LE65	tr-LcrH	site	directed	mutagenesis	was	performed	
on	 the	 pTrc-GST	 expression	 plasmid	 containing	 the	 tr-LcrH	 gene	 (Section	 2.1.5).	
Confirmation	of	 the	mutation	was	obtained	 through	DNA	sequencing	by	Beckman	Coulter	
Genomics	Ltd.	(Section	2.1.2.1.7).	
	
(a)	 (b)	
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3.3.6 Expression	and	Purification	of	L65E	tr-LcrH	
The	protein	was	produced	using	 the	protocol	 identical	 to	 that	used	 for	 the	production	of	
GST-tagged	 fl-LcrH	 (Section	 3.3.2)	 and	 GST-tagged	 tr-LcrH	 (Section	 3.3.3)	 proteins.	 The	
protein	samples	were	loaded	onto	an	18	%	SDS-PAGE	for	analysis	and	Figure	3.12	shows	the	
protein	 production,	 affinity	 purification	 and	 cleavage	 of	 the	 GST	 tag	 using	 thrombin	
protease.	
	
	
Figure	 3.12:	 (a)	 Size	 exclusion	 chromatography	 elution	 profile	 of	 L65E	 tr-LcrH	 using	 Superdex	 200	 16/60	
column.	Eluted	protein	fractions	from	70-115	ml	were	pooled	and	concentrated	further.	(b)	18	%	SDS-PAGE	
gel	showing	the	GST-tagged	L65E	tr-LcrH	production,	its	affinity	purification	profile	and	cleavage	of	GST	tag	
using	thrombin	protease.	Lane	1	–	protein	ladder,	lane	2	–	lysed	cells,	lane	3	–	supernatant	protein,	lane	4	–	
flow	through,	 lanes	5	&	6	–	 resin	sample	showing	 the	bound	GST-tagged	L65E	 tr-LcrH,	 lanes	7	&	8	–	 resin	
sample	 showing	 the	 thrombin	 cleavage	 of	 GST-tagged	 L65E	 tr-LcrH,	 lanes	 9	 &10	 –	 eluted	 L65E	 tr-LcrH	
showing	a	band	≈	16	KDa,	identical	to	tr-LcrH	protein.	
	
The	eluted	L65E	tr-LcrH	after	cleavage	of	GST-tag	showed	a	pure	L65E	tr-LcrH	band	of	≈	16	
kDa,	identical	to	tr-LcrH	(Figure	3.11	(b)).	L65E	tr-LcrH	was	then	subjected	to	size	exclusion	
chromatography	for	the	removal	of	thrombin	protease	and	achieve	more	than	95	%	purity.	
Importantly,	 the	 size	exclusion	chromatography	 showed	 that	 the	 LE65	mutant	eluted	at	a	
larger	 volume	 than	 tr-LcrH	 (~95	ml	 vs	~80	ml).	 	 This	 is	 consistent	with	 LE65	 tr-LcrH	being	
monomeric	and	tr-LcrH	being	dimeric.	
	
(a)	 (b)	
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3.3.7 Initial	characterization	of	LcrH	constructs	
3.3.7.1 Defining	buffer	&	protein	concentrations	to	maintain	“native”	oligomeric	
states	of	LcrH	constructs	
During	 the	 purification	 of	 all	 LcrH	 constructs	 it	 was	 obvious	 that	 they	 were	 prone	 to	
aggregation.	 This	 manifested	 itself	 mainly	 during	 concentration	 steps	 where:	 (i)	 protein	
concentration	was	lost	and	(ii)	UV-Vis	absorbance	showed	high	signal	at	320	nm.	Therefore	
it	was	important	to	define	suitable	buffer	and	protein	concentrations	conditions	were	they	
would	remain	in	“native”	oligomeric	states.		
Buffer	 conditions	were	 chosen	 by:	 (i)	 calculating	 the	 isoelectric	 point	 (pI)	 of	 the	 proteins	
using	the	ExPASy	–	ProtParam	tool	[166-168,194]	and	(ii)	choosing	a	pH	that	was	2	pH	units	
away	from	the	pI.	The	theoretical	pI	of	the	proteins	is	as	follows:	4.70	for	fl-LcrH,	4.95	for	tr-
LcrH	and	4.87	for	L65E	tr-LcrH.	Thus,	50	mM	phosphate	buffer	at	pH	7.0	was	chosen	(this,	
fortuitously,	also	emulated	physiological	conditions).	Phosphate	buffer	was	also	chosen	as	it	
can	 specifically	 stabilise	 certain	 proteins.	 In	 addition	 5	 mM	 DTT	 was	 added	 to	 prevent	
disulphide	bond	formation.		
To	 determine	 what	 protein	 concentrations	 these	 buffer	 conditions	 enabled	 (i.e.	 no	
aggregation	 was	 observed)	 the	 proteins	 were	 firstly	 concentrated	 until	 protein	 loss	 was	
observed	through	gain	of	UV	absorbance	at	320	nm	and	 loss	at	280	nm.	The	highest	non-
aggregating	concentrations	for	fl-LcrH,	tr-LcrH	and	LE65	tr-LcrH	were	300	µM,	500	µM	and	
150	µM,	respectively.	To	confirm	whether	these	conditions	were	stable	over	1	week,	each	
protein	 was	 concentrated	 to	 the	 aforementioned	 value	 and	 subjected	 to	 analytical	 SEC	
(Section	 2.3.1).	 They	were	 then	 stored	 at	 4	 °C	 for	 one	week	 and	 then	 analytical	 SEC	was	
repeated.	Figure	3.13	shows	the	analytical	SEC	traces	for	each	LcrH	protein	before	and	after	
1	week	at	4°C.	
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Figure	 3.13	 Analytical	 size	 exclusion	 chromatography	 profile	 of	 LcrH	 proteins	 using	 SuperdexTM	 75	 10/30	
column	before	and	after	1	week:	(a)	fl-LcrH	at	300	µM,	(b)	tr-LcrH	at	500	µM	and	(c)	L65E	tr-LcrH	at	150	µM.	
The	elution	profile	in	black	denotes	the	first	analytical	SEC	run	for	the	respective	LcrH	protein	samples	at	the	
aforementioned	protein	 concentrations.	The	elution	profile	 in	 red	denotes	 the	analytical	 SEC	of	 the	 same	
protein	samples	stored	 for	1	week	at	4	 °C.	TPR	standards:	CTPR3	 (blue)	and	CTPRa6	 (green).	Each	protein	
sample	at	the	respective	concentrations	was	loaded	using	100	µl	sample	loop	in	50	mM	Phosphate,	pH	7.0,	5	
mM	 DTT	 at	 25	 °C.	 	 Figure	 was	 prepared	 using	 KALEIDAGRAPH	 4.0.
	
Figure	3.13(a)	did	not	show	any	evidence	of	aggregation	in	the	protein	samples.	The	elution	
peak	for	both	samples	i.e.	before	and	after	storage	at	4	°C	was	≈	9.8	ml.	However,	a	tailing	
peak	at	≈	11-13	ml	was	observed	 in	both	sample	runs,	which	can	be	attributed	to	protein	
degradation.	Figure	3.13	 (b)	 shows	 the	analytical	SEC	profile	 for	 tr-LcrH	at	500	µM	before	
and	 after	 storage	 at	 4	 °C.	 The	 elution	 profile	 for	 both	 sample	 runs	 was	 identical.	 The	
(a)	
(c)	
(b)	
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difference	 in	 the	 absorbance	 peaks	 between	 the	 two	 samples	 could	 be	 attributed	 to	 the	
variability	 in	 sample	 runs.	 The	 analytical	 SEC	 profile	 for	 L65E	 tr-LcrH	 at	 150	 µM	 was	
indistinguishable	for	both	sample	runs.	The	elution	volume	for	both	sample	runs	was	≈	10.8	
ml.	 Additionally,	 the	 elution	 volumes	 of	 both	 tr-LcrH	 and	 fl-LcrH	 are	 close	 to	 that	 of	 the	
dimeric	TPR	standard	CTPRa6	(10.55	ml).	Thus,	confirming	the	dimeric	oligomeric	state	of	tr-
LcrH	and	fl-LcrH.	Figure	3.13	(c)	represents	the	analytical	SEC	profile	of	monomeric	mutant	
L65E	tr-LcrH.	Both	elution	profiles	for	L65E	tr-LcrH	are	nearly	identical.	The	elution	profiles	
gives	an	indication	of	aggregation	(small	elution	peaks	before	the	void	volume	(Vo)	=	8.5	ml)	
and	some	degradation	products	(tailing	peaks)	in	both	sample	runs.		
On	 comparing	 the	 analytical	 SEC	 profile	 of	 LcrH	 proteins	 at	 their	 respective	 protein	
concentrations	 it	 was	 observed	 that	 over	 the	 course	 of	 one	 week	 the	 proteins	 did	 not	
undergo	 significant	 changes.	 This	 confirmed	 that	 the	 highest	 non-aggregating	 protein	
concentrations	 determined	 for	 each	 of	 LcrH	 protein	 constructs	 and	 the	 buffer	 conditions	
used	were	stable	over	time.	As	can	be	seen	all	proteins	were	stable	over	this	time	course	at	
their	 respective	concentrations	with	 little	 loss	of	protein.	This	was	confirmed	by	obtaining	
the	 concentration	of	 each	protein	 by	UV-Vis	 absorbance	 at	 280	nm	before	 and	 after	 one	
week	at	4	°C.			
The	elution	profiles	of	the	protein	samples	before	and	after	one	week	storage	at	4	°C	were	
identical.	For	fl-LcrH,	tr-LcrH	and	L65E	tr-LcrH	this	equated	to	peak	elution	volumes	of	~9.6	
ml,	 ~9.8	 ml	 and	 ~10.8	 ml	 respectively.	 The	 tailing	 peak	 in	 the	 fl-LcrH	 elution	 profile	 is	
consistent	with	slight	degradation	(similar	in	both	runs).	The	slight	difference	in	the	size	of	
the	elution	peaks	 is	simply	due	to	the	variability	of	the	UV-Vis	detector	of	the	AKTA	FPLC.	
The	protein	concentration	was	confirmed	by	obtaining	UV-Vis	absorbance	at	280	nm	of	each	
protein	 before	 and	 after	 one	 week	 prior	 to	 each	 analytical	 SEC	 run.	 Interestingly,	 a	
difference	in	size	of	the	elution	peaks	of	LcrH	proteins	was	observed.	The	peak	sizes	for	LcrH	
proteins	were	 in	 the	 following	order:	 fl-LcrH>tr-LcrH>L65E	 tr-LcrH.	 This	 is	 suggestive	of	 fl-
LcrH	and	tr-LcrH	being	dimeric	and	L65E	tr-LcrH	monomeric	(discussed	in	Chapter	4).		
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3.3.7.2 Far-UV	circular	dichroism	of	native	LcrH	constructs	
To	confirm	that	the	conditions	used	above	produced	correctly	folded	LcrH	constructs	far-UV	
CD	spectra	were	obtained	(section	2.4.1).	Figure	3.14	shows	the	native	and	urea	denatured	
far-UV	CD	spectra	of	 fl-LcrH,	tr-LcrH	and	L65E	tr-LcrH	at	3	µM	(spectra	measured	 in	5	mm	
path	 length	 cuvette)	 and	 50	 µM	 (spectra	 measured	 in	 1	 mm	 path	 length	 cuvette)	
respectively.	 	 The	 native	 spectra	 clearly	 show	 correctly	 alpha-helically	 folded	 protein,	 as	
they	possess	minima	at	222	nm	and	208	nm.		Interestingly	the	fl-LcrH	has	approximately	10	
%	 greater	 signal	 at	 222	 nm	 than	 both	 tr-LcrH	 and	 its	 LE65	mutant	 (which	 are	 identical).	
When	8	M	urea	is	added	to	LcrH	proteins	there	is	a	complete	loss	of	secondary	structure	as	
shown	by	the	disappearance	of	the	minima	at	208	&	222	nm.	
	
Figure	 3.14	 Far-UV	 CD	 spectra	 comparing	 native	 fl-LcrH	 (black),	 tr-LcrH	 (blue).	 L65E	 tr-LcrH	 (green)	 and	
denatured	L65E	tr-LcrH	 in	8	M	urea	 (red)	 for	concentrations:	 (a)	3µM	(spectra	measured	using	5	mm	path	
length	cuvette)	and	(b)	50µM	(spectra	measured	using	1	mm	path	 length	cuvette)	The	detector	on	the	CD	
spectrophotometer	became	 saturated	with	HT	 voltage	exceeding	850	 volts	 after	 212	nm	 for	 samples	 in	 5	
mm	 cuvette	 and	 after	 208	 nm	 for	 samples	 in	 1	 mm	 path	 length	 cuvette.	 Figure	 was	 prepared	 using	
KALEIDAGRAPH	4.0.		
	
In	the	above	Figure	3.14,	 far-UV	CD	spectra	for	LcrH	protein	samples	at	3	μM	and	50	μM,	
were	 masked	 beyond	 wavelengths	 at	 212	 nm	 and	 208	 nm	 respectively	 because	 the	 HT	
voltage	of	 the	detector	of	 the	CD	spectropolarimeter	 increased	to	above	800	volts.	This	 is	
because	if	the	HT	voltage	goes	above	~800	volts	the	noise	becomes	disproportionate	to	the	
sample	 signal	 and	 the	 output	 is	 completely	 unreliable	 (Section	 2.4.1	 and	 Jasco	 J-715	
Spectropolarimeter	Operating	Manual).	
	
	
(b)	(a)	
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3.3.8 Conclusion	
The	 three	 protein	 constructs	 of	 LcrH	 –	 fl-LcrH,	 tr-LcrH	 and	 L65E	 tr-LcrH	were	 successfully	
produced	and	purified.	We	were	able	 to	define	 suitable	buffer	 and	protein	 concentration	
conditions	 for	maintenance	of	native	oligomeric	 states	of	 the	 respective	proteins	 through	
analytical	size	exclusion	chromatography.	Far-UV	CD	spectroscopy	enabled	to	confirm	that	
the	conditions	used	produced	correctly	folded	proteins.	In	the	following	chapter	we	explore	
the	oligomeric	states	and	thermodynamic	stability	of	LcrH	protein	constructs.	
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Chapter	4 Oligomeric	 State,	 Flexibility	 and	 Thermodynamic	
Stability	of	LcrH	protein	constructs	
	
4.1 Introduction	
In	this	chapter	we	explore	the	oligomeric	state,	flexibility	and	thermodynamic	stability	
of	each	of	our	constructs	of	LcrH.	These	investigations	enable	the	dissection	of	the	role	
of	oligomeric	state	and	stability	on	LcrH’s	biological	function.	
	
4.2 Experimental	Approaches	
The	monomer-dimer	equilibrium	and	the	oligomeric	state	of	the	different	constructs	of	
LcrH	 was	 determined	 by	 analytical	 size	 exclusion	 chromatography,	 dynamic	 light	
scattering	 and	 analytical	 ultracentrifugation	 We	 then	 examine	 the	 thermodynamic	
stability	 and	 flexibility	 of	 our	 different	 LcrH	 constructs	 by	 performing	 equilibrium	
unfolding	 through	 chemical	 denaturation.	 The	 unfolding	 was	 monitored	 by	 far-UV	
circular	dichroism	and	fluorescence	spectroscopy	as	probes	for	secondary	and	tertiary	
structures	respectively.		
	
4.3 Results	
4.3.1 Oligomeric	 States	 of	 LcrH	 using	 Analytical	 Size	 Exclusion	
Chromatography	(SEC)	
Class	II	chaperones	of	the	type	three	secretion	system	(TTSS)	in	gram	negative	bacteria	
Yersinia,	 Shigella	and	Pseudomonas	 species	 have	 been	 shown	 to	 be	 homodimeric	 in	
solution	[166-168,195].	In	Chapter	3	we	obtained	conditions	where	fl-LcrH,	tr-LcrH	and	
L65E	 tr-LcrH	 were	 ‘’stable’’	 (i.e.	 maintained	 a	 ‘‘native’’	 oligomeric	 state).	 These	
experiments	 were	 carried	 out	 at	 high	 concentrations	 and	 gave	 elution	 profiles	 in	
analytical	SEC	of	dimeric	size	for	fl-LcrH	and	tr-LcrH	but	monomeric	for	L65E	tr-LcrH.	To	
qualitatively	 probe	 the	monomer-dimer	 equilibrium	 of	 fl-LcrH	 and	 tr-LcrH,	 analytical	
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SEC	 was	 performed	 over	 a	 range	 of	 protein	 concentrations.	 LcrH	 is	 a	 non-globular	
protein	with	each	monomeric	unit	comprising	of	3.5	modular	tetratricopeptide	repeats	
(TPRs).	 Thus,	 two	 non-globular	 protein	 standards	 –	 CTPR3	 (3.5	 continuously	 arrayed	
TPR	motifs)	and	CTPRa6	(6.5	continuously	arrayed	TPR	motifs)	were	chosen	as	protein	
standards	 for	 comparing	 the	 molecular	 sizes.	 The	 crystal	 structure	 of	 SycD	 (99%	
identical	 to	 LcrH)	 shows	 that	 the	 dimeric	 form	 of	 the	 protein	 produces	 a	 ‘’head-to-
head’’	dimer.	Thus,	dimeric	LcrH	should	have	a	similar	size	to	that	of	CTPRa6.	Whereas	
the	 monomeric	 LcrH	 (L65E	 tr-LcrH)	 should	 elute	 with	 size	 similar	 to	 that	 of	 CTPR3	
(Figure	4.1).		
	
Figure	4.1	Ribbon	representation	of	the	crystal	structures	of	(a)	head-to-head	confirmation	of	dimeric	
SycD21-163	 [Protein	 Data	 Bank	 (PDB)	 entry:	 2VGX],	 chains	 A	 and	 B	 are	 shown	 in	 cyan	 and	 red	
respectively,	(b)	CTPR3	(PDB	entry:	1NA0),	(c)	CTPRa6.	The	figure	was	prepared	using	PYMOL.		
	
Figure	4.2	(a)	and	Figure	4.2	(b)	show	the	analytical	SEC	profile	for	fl-LcrH	and	tr-LcrH	
from	3	–	100	µM	respectively.	These	show	that	at	higher	concentrations	(100	µM),	fl-
LcrH	 and	 tr-LcrH	 eluted	 with	 volumes	 of	 9.7	 ml	 and	 9.6	 ml	 respectively,	 and	 were	
consistent	with	a	homodimeric	structure	(in	close	agreement	with	an	elution	peak	of	
9.6	 ml	 for	 the	 designed	 TPR	 protein	 CTPRa6	 containing	 6.5	 stacked	 repeats).	
(a)	
(b)	
(c)	
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Interestingly,	 when	 the	 protein	 concentrations	 were	 lowered	 to	 more	 physiological	
concentrations	 i.e.	from	100	µM	to	3	µM,	the	elution	volumes	for	fl-LcrH	and	tr-LcrH	
were	observed	to	shift	to	that	of	a	monomeric	sized	protein.	The	lowest	concentration	
of	3	µM	for	tr-LcrH	eluted	at	10.7	ml,	which	was	identical	to	the	elution	volume	of	10.7	
ml	 for	monomeric	 L65E	 tr-LcrH	and	 similar	 to	 elution	 volume	of	 10.55	ml	 for	CTPR3	
protein	(containing	3.5	stacked	repeats).	
Figure	 4.2	 Analytical	 size	 exclusion	 chromatography	 profile	 of	 fl-LcrH	 (a)	 and	 tr-LcrH	 (b)	 using	
Superdex	 75	 HR	 10/30	 column	 at	 protein	 concentrations	 of	 100	 µM	 (red),	 50	 µM	 (blue),	 25	 µM	
(brown),	12	µM	(green),	6	µM	(purple)	and	3	µM	(orange).	For	calibration,	 two	protein	 standards	–	
CTPRa6	and	CTPR3	were	 also	 run.	 CTPRa6	 is	 a	 designed	TPR	protein	 that	 contains	 6.5	 continuously	
arrayed	TPR	motifs.	CTPR3	is	also	a	designed	TPR	protein	that	contains	3.5	continuously	arrayed	TPR	
motifs.	Both	the	protein	standards	are	coloured	black;	with	cTPRa6	having	elution	volume	of	9.6	ml	
and	cTPR3	shows	an	elution	volume	of	10.55	ml.	Monomeric	L65E	tr-LcrH	is	shown	in	grey	and	has	an	
elution	 volume	of	 10.7	ml.	 In	 the	 respective	 inset	 figures,	 the	elution	 volumes	of	 LcrH	proteins	 are	
plotted	 against	 their	 respective	 protein	 concentrations.	 Figure	 was	 prepared	 using	 KALEIDAGRAPH	
4.0.
(a)	
(b)	
102	
	
	 	
The	change	in	elution	profile	shows	that	LcrH	is	present	in	monomer-dimer	equilibrium	
at	 physiological	 protein	 concentrations	 and	 therefore	 has	 a	 relatively	 weak	
dimerisation	 interaction.	 It	 also	 suggests	 that	 its	 KD	 value	 should	 be	 in	 the	 low	
micromolar	range.		
4.3.2 Determination	of	Dimerization	Dissociation	Constant	(KD)	using	
Analytical	Ultracentrifugation	(AUC)	
The	previous	section	suggested	that	the	dimerization	dissociation	constant	(KD)	should	
be	in	the	low	micromolar	(µM)	concentration	range	for	tr-LcrH	and	fl-LcrH.	In	order	to	
accurately	 determine	 the	 KD	 value,	 equilibrium	 sedimentation	 by	 analytical	
ultracentrifugation	 for	 tr-LcrH	 was	 performed	 (section	 2.3.2,	 Figure	 4.3).	
Figure	 4.3	 Equilibrium	 Analytical	 Ultracentrifugation	 (AUC)	 for	 tr-LcrH,	 the	 figure	 shows	 (a)	 the	
representative	 curve	 obtained	 from	 equilibrium	 sedimentation	 using	 analytical	 ultracentrifugation	
denoted	by	black	dots	and	the	line	of	best	fit	(red)	to	a	monomer-dimer	equilibrium	model	using	the	
program	Ultrascan,	(b)	fitted	residuals	shown	by	black	filled	circles.		
(a)	
0 
(b)	
0 
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From	 Figure	 4.3	 (b),	 it	 can	 be	 observed	 that	 the	 residuals	 from	 the	 fit	 appear	 to	 be	
scattered	 randomly	 and	 have	 an	 absorbance	 close	 to	 zero.	 This	 deemed	 the	 fit	
appropriate.	No	other	trends	can	be	observed	in	the	residuals	so	does	not	need	to	be	
fitted	to	another	model	except	the	monomer-dimer	equilibrium	model	(Equation	2.6).	
Multiple	 curves	 from	 the	 equilibrium	 sedimentation	 experiment	 were	 fitted	 and	
calculations	 were	 carried	 out	 using	 the	 Equation	 2.6.	 This	 gave	 a	 dimerization	
dissociation	 constant	 𝐾!	 of	 15	 ±	 5	 µM.	 The	 errors	 and	 confidence	 limits	 were	
calculated	as	mentioned	in	section	2.3.2.		
4.3.2.1 Calculating	percentage	of	dimer	at	a	given	protein	concentration	
After	determining	the	dimerization	dissociation	constant	𝐾!for	tr-LcrH,	the	percentage	
of	the	protein	population	that	is	dimeric	can	be	calculated	as	follows:	
The	 monomer-dimer	 chemical	 equilibrium	 at	 a	 given	 protein	 concentration	 can	 be	
illustrated	by	the	Equation	4.1	below.		
Equation	4.1	 𝑀 +𝑀 ⇌ 𝐷	
Where	 D	 is	 the	 dimer	 and	 M	 is	 the	 monomer.	 Thus,	 the	 dimerization	 dissociation	
constant	𝐾!	of	this	equilibrium	is:	
Equation	4.2	
𝐾! =  𝑀 [𝑀][𝐷] =   [𝑀]![𝐷] 	
The	total	protein	concentration (𝐶!)	for	the	dimeric	system	can	be	written	as:	
Equation	4.3	 [𝐶!] = M + 2[D] 	
Rearranging	Equation	4.3	and	solving	for	M	gives	
Equation	4.4	 𝑀 = 𝐶! − 2 𝐷 	
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Substituting	Equation	4.4	into	the	𝐾!	expression	(Equation	4.2)	gives	
Equation	4.5	 𝐾! =  (𝐶! − 2𝐷)(𝐶! − 2𝐷)𝐷 	
	
Solving	the	above	Equation	4.5	into	quadratic	form	gives:	
Equation	4.6	
𝐷 =  4𝐶! +  𝐾!  ±  (8𝐶! ∗ 𝐾! +  𝐾!!)8 	
Fraction	of	dimeric	species	(𝐹!)	at	any	given	protein	concentration	can	be	defined	by:		
Equation	4.7	 𝐹! =  2[𝐷][𝐶!] 	
	‘𝐹!′	is	the	fraction	of	total	‘D’	(dimer),	which	can	vary	from	0	to	1	and	′𝐶!′	is	the	total	
protein	concentration.		
Thus,	by	substituting	Equation	4.6	in	Equation	4.7	we	obtain:	
Equation	4.8	
𝐹! = 4𝐶! +  𝐾!  ±  (8𝐶! ∗ 𝐾! +  𝐾!!)4[𝐶!]  	
	
A	 saturation-binding	 curve	 of	 𝐹!	 (fraction	 of	 total	 dimer)	 vs	 𝐶! 	 (total	 protein	
concentration)	using	Equation	4.8	with	the	dimerization	dissociation	constant	𝐾!	value	
of	15	µM	was	plotted	(Figure	4.4).		
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Figure	4.4	Saturation	binding	curve	for	dimerization	of	tr-LcrH	showing	a	graph	of	Y	vs	𝑪𝑻,	where	Y	is	
the	fraction	of	total	possible	dimer	which	varies	between	0	to	1,	𝑪𝑻	is	the	total	protein	concentration	
(µM)	and	the	dimerization	dissociation	constant	𝑲𝑫	=	15	±	5	µM.	
	
The	curve	in	Figure	4.4	is	hyperbolic	with	half-maximal	dimer	formation	occurring	at	a	
total	protein	concentration	of	𝐶! 	=	𝐾!.	It	can	also	be	noted	that	even	at	a	total	protein	
concentration	 of	 600	 µM,	 which	 is	 40-fold	 greater	 than	𝐾!,	 only	 90	 %	 of	 the	 total	
possible	 dimer	 (D)	 is	 formed	 (𝐹!=	 0.90).	When	𝐶! 	 =	 90	 µM,	 75	%	 of	 the	 protein	 is	
dimeric	 (𝑌	 =	 0.75).	 The	 percentages	 of	 dimer	 at	 protein	 concentrations	we	will	 use	
later	are	shown	in	Table	4.1.	The	table	shows	that	even	at	lower	concentrations	of	tr-
LcrH	there	is	some	dimer	present.	
Table	4.1:	Dimer	percentages	at	resepective	protein	concentrations	of	tr-LcrH	
	
	
	
	
	
	
	
	
	
	
Total	Protein	
Concentration	(µM)	
Percentage	of	Dimer	
(%)	
1	 11	
3	 23	
6	 34	
12	 46	
25	 58	
50	 68	
80	
100	
74	
76	
The	 table	 shows	 percentages	 of	 dimer	 population	 of	 tr-
LcrH	 at	 the	 given	 total	 protein	 concentrations	 (µM).	 The	
dimer	 percentages	 have	 been	 rounded	 up	 to	 the	 next	
highest	number.		
106	
	
	 	
4.3.3 Loss	 of	 LcrH’s	 α-Helical	 Structure	 on	 N-terminal	 Deletion	 and	
Concentration	Reduction	
As	 LcrH	 is	 a	 completely	 α-helical	 protein,	 far-UV	 CD	 provides	 an	 excellent	 probe	 for	
monitoring	 its	 secondary	 structure	 in	 solution.	 In	 the	 previous	 chapter	we	 observed	
that	 under	 our	 conditions	 all	 LcrH	 constructs	 exhibit	 strong	 α-helical	 signals	 with	
indicative	minima	 at	 208	 and	 222	 nm.	 Thus,	 to	 probe	whether	 any	 structure	 is	 lost	
between	fl-LcrH	and	tr-LcrH	or	transition	from	dimer	to	monomer,	far-UV	CD	spectra	
were	 recorded	 for	 protein	 concentrations	 of	 3	 –	 100	 µM.	 The	 CD	 ellipticity	 at	 each	
concentration	 was	 converted	 to	 molar	 ellipticity	 (Equation	 2.9)	 for	 ease	 of	 data	
comparison	 and	 to	 correct	 for	 path	 length	 and	 protein	 concentration	 (Figure	 4.5).
	
	
	
	
	
	
	
	
	
	
	
Figure	4.5	far-UV	CD	spectra	showing	molar	ellipticity	from	200	to	300	nm	for	native	fl-LcrH	(a)	and	tr-
LcrH	 (b)	 at	 concentrations	 of	 100	 µM	 (red),	 50	 µM	 (blue),	 25	 µM	 (brown),	 12	 µM	 (green),	 6µM	
(purple),	and	3	µM	(orange).	Figure	was	prepared	using	KALEIDAGRAPH	4.0.	
Interestingly,	we	observed	a	reduction	in	the	signal	(molar	ellipticity	at	222	nm)	when	
tr-LcrH	was	 compared	with	 fl-LcrH	 and	when	 the	 concentration	of	 each	protein	was	
decreased.	In	each	case	the	change	was	small	as	follows:	at	50	µM,	fl-LcrH	and	tr-LcrH	
(a)	
(b)	
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have	molar	 ellipticities	 at	 222	 nm	 of	 -3.1	 ×	 106	 and	 -2.7	 ×	 106	 degrees	 cm2	 dmol-1,	
respectively,	and	at	3.1	µM,	fl-LcrH	and	tr-LcrH	have	molar	ellipticities	of	-2.8	×	106	and	
-2.5	 ×	 106	 degrees	 cm2	 dmol-1,	 respectively.	 In	 both	 comparisons	 this	 equates	 to	 a	
maximal	 change	 of	 ≈	 10	%.	 The	 reduction	 of	 α-helical	 signal	 from	 fl-LcrH	 to	 tr-LcrH	
suggested	that	the	N-terminal	20	amino	acid	deletion	of	LcrH	removes	some	α-helical	
structure.	 The	 loss	 of	 α-helical	 signal	 with	 a	 decrease	 in	 protein	 concentration	 is	
consistent	 with	 the	 weak	 monomer/dimer	 equilibrium	 i.e.	 the	 reduction	 in	
concentration	of	LcrH	results	in	a	monomeric	state,	which	is	less	α-helically	structured	
than	the	dimer.		
	
4.3.4 Equilibrium	Unfolding	and	Thermodynamic	Stability	of	LcrH	
To	determine	the	flexibility	and	thermodynamic	stability	of	fl-LcrH,	tr-LcrH	and	L65E	tr-
LcrH	equilibrium	chemical	denaturation	experiments	were	performed	 (section	2.5.3).	
However,	to	achieve	analysable	denaturation	experiments	that	were	reproducible,	we	
first	needed	to	determine	the	following:	
i. The	best	structural	probe	to	monitor	the	chemical	denaturation		
ii. The	most	suitable	chemical	denaturant		
iii. The	minimum	equilibration	 time	 that	produced	a	proper	equilibrium	at	every	
denaturant	concentration	
iv. The	reversibility	of	equilibrium	unfolding		
4.3.4.1 The	Best	Structural	Probe	to	Monitor	Chemical	Denaturation	
In	general,	two	highly	used	biophysical	probes	for	protein	structural	change	are	far-UV	
circular	dichroism	(far-UV	CD)	and	fluorescence.	This	is	because	both	these	techniques	
require	small	concentrations	of	protein	sample,	 low	sample	volumes	and	exhibit	high	
sensitivity.	Far	UV	CD	is	an	absorbance-based	technique	that	monitors	the	secondary	
structure	of	a	protein	while	fluorescence	monitors	the	tertiary	structural	changes.	LcrH	
should	 be	 amenable	 to	 both	 techniques,	 as	 firstly	 it	 has	 a	 high	 alpha-helical	 native	
structure	 thereby	making	 it	 easy	 to	 gain	 information	 about	 the	 secondary	 structure	
and	folded	state	of	proteins	using	far	UV	CD.	 	Secondly,	 fl-LcrH	and	tr-LcrH	contain	8	
and	 7	 tyrosine	 residues	 respectively.	 Hence,	 tyrosine	 fluorescence	 can	 be	 used	 as	 a	
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tertiary	structure	probe	to	monitor	changes	in	LcrH’s	protein	structure	when	subjected	
to	unfolding.		
To	observe	the	change	in	signal	of	both	these	probes	on	LcrH’s	unfolding,	each	protein	
construct	was	incubated	with	8	M	urea.	Figure	4.6	(a-c)	shows	the	far-UV	CD	spectra	of	
native	and	denatured	 LcrH	proteins	 (fl-LcrH,	 tr-LcrH	and	 L65E	 tr-LcrH)	 at	 3	µM	 in	50	
mM	Phosphate,	pH	7.0,	5	mM	DTT.	The	native	and	8	M	urea	denatured	LcrH	protein	
samples	were	incubated	at	25	°C	for	6	hours	prior	to	recording	far-UV	CD	spectra.	The	
native	protein	samples	showed	strong	α-helical	signal	with	minima	at	222	nm	and	208	
nm	 (minima	at	208	nm	not	 shown	 in	 figure).	 This	 is	 consistent	with	 their	high	alpha	
helical	native	secondary	structure.	When	a	high	molarity	of	chemical	denaturant	(8	M	
urea)	was	 introduced	 these	 indicative	minima	disappeared,	 displaying	 that	 all	 native	
structure	 was	 unfolded.	 Importantly,	 the	 change	 in	 signal	 between	 folded	 and	
unfolded	 protein	 samples	 was	 suitably	 large.
Figure	4.6	Far-UV	CD	spectra	at	3	µM	protein	concentration	of	(a)	fl-LcrH,	(b)	tr-LcrH,	(c)	L65E	tr-LcrH	
showing	native	(black	filled	circles)	and	8	M	urea	denatured	(red	filled	circles).	The	CD	spectra	of	the	
samples	was	 taken	using	5	mm	path	 length	quartz	cuvette	at	25	±	0.2	 °C.	The	data	was	masked	 for	
wavelengths	below	212	nm	as	the	CD	detector	became	saturated	with	voltage	exceeding	850	HT	volts.	
(d)	Tyrosine	fluorescence	of	3	µM	tr-LcrH	showing	native	(black)	and	8	M	urea	denatured	(blue).	The	
excitation	wavelength	was	274	nm,	the	fluorescence	spectra	was	measured	from	294	nm	to	400	nm	in	
1	 cm	 pathlength	 quartz	 cuvette	 at	 25	 ±	 5	 °C.	 Figure	 was	 prepared	 using	 KALEIDAGRAPH	 4.0.
(a)	 (b)	
(c)	 (d)	
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After	monitoring	the	secondary	structure	of	LcrH	proteins	using	far-UV	CD,	it	was	then	
decided	 to	 use	 fluorescence	 spectroscopy	 to	 compare	 the	 native	 and	 denatured	
tertiary	 structure	 of	 LcrH.	 Figure	 4.6	 (d)	 shows	 the	 comparison	 between	 the	
fluorescence	 intensities	 of	 native	 and	 8	 M	 urea	 denatured	 3	 µM	 tr-LcrH	 protein	
samples.	Here,	the	sample	was	excited	at	274	nm	and	emission	spectrum	from	294	nm	
to	 400	nm	was	 recorded.	 	 A	 peak	 due	 to	 tyrosine	 emission	 can	 be	 seen	 at	 303	 nm,	
which	decreases	on	addition	of	urea.	 	However,	 it	 is	also	obvious	 that	 the	change	 in	
signal	in	fluorescence	on	unfolding	was	not	as	great	a	change	as	that	observed	for	the	
far-UV	 CD.	 Figure	 4.6	 showed	 that	 the	 largest	 difference	 in	 the	 far-UV	 CD	 signal	
between	the	native	and	denatured	LcrH	samples	was	observed	at	222	nm,	which	was	
then	 used	 to	 monitor	 equilibrium	 unfolding.
Figure	 4.7:	 (a)	 Tyrosine	 fluorescence	 monitored	 at	 303	 nm	 (black	 filled	 circles)	 for	 urea	 induced	
equilibrium	 unfolding	 of	 3	 µM	 tr-LcrH.	 The	 excitation	 wavelength	 was	 274	 nm	 and	 slit	 width	 for	
excitation	and	emission	was	5	nm.	Fluorescence	emission	was	recorded	using	1	cm	path	length	quartz	
cuvette	at	25	±	5	°C.	(b)	Equilibrium	unfolding	profile	of	3	µM	tr-LcrH	monitored	by	far-UV	CD	at	222	
nm	wavelength.	Measurements	were	taken	using	0.5	cm	path	length	quartz	cuvette	at	25	±	5	°C	in	50	
mM	Phosphate,	pH	7.0	and	5	mM	DTT.	The	samples	were	incubated	at	25	°C	for	6	hours	prior	to	far-
UV	CD	and	fluorescence	measurements.	Figure	was	prepared	using	KALEIDAGRAPH	4.0.	
	
Given	 that	 both	 probes	 showed	 a	 clear	 difference	 between	 native	 and	 denatured	
protein,	 it	 was	 decided	 to	 obtain	 a	 full	 equilibrium	 chemical	 denaturation.	 Here	
samples	containing	3	µM	tr-LcrH	were	prepared	with	a	series	of	urea	concentrations	
from	0	to	8	M	urea	(section	2.5.3.1).	The	samples	were	incubated	for	6	hours	at	25	°C	
(a)	 (b)	
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before	 taking	 far-UV	 CD	 and	 fluorescence	measurements.	 The	 equilibrium	 unfolding	
profile	of	3	µM	tr-LcrH	for	each	probe	 is	shown	 in	Figure	4.7.	When	the	two	profiles	
are	 compared,	 a	 number	 of	 striking	 differences	 become	 obvious.	 The	 tyrosine	
fluorescence	 monitored	 equilibrium	 unfolding	 showed	 that	 tr-LcrH	 possesses	 no	
sigmoidal	 co-operative	 transition.	 In	 contrast,	 although	 far-UV	 CD	 monitored	
equilibrium	unfolding	(Figure	4.6	(b))	also	showed	an	 initial	gradual	unfolding	profile,	
there	is	a	distinct	sigmoidal	transition	between	the	initial	(folded)	and	final	(unfolded)	
states.	 The	 fluorescence	monitored	 unfolding	 data	 did	 not	 bear	 any	 resemblance	 to	
the	sigmoidal	unfolding	pattern	observed	in	far-UV	CD	monitored	unfolding	data.	One	
explanation	of	the	differing	curves	can	be	suggested	by	the	positioning	of	the	tyrosine	
residues	 in	 tr-LcrH	 (Figure	 4.8).	 The	 surface	 analysis	 of	 the	 tr-LcrH	 protein	 structure	
showed	that	50	%	of	the	tyrosine	residues,	which	are	located	in	the	N-terminus	of	the	
protein	 were	 found	 to	 be	 solvent	 exposed	 in	 the	 native	 state	 of	 the	 protein.		
Consequently,	 as	 the	 protein	 undergoes	 unfolding,	 the	 remaining	 50	 %	 of	 tyrosine	
residues	too	become	solvent	exposed.	However,	resultant	change	in	the	fluorescence	
intensity	 between	native	 and	unfolded	 LcrH	protein	 in	 comparison	 to	 the	 secondary	
structural	change	observed	from	far-UV	CD	data	(Figure	4.6)	was	much	 lower.	This	 is	
because	 fluorescence	 is	 based	 on	 the	 environment	 of	 fluorophores	 i.e.	 tryptophans	
and	tyrosines	that	are	solvent	exposed	fluoresce	at	a	different	wavelength	compared	
to	those	in	a	non-solvent	exposed	environment	(the	hydrophobic	core	of	the	protein).	
In	 order	 to	 observe	 a	 difference	 in	 fluorescence	 between	 a	 native	 and	 unfolded	
protein,	 there	must	 be	 an	 overall	 change	 in	 the	 interaction	 of	 the	 solvent	 exposed	
tyrosines	 and	 tryptophans	 with	 the	 solution.	 Tryptophan	 has	 stronger	 fluorescence	
and	higher	quantum	yield	 in	 comparison	 to	 tyrosine.	But,	 LcrH	does	not	 contain	any	
tryptophan	 residues.	Although,	 tyrosine	 is	 a	weaker	emitter	 than	 tryptophan,	 it	may	
still	contribute	significantly	to	protein	fluorescence	if	present	in	great	numbers.	tr-LcrH	
and	 fl-LcrH	 contain	 only	 7	 and	 8	 tyrosine	 residues	 respectively,	which	 is	 not	 a	 large	
number.	 Furthermore,	 tyrosine	 is	 frequently	 quenched	due	 to	 loss	 of	 proton	on	 the	
aromatic	 hydroxyl	 group	 by	 undergoing	 ionization	 in	 the	 excited	 state	 or	 due	 to	 its	
interaction	 with	 the	 peptide	 chain.
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(a)	 (b)	
Figure	
4.8	 (a)	
Ribbon	representation	of	dimeric	tr-LcrH	(LcrH21-163)	 (PDB	entry:	2VGX).	Chains	A	and	B	are	coloured	
green	and	blue	respectively.	There	are	7	tyrosine	residues	in	each	chain,	which	are	coloured	in	red	and	
shown	as	sticks.	(b)	Solvent	accessible	surface	representation	of	dimeric	tr-LcrH	(green)	with	tyrosine	
residues	coloured	red.	The	figures	were	prepared	using	PyMOL.	
	
Thus,	the	equilibrium	unfolding	monitored	by	tyrosine	fluorescence	was	not	found	to	
be	 suitable.	 	 Far-UV	 CD	 proved	 to	 be	 the	 best	 structural	 probe	 for	 monitoring	 the	
equilibrium	unfolding	of	LcrH’s	protein	constructs.		
4.3.4.2 Determining	the	most	suitable	chemical	denaturant		
It	was	previously	shown	that	LcrH	underwent	complete	loss	of	secondary	structure	on	
denaturation	 with	 high	molar	 concentration	 (8	M)	 of	 the	 chemical	 denaturant	 urea	
(Figure	4.6).	When	6	M	Guanidine	hydrochloride	(GdmHCl)	was	used	to	unfold	3-	µM	
tr-LcrH,	same	result	was	achieved	(Figure	4.9).	
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Figure	4.9	Far-UV	CD	spectra	of	3	µM	tr-LcrH	showing	native	(black	filled	circles),	8	M	urea	denatured	
(blue)	and	6	M	GdmHCl	denatured	(green).	The	CD	measurements	were	taken	using	5	mm	pathlength	
quartz	 cuvette	 at	 25	 ±	 0.2	 °C	 in	 50	mM	Phosphate,	 pH	 7.0,	 5mM	DTT.	 	 Figure	was	 prepared	 using	
KALEIDAGRAPH	 4.0.
	
After	 observing	 the	 effect	 of	 GdmHCl,	 it	 was	 decided	 to	 perform	 an	 equilibrium	
chemical	denaturation	experiment	using	GdmHCl	as	a	chemical	denaturant	and	3	µM	
tr-LcrH	protein	as	the	protein	sample	(Section	2.5.3).	The	samples	were	 incubated	at	
25	 ±	 0.2°C	 for	 6	 hours	 followed	 by	 far-UV	 CD	measurements.	 The	 GdmHCl	 induced	
equilibrium	 unfolding	 of	 tr-LcrH	 was	 compared	 to	 the	 urea	 induced	 equilibrium	
unfolding	 (Figure	4.10).	GdmHCl	 is	 a	 stronger	 chemical	 denaturant	 than	urea.	 Figure	
4.10	 shows	 that	 tr-LcrH	 undergoes	 unfolding	 at	 lower	 concentration	 of	 GdmHCl	
compared	 to	 that	 of	 urea.	 Importantly,	 the	 data	 comparison	 showed	 that	 there	 is	 a	
lack	 of	 folded	 (native)	 baseline	 for	 GdmHCl	 induced	 unfolding	 compared	 to	 that	 of	
urea.	 This	 lack	 of	 native	 baseline	 caused	 difficulties	 in	 fitting	 equilibrium	 unfolding	
curves	to	2-state	or	multi-state	denaturation	models.		
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Figure	 4.10	 Equilibrium	 denaturation	 of	 3	 µM	 tr-LcrH	 using	 urea	 (black	 filled	 circles)	 and	 GdmHCl	
(black	filled	diamonds)	monitored	by	changes	in	far-UV	CD	at	222	nm	plotted	against	the	denaturant	
concentrations	(M)	of	urea	and	GdmHCl	respectively.	The	samples	were	equilibrated	for	6	hours	prior	
to	taking	far-UV	CD	scans,	in	5	mm	path	length	quartz	cuvette	at	25	°C	±	0.2	°C,	in	50	mM	Phosphate	
pH	 7.0,	 5	 mM	 DTT.	 	 Figure	 was	 prepared	 using	 KALEIDAGRAPH	 4.0.
	
Therefore,	 it	 was	 decided	 that	 urea	 was	 the	 most	 suitable	 chemical	 denaturant.	
Henceforth,	all	the	equilibrium-unfolding	experiments	of	LcrH	protein	constructs	were	
carried	out	using	urea.		 	
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4.3.4.3 Minimum	Equilibration	Time	for	Equilibrium	Chemical	Denaturation	
It	 is	 important	 to	 confirm	 that	 all	 protein	 samples	 at	 each	denaturant	 concentration	
reach	equilibrium.	If	insufficient	time	is	allowed	for	equilibration,	an	incorrect	stability	
and/or	non-reproducible	experiments	may	occur	[195-197].	In	order	to	determine	the	
minimum	 equilibration	 time	 for	 LcrH,	 3	 µM	 tr-LcrH	 was	 chosen	 as	 a	 test	 case.	 A	
mixture	of	protein	and	urea	 in	buffer	were	prepared	(Section	2.5.3)	and	the	samples	
were	incubated	for	differing	lengths	of	time	(4,	12	and	24	hours).	This	was	followed	by	
taking	far-UV	CD	measurements	at	222	nm	in	a	thermostatted	cuvette	holder	at	25	±	
0.2	°C	in	a	5	mm	path	length	quartz	cuvette.	Figure	4.11	shows	the	overlaid	results.	
	
Figure	 4.11	 Urea	 induced	 equilibrium	 denaturation	 of	 tr-LcrH	 monitored	 by	 changes	 in	 far-UV	 CD	
signal	 (ellipticity	 in	 millidegrees)	 at	 222	 nm	 plotted	 against	 the	 concentration	 of	 urea	 (M).	 The	
superimposed	 equilibrium	 unfolding	 profiles	 of	 3	 µM	 tr-LcrH	 corresponds	 to	 differing	 equilibration	
times:	4	hours	(filled	circles),	12	hours	(open	circles)	and	24	hours	(closed	squares)	respectively.	The	
inset	 figure	 shows	 the	 same	 unfolding	 profiles	 converted	 to	 relative	 spectroscopic	 signal	 (fraction	
unfolded)	for	easy	comparison	of	different	data	sets.		Figure	was	prepared	using	KALEIDAGRAPH	4.0.
	
Importantly,	 all	 three	 differing	 equilibration	 times	 were	 observed	 to	 be	
superimposable.	It	could	thus	be	inferred	that	4	hours	was	the	minimum	time	required	
for	 achieving	 chemical	 equilibrium.	 Therefore,	 all	 equilibrium-unfolding	 experiments	
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were	left	for	a	minimum	equilibration	time	of	4	hours	prior	to	taking	measurements	on	
the	CD	spectrophotometer.	
4.3.4.4 The	Reversibility	of	Equilibrium	Unfolding	
The	 final	 control	 required	 was	 to	 confirm	 that	 the	 chemical	 denaturations	 were	
reversible.	 This	 is	 requirement,	 as	 otherwise	 thermodynamic	 parameters	 observed	
from	 fitting	 the	 curves	 will	 not	 report	 on	 the	 unfolding	 process,	 but	 instead	 on	
aggregation.	For	 this	experiment,	 tr-LcrH	and	 fl-LcrH	protein	 samples	at	27	µM	were	
unfolded	 with	 8	 M	 urea,	 equilibrated	 for	 4	 hours	 at	 25	 ±	 0.2	 °C	 respectively.	 The	
unfolded	protein	samples	of	both	protein	constructs	were	then	refolded	by	aliquoting	
into	 buffer	 with	 differing	 concentrations	 of	 urea.	 This	 gave	 a	 final	 protein	
concentration	 of	 3	 µM	 in	 each	 differing	 urea	 concentration.	 The	 diluted/refolded	
samples	were	re-equilibrated	for	4	hours	followed	by	far-UV	CD	measurement	at	222	
nm.	 	 Figure	 4.12	 shows	 the	 far-UV	 CD	 monitored	 refolded	 equilibrium	 titrations	
superimposed	 onto	 the	 unfolded	 equilibrium	 titrations	 at	 3	 µM	 concentration	 of	 tr-
LcrH	and	fl-LcrH	respectively.	
	
Figure	4.12	Reversibility	of	urea	 induced	equilibrium	unfolding	of	 (a)	 tr-LcrH	and	(b)	 fl-LcrH	at	3	µM	
protein	concentration	showing	the	unfolded	titrations	(black	closed	diamonds)	and	refolded	titrations	
(green	closed	circles)	respectively.	The	unfolding	and	refolding	equilibrium	titrations	were	monitored	
by	changes	 in	far-UV	CD	at	222	nm,	 in	5	mm	path	length	quartz	cuvette	at	25	°C	±	0.2	°C,	 in	50	mM	
Phosphate,	 pH	 7.0,	 5	 mM	 DTT.	 Figure	 was	 prepared	 using	 KALEIDAGRAPH	 4.0.
The	unfolded	and	subsequently	refolded	sampled	retained	nearly	100	%	of	their	native	
far-UV	CD	 signal.	 This	 confirmed	 that	urea	 induced	equilibrium	unfolding	of	 both	 tr-
LcrH	and	fl-LcrH	is	completely	reversible	under	the	buffer	conditions	used.		
(a)	 (b)	
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4.3.5 Equilibrium	Chemical	Denaturation	of	LcrH’s	Protein	Constructs		
Having	 determined	 conditions	 where	 reversible,	 aggregation-free	 chemical	
denaturations	 of	 LcrH	 can	 be	 performed	 and	 monitored,	 we	 conducted	 such	
denturations	at	a	number	of	different	protein	concentrations.	For	fl-LcrH,	these	were	3	
and	50	µM	(Figure	4.13),	for	tr-LcrH	these	ranged	from	1	to	80	µM	(Figure	4.14)	and	for	
monomeric	L65E	tr-LcrH	these	were	1.5	and	3	µM	(Figure	4.15).	Reproducibility	of	each	
denaturation	was	confirmed	by	repeating	each	experiment	at	least	once	(shown	in	the	
aforementioned	 figures).	 For	 both	 fl-LcrH	 and	 tr-LcrH	 the	 50	 and	 80	 µM	 chemical	
denaturations	 were	 the	 highest	 protein	 concentration	 that	 could	 be	 prepared.	 This	
was	due	to	the	methodology	that	chemical	denaturations	require,	i.e.	the	protein	stock	
solution	is	diluted	to	the	same	amount	into	a	series	of	increasing	urea	concentrations.	
	
	
Figure	4.13	Urea	induced	equilibrium	chemical	denaturation	of	fl-LcrH	at	protein	concentrations	of	(a)	
3	 µM	 shown	by	 blue	 filled	 circles,	 far-UV	 CD	measurements	were	 taken	 using	 a	 5	mm	path	 length	
cuvette	 and	 (b)	 50	 µM	 shown	 by	 open	 and	 filled	 blue	 triangles	 for	 reproducibility,	 far-UV	 CD	
measurements	 were	 taken	 using	 a	 1	 mm	 path	 length	 cuvette.	 	 Figure	 was	 prepared	 using	
KALEIDAGRAPH	 4.0.
	
	
	 	
(a)	 (b)	
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Figure	4.14	Urea	induced	unfolding	of	tr-LcrH	monitored	by	change	in	far-UV	CD	at	222	nm	at	protein	
concentrations:	 (a)	 1	 µM	 (1	 cm	 path	 length),	 (b)	 3	 µM	 (5	mm	 path	 length),	 (c)	 6	 µM	 (5	mm	 path	
length),	(d)	12	µM	(2	mm	path	length),	(e)	25	µM	(1	mm	path	length),	(f)	50	µM	(1	mm	path	length)	
and	 (g)	 80	 µM	 (1	 mm	 path	 length).	 The	 inset	 figures	 are	 the	 denaturation	 profiles	 at	 respective	
concentrations	with	the	CD	signal	changed	to	relative	spectroscopic	signal	(fraction	unfolded)	for	ease	
of	comparison.	Each	experiment	was	repeated	at	least	once	to	confirm	reproducibility	and	shown	by	
black	open	and	filled	circles.	Figure	was	prepared	using	KALEIDAGRAPH	4.0.		
(a)	 (b)	
(c)	 (d)	
(e)	 (f)	
(g)	
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Figure	4.15	Urea	induced	equilibrium	chemical	denaturation	of	monomeric	mutant	L65E	tr-LcrH	at	
protein	concentrations	of	(a)	1.5	µM	shown	by	open	blue	circles	and	(b)	3	µM	shown	by	closed	blue	
circles.	Far-UV	CD	measurements	were	taken	using	a	5	mm	path	length	quartz	cuvette	at	25	±	0.2°C.	
Figure	was	prepared	using	KALEIDAGRAPH	4.0.		
	
For	ease	of	comparison,	each	denaturation	was	converted	from	ellipticity	at	222	nm	vs	
urea	 to	 relative	 spectroscopy	 signal	 vs	 urea	 (Equation	 2.9,	 Materials	 &	 Methods).	
Figure	4.16	 shows	 fl-LcrH	overlaid	with	 tr-LcrH	and	 the	overlaid	plots	 tr-LcrH	 from	1	
µM	to	80	µM,	respectively.		From	these	graphs	the	following	features	and	trends	were	
immediately	apparent.		
	
4.3.5.1 Biphasic	 Denaturations	 Show	 LcrH	 Unfolds	 via	 Partially	 Folded	
Dimeric	Intermediate	
The	profile	of	each	equilibrium	denaturation	and	its	protein	concentration	dependence	
delineates	 the	 mechanism	 by	 which	 oligomeric	 proteins	 unfold.	 Such	 concentration	
dependence	 is	 a	 unique	 characteristic	 of	 oligomeric	 protein	 systems	 and	 is	 a	 direct	
consequence	 of	 protein	 unfolding	 being	 coupled	 with	 oligomeric	 dissociation.	 Once	
determined,	 the	 data	 can	 be	 fit	 to	 the	 correct	 dimer	 denaturation	model	 and	 thus	
obtain	thermodynamic	stability	of	the	protein.	Figure	4.16	shows	that	for	both	forms	
of	 LcrH	 the	 denaturation	 profile	 of	 each	 protein	 concentration	 consists	 of	 two	
transitions	which	becomes	clearer	with	the	increase	in	protein	concentrations.	
	
	
	
(a)	 (b)	
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Figure	 4.16	 Urea	 denaturations	 monitored	 by	 changes	 in	 far-UV	 CD	 at	 222	 nm	 and	 converted	 to	
relative	 spectroscopic	 signal	 (see	 Equation	 2.9)	 for	 (a)	 fl-LcrH	 and	 tr-LcrH.	 For	 clarity,	 only	 one	
denaturation	is	shown	per	concentration:	3	µM	(fl-LcrH,	blue-filled	circles;	tr-LcrH,	black-filled	circles)	
and	 50	 µM	 (fl-LcrH,	 blue-filled	 triangles;	 tr-LcrH,	 black-filled	 triangles).	 (b)	 	 tr-LcrH	 For	 ease	 of	
observation	 only	 one	 denaturation	 is	 shown	 per	 concentration	 –	 1	 µM	 (filled	 circles),	 3	 µM	 (open	
circles),	6	µM	(filled	squares),	12	µM	(open	squares),	25	µM	(filled	triangles),	50	µM	(open	triangle)	
and	80	µM	(filled	diamonds).	Figure	was	prepared	using	KALEIDAGRAPH	4.0.	
	
The	 initial	 unfolding	 produces	 a	 first	 sloping	 transition	 that	 accounts	 for	 the	 loss	 of	
approximately	one	third	of	the	native	α-helical	signal.	This	ends	at	a	saddle	point	at	≈	3	
M	 urea.	 At	 higher	 denaturant	 concentrations,	 a	 second	 sharper	 transition	 was	
observed.	This	results	in	the	complete	unfolding	of	the	protein	at	urea	concentrations	
of	 greater	 than	 6	M.	 The	 biphasic	 unfolding	 pattern	 showed	 that	 a	 stable,	 partially	
structured	 intermediate	 is	 populated	 during	 the	 unfolding	 of	 LcrH.	 Significantly,	 the	
first	 transition	 is	 concentration-independent,	 and	 the	 second	 transition	 is	
(a)	
(b)	
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concentration-dependent	 (the	 midpoint	 ‘[D]50%’	 shifts	 to	 higher	 urea	 concentration	
with	an	increase	in	protein	concentration).	The	observed	pattern	of	unfolding	(protein	
concentration-independent	 first	 transition	 to	 a	 stable	 partially	 folded	 intermediate	
followed	by	a	protein	concentration-dependent	second	transition)	is	consistent	with	a	
scheme	where	native	dimer	(N2)	partially	unfolds	to	a	dimeric	intermediate	(I2),	which	
then	unfolds	to	a	denatured	monomer	(2D),	𝑁! ⇌  𝐼!	⇌ 2D	(Figure	4.17).	Moreover,	it	
is	 important	 to	 note	 that	 the	 shallow	 nature	 of	 the	 first	 unfolding	 transition,	 native	
dimer	to	partially	unfolded	intermediate,	shows	a	lack	of	co-operative	unfolding.	This	
indicates	 the	 structure	 of	 LcrH	 is	 particularly	 flexible	 and	 can	 easily	 adopt	 partially	
unfolded	confirmations.	
	
Figure	4.17	Schematic	illustration	of	the	proposed	equilibrium	unfolding	pathway	of	LcrH.	A	head-to-
head	dimeric	structure	of	SycD	(PDB	entry:	2VGX)	is	shown	next	to	a	topological	map	of	the	fold	for	
reference	 (helices	 are	 shown	 as	 circles	 with	 the	 individual	 protein	 chains	 coloured	 red	 and	 blue).	
During	 unfolding,	 the	 native	 state	 (N2)	 non-cooperatively	 frays	 through	 unfolding	 of	 C-terminal	
helices.	This	 leaves	an	N-terminal	dimeric	 intermediate	 (I2).	We	note	 that	various	partially	unfolded	
dimeric	 intermediate	 conformations	 could	 be	 populated	 during	 the	 unfolding	 transition.	 These	 are	
presented	by	 showing	 the	 two	extreme	possible	examples	 (one	monomer	of	 the	dimer	 fully	 folded	
and	the	other	mostly	unfolding)	and	a	third	that	is	the	median	(both	subunits	partially	unfolded	to	the	
same	 extent).	 These	 possible	 intermediate	 structures	 are	 shown	 in	 the	 grey	 box.	 At	 higher	
concentrations	of	urea	the	 intermediate	dissociates	and	denatures	 to	a	monomeric	denatured	state	
(2D,	where	D	is	the	denatured	state).		
	
To	confirm	the	dimeric	intermediate	unfolding	mechanism,	analytical	SEC	and	dynamic	
light	scattering	of	tr-LcrH	at	50	µM	were	performed	in	urea	concentrations	of	0	–	6	M	
urea.	 Both	 methods	 showed	 that	 there	 was	 an	 increase	 in	 the	 size	 of	 tr-LcrH	 on	
increasing	 urea	 concentrations	 (Figure	 4.18).	 In	 particular,	 the	 size	 of	 tr-LcrH	 was	
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similar	 from	0	 to	2	M	urea	but	 then	 significantly	 increased	 in	3	M	urea	as	observed	
from	the	analytical	SEC	profile	of	tr-LcrH	(Figure	4.18	(b)).	In	order	to	investigate	LcrH’s	
increase	 in	 molecular	 size,	 the	 hydrodynamic	 radii	 at	 respective	 denaturant	
concentrations	were	plotted	against	the	urea	concentrations	used	for	unfolding	(Figure	
4.18	 (a)	 inset).	 It	 was	 revealed	 that	 tr-LcrH	 increased	 in	 size	 until	 5	 M	 urea	 and	 a	
reduction	in	hydrodynamic	radius	was	observed	in	6	M	urea.	It	can	be	inferred	that	the	
first	 unfolding	 transition	 of	 LcrH	 involves	 partial	 unfolding	 to	 an	 expanded	 dimeric	
intermediate.	By	6	M	urea,	tr-LcrH	undergoes	complete	denaturation,	with	the	shape	
of	the	peak	by	SEC	becoming	more	symmetric.	At,	0	M	urea,	tr-LcrH	elutes	at	~	10.2	ml	
near	 the	 elution	 volume	 of	 10.55	 ml	 of	 the	 monomeric	 sized	 TPR	 standard	 CTPR3	
which	elutes	at	10.55	ml	(Figure	4.18	(b)	and	section	4.3.1).	At	6	M	urea,	tr-LcrH	elutes	
at	~	8.6	ml	in	comparison	to	the	dimeric	TPR	standard	CTPRa6’s	elution	volume	of	9.6	
ml	(Figure	4.18	(b)	and	section	4.3.1).	Thus,	from	the	Figure	4.18	below,	it	can	be	seen	
that	further	unfolding	of	tr-LcrH	produced	an	expanded	monomeric	species,	which	was	
greater	in	size	than	the	dimeric	TPR	standard	CTPRa6.		
	
	
Figure	4.18	(a)	Dynamic	light	scattering	[volume	of	protein	(%)	against	the	hydrodynamic	radius	(nm)]	
of	50	µM	tr-LcrH	when	in	0	M	urea	(black),	1	M	urea	(blue),	2	M	urea	(green),	3	M	urea	(pink),	4	M	
urea	 (orange),	5	M	urea	 (purple),	6	M	urea	 (red)	and	 inset:	Hydrodynamic	 radius	 (nm)	against	Urea	
concentration	(M),	smooth	curve	plotted	 in	black.	 (b)	Analytical	SEC	using	S75	HR	10/30	column:	50	
µM	 tr-LcrH	 in	 0	M	urea	 (black),	 3	M	urea	 (pink),	 6	M	urea	 (red),	 TPR	 standards	 -	 CTPR3	 (blue)	 and	
CTPRa6	 (green).	 Figure	 was	 prepared	 using	 KALEIDAGRAPH	 4.0.
	
	
(a)	 (b)	
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4.3.5.2 Deletion	of	N-terminus	Causes	No	Change	in	Equilibrium	Unfolding	
When	the	equilibrium	denaturations	of	 fl-LcrH	and	tr-LcrH	are	compared	at	3	and	50	
µM,	 their	profiles	are	 indistinguishable	 (Figure	4.16).	 It	 is	 therefore	clear	 that	 fl-LcrH	
and	tr-LcrH	have	identical	thermodynamic	equilibrium	unfolding	and	thus	must	infold	
via	the	same	mechanism	and	have	the	same	stability.	This	shows	that	although,	the	N-
terminus	 of	 LcrH	 may	 possess	 some	 α-helical	 content,	 it	 does	 not	 alter	 the	
conformational	stability	or	the	nature	of	equilibrium	unfolding	of	the	protein.		
	
4.3.6 Thermodynamic	stability	of	LcrH	
Having	 delineated	 the	 precise	 mechanism	 of	 LcrH’s	 unfolding,	 the	 thermodynamic	
stabilities	of	 the	 intermediate	and	native	states	were	obtained	by	globally	 fitting	 the	
chemical	denaturations	performed	at	50	and	80	µM	for	tr-LcrH	and	50	µM	for	fl-LcrH	
to	 a	 three-state	 unfolding	 model	 with	 a	 dimeric	 intermediate	 (Figure	 4.19).	 The	
derivation	of	 the	 three-state	unfolding	model	and	Equations	used	 to	 fit	 the	data	are	
described	in	detail	in	the	following	data	analysis	section.	Lower	protein	concentration	
denaturations	were	excluded,	as	the	intermediate	state	was	not	sufficiently	populated	
to	enable	explicit	fitting.	
	
Figure	4.19	Urea	denaturation	of	tr-LcrH	monitored	by	changes	 in	far-UV	CD	at	222	nm	showing	the	
global	fit	of	the	50	and	80	µM	data	sets	to	a	three-state	model	with	a	dimeric	intermediate	(Equation	
4.4).	For	clarity,	only	one	denaturation	is	shown	per	concentration:	6	µM	(filled	squares),	12	µM	(open	
squares),	 25	 µM	 (filled	 triangles),	 50	 µM	 (open	 triangle)	 and	 80	 µM	 (filled	 diamonds).	 Figure	 was	
produced	 using	 GraphPad	 Prism	 6.0.	
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4.3.6.1 Data	analysis			
In	this	study	the	unfolding	of	LcrH	was	fitted	to	a	three-state	model,	which	involves	a	
dimeric	intermediate	(scheme	1)	
𝑁!𝐾!⇌𝐼!𝐾!⇌2D			 	 Scheme	1	
where	N2	is	the	native	dimer,	I2	is	the	intermediate	dimer	and	D	is	the	denatured	state.	
In	this	model	the	equilibrium	constants	for	the	first	(K1)	and	second	(K2)	transitions	can	
be	 defined,	 respectively,	 as	 K1	 =	 [I2]/[N2]	 and	 K2	 =	 [D]2/[I2].	 The	 total	 protein	
concentration	 is	 Pt	 =	 2[N2]	 +	 2[I2]	 +	 [D],	 and	 the	 sum	 of	 the	 fractions	 of	 individual	
species	 is	 equal	 to	 1:	 fN	 +	 fI	 +	 fD	 =	 1,	where	 fI	 represents	 the	 fraction	of	monomeric	
subunits	involved	in	the	intermediate	state.	Combining	these	relationships	gives:	
	
Equation	4.9																																				𝐾! = !I!N  	
																																																													and	
Equation	4.10																																		𝐾! = !!!!!!!I 	
	
Rearranging	 and	 substitution	 of	 the	 above	 Equations	 in	 terms	 of	 fD	 (fraction	 of	
denatured	protein)	allows	fD	to	be	expressed	in	terms	of	K1,	K2	and	Pt:	
	
Equation	4.11																									𝒇𝐃 = !𝑲𝟏𝑲𝟐! 𝑲𝟏𝑲𝟐 𝟐!𝟖 𝟏!𝑲𝟏 𝑲𝟏𝑲𝟐 𝑷𝒕𝟒𝑷𝒕 𝟏!𝑲𝟏 	
	 	
In	this	model	the	spectroscopic	signal	obtained	becomes:	
	
Equation	4.12																											𝝀𝒐𝒃𝒔 = 𝝀𝑵𝒇𝑵 + 𝝀𝑰𝒇𝑰 + 𝝀𝑫𝒇𝑫			 	
	
124	
	
	 	
Where	λobs	is	the	spectroscopic	signal,	λN	is	the	signal	of	the	native	state,	λI	is	the	signal	
of	the	intermediate	state	and	λD	is	the	signal	of	the	native	state.	Substituting	Equation	
4.9	and	Equation	4.10	into	Equation	4.12	gives	the	final	fitting	Equation:	
	
Equation	4.13																										𝝀𝒐𝒃𝒔 = 𝝀𝑵 𝟐𝑷𝒕𝒇𝑫𝟐𝑲𝟏𝑲𝟐 + 𝝀𝑰 𝟐𝑷𝒕𝒇𝑫𝟐𝑲𝟐 + 𝝀𝑫𝒇D	
	 	 	
Global	fitting	to	the	three-state	dimer	denaturation	model	
To	 fit	 the	 denaturant	 dependent	 data	 and	 obtain	 ΔG	 values	 of	 each	 step	 in	 the	
unfolding,	K1	and	K2	can	be	defined	according	to	the	linear	free	energy	model,	which	
states	 that	 the	 free	 energy	 of	 each	 unfolding	 process	 varies	 linearly	 with	 the	
concentration	of	denaturant	[196-198]:	
Equation	4.14																					𝚫𝑮𝒙 = −𝑹𝑻ln 𝑲𝒙 = 𝚫𝑮𝑯𝟐𝑶𝒙 −𝒎 denaturant 																											
	 	 	
Where	ΔGx	is	the	free	energy	of	the	process	x	at	a	specific	denaturant	concentration,	Kx	
is	the	equilibrium	constant	of	the	process	x	 (in	this	case	K1	and	K2),	ΔGxH20	 is	the	free	
energy	 of	 process	 x	 in	 the	 absence	 of	 denaturant	 and	 m	 is	 a	 constant	 that	 is	
proportional	 to	 the	 solvent	exposure	difference	between	 the	 initial	 and	end	state	of	
unfolding	process	x.	
Equation	 4.11,	 with	 fD,	 K1	 and	 K2	 defined	 by	 Equation	 4.9	 and	 Equation	 4.10	
(respectively),	 was	 then	 used	 to	 globally	 fit	 the	 LcrH	 denaturations	 of	 differing	
concentrations	using	the	non-linear,	 least-squares	fitting	programme	Prism.	This	gave	
global	 thermodynamic	 parameters	Δ𝐺!!!! ,	Δ𝐺!!!! 	 (stabilities	 of	 the	 first	 and	 second	
unfolding	transitions,	 respectively)	and	m1,	m2	 (the	m-values	 for	 the	 first	and	second	
unfolding	 transitions,	 respectively).	 λN,	 λI	 and	 λD	 (the	 spectral	 signals	 of	 the	 native,	
intermediate	and	denatured	states	 respectively)	were	allowed	to	vary	 independently	
with	 each	 dataset.	 λI	 was	 assumed	 not	 to	 vary	 with	 denaturant	 concentration	 to	
minimize	the	number	of	parameters	needed.	Further,	to	reduce	any	baseline	artifacts,	
the	 baselines	 (λN	 and	 λD)	 were	 constrained	 to	 zero	 slope.	 The	 thermodynamic	
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parameters	obtained	are	presented	in	Table	4.2	and	confirm	the	identical	stabilities	of	
fl-LcrH	and	tr-LcrH.		
Table	4.2	Thermodynamic	parameters	for	the	global	fitting	of	fl-LcrH	&	tr-LcrH	at	25	°C	using	
the	three	state	dimer	model	with	a	dimeric	intermediate	
	
Global	parameters	
Protein	
	 𝚫𝑮𝐇𝟐𝐎𝐍𝟐⇌𝐈𝟐 	 𝒎𝐍𝟐⇌𝐈𝟐 	 𝚫𝑮𝐇𝟐𝐎𝐈𝟐⇌𝟐𝐃 	 𝒎𝐈𝟐⇌𝟐𝐃	 a𝚫𝑮𝐇𝟐𝐎𝐍𝟐⇌𝟐𝐃 	
	
	 (kcal	mol
-1)	 (kcal	mol-1	M-1)	 (kcal	mol
-
1)	 (kcal	mol
-1	M-1)	 (kcal	mol-1)	
fl-LcrH	 	 1.7	±	0.5	 1.0	±	0.3	 5.6	±	1.8	 1.7	±	0.4	 7.3	±	1.9	
tr-LcrH	 	 1.7	±	0.4	 1.1	±	0.2	 5.7	±	1.2	 1.7	±	0.2	 7.4	±	1.3	
	
Individual	parameters	
Protein	 	
	
[Total				
Protein]	
bλN	 	 cλI	 dλD	
Cuvette	
pathlength	
	 	 (µM)	 (millideg.)	 	 (millideg.)	 (millideg.)	 (cm)	
fl-LcrH	 	 50	*	1	 -99	±	5	 	 	54	±	6	 -5	±	2	 0.05	
fl-LcrH	 	 50	*	2	 -95	±	5	 	 	54	±	6	 -5	±	2	 0.05	
tr-LcrH	 	 50	*	1	 -132	±	5	 	 -73	±	6	 -4	±	2	 0.1	
tr-LcrH	 	 50	*	2	 -133	±	5	 	 -70	±	6	 -3	±	2	 0.1	
tr-LcrH	 	 80	*	1	 -226	±	8	 	 -126	±	9	 -9	±	3	 0.1	
tr-LcrH	 	 80	*	2	 -206	±	7	 	 -122	±	8	 -14	±	4	 0.1	
Errors	 given	 are	 from	 the	 fit	 of	 all	 the	 data	 and	 are	 quoted	 at	 a	 95	 %	 confidence	 level	 (2	
standard	 errors).	 aΔ𝐺!!!!!⇌!! =	Δ𝐺!!!!!⇌!! 	 + Δ𝐺!!!!!⇌!! ,	 with	 the	 error	 calculated	 by	 propagating	
the	fitting	errors.		bλN,	cλI	and	dλD	are	the	CD	spectroscopic	signals	for	native,	intermediate	and	
denatured	LcrH,	respectively,	at	222	nm.	
	
These	show	that	the	initial	unfolding	step	(N2	⇌	I2)	has	a	Δ𝐺!!!!!⇌!! 	of	only	1.7	±	0.4	kcal	
mol-1.	Thus,	the	majority	of	LcrH’s	stability	resides	 in	the	dimerization	structure	(I2	⇌	
2D)	as	it	requires	an	extra	5.7	±	1.2	kcal	mol-1	to	unfold.	This	means	the	total	stability	
of	 the	 protein	 (Δ𝐺!!!!!⇌!! )	 is	 7.4	 ±	 1.3	 kcal	 mol-1.	 Interestingly,	 LcrH’s	 stability	
(Δ𝐺!!!!!⇌!! )	 is	 less	than	many	other	dimeric	proteins	that	have	been	shown	to	unfold	
via	dimeric	intermediate	(Table	4.3).	In	particular,	the	first	transition	(N2	⇌	I2)	of	LcrH	
was	 significantly	 lower	 than,	 for	 example,	 eAATase,	 Ure2p,	 SecA,	 OPH	 and	 AAO	
proteins.	 	 This	 confirms	 the	 non-cooperative	 and	 labile	 nature	 of	 LcrH’s	 initial	
unfolding.	
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Table	 4.3	 Thermodynamic	 parameters	 characteristic	 of	 chemical	 induced	 unfolding	 of	
dimeric	proteins	by	a	three-state	transition	with	dimeric	intermediate	
Protein	 	Temp.	 𝚫𝑮𝐇𝟐𝐎𝐍𝟐⇌𝐈𝟐 	 𝒎𝐍𝟐⇌𝐈𝟐 	 𝚫𝑮𝐇𝟐𝐎𝐈𝟐⇌𝟐𝐃 	 	 𝒎𝐈𝟐⇌𝟐𝐃	 a𝚫𝑮𝐇𝟐𝐎𝐍𝟐⇌𝟐𝐃 	
	 (°C)	 (kcal	mol
-1)	 (kcal	mol-1	M-1)	 (kcal	mol-1)	 (kcal	mol-1M-1)	 (kcal	mol-1)	
tr-LcrH	 25	 1.7	 1.1	 5.7	 1.7	 7.4	
beAATase	 25	 12.0	 4.8	 24.4	 3.4	 36.4	
cSecA	 20	 8.4	 4.1	 14.1	 1.5	 22.5	
dOPH	 25	 4.3	 1.0	 36.1	 4.3	 40.4	
eAAO	 10	 3.5	 1.7	 13.6	 1.2	 17.1	
aΔ𝐺!!!!!⇌!! =	Δ𝐺!!!!!⇌!! 	 + Δ𝐺!!!!!⇌!! .	 	 To	 give	 the	best	 comparison	with	our	data	on	 LcrH	 the	proteins	
chosen	in	this	table	were	selected	as	the	experimental	conditions	used	to	obtain	them	were	similar	to	
ours.	i.e.	urea	as	chemical	denaturant,	CD	or	fluorescence	globally	fitted,	temperature	between	10	–	
25	⁰C	and	pH	of	between	7-8.	The	values	quoted	above	are	 from	the	 following	studies:	 beAATase	 -
[198,199],	cSecA	-[199,200],	dOPH	-[200,201]	and	eAAO	-[201-203].	
	
An	 apparent	 𝐾! 	 (𝐾!!"" )	 for	 the	 dissociation	 of	 the	 intermediate	 to	 denatured	
monomer	 can	 also	 be	 calculated	 from	 the	 equilibrium	 data.	 As	  Δ𝐺!!!!!⇌!! (from	 the	
seconds	 unfolding	 transition)	 is	 the	 free	 energy	 of	 unfolding	 and	 dissociation	 of	 the	
intermediate	 LcrH	 to	 denatured	 monomeric	 LcrH,	 it	 is	 related	 to	 the	 𝐾!!"" by	 Δ𝐺!!!!!⇌!! =	-RTln𝐾!!"" .	Thus,	𝐾!!"" can	be	simply	obtained	by	rearranging	this	Equation.	
However,	two	caveats	need	to	be	considered	before	delineating	its	true	significance.		
(i)	𝐾!!"" corresponds	 to	 both	 unfolding	 and	 dissociation	 of	 the	 intermediate	 state	 of	
LcrH.	 This	 is	 not	 exactly	 equivalent	 to	 the	𝐾! value	 obtained	 from	 the	 SEC	 and	 AUC	
data,	which	correspond	to	the	dissociation	of	folded	dimeric	LcrH	to	folded	monomeric	
LcrH.	(ii)	the	𝐾!!"" obtained	in	different	solution	conditions	(high	urea	concentration).	
Given	these	caveats,	the	𝐾!!"" calculated	was	65	±	65	µM	and	is	consistent	with	the	𝐾! 	
calculated	from	AUC	data	and	inferred	from	SEC	data.		
	
4.3.6.2 Proposed	equilibrium	unfolding	pathway:		
The	 ability	 of	 LcrH	 to	 easily	 fray	 into	 partially	 folded	 structures	 is	 facilitated	 by	 its	
modular	 tetratricopeptide	 repeat	 (TPR)	 structure.	 Unlike	 globular	 proteins,	 TPR	 and	
other	repeat	containing	proteins	are	formed	from	the	stacking	of	modular	secondary	
structure	motifs	 [202-206].	 This	 causes	 their	 native	 structures	 to	 be	 dominated	 and	
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stabilized	by	interactions	from	amino	acid	residues	that	are	close	in	primary	sequence,	
whereas	globular	proteins	have	many	stabilizing	interactions	from	amino	acids	that	are	
distant	in	primary	sequence.	This	arrangement	can	enable	sections	of	repeat	proteins	
to	unravel	without	unfolding	the	complete	structure.	We	have	studied	the	folding	of	a	
number	of	designed	TPR	proteins	 and	 shown	 that	when	partial	 unfolding	occurs	 the	
proteins	tend	to	unravel	from	the	less	stable	outer	repeats	first	[168,204-206].	As	the	
N-termini	 of	 LcrH	 form	 the	 dimeric	 interface	 (which	 our	 results	 show	 is	 the	 most	
thermodynamically	 stable	 part	 of	 the	 structure),	 the	 unraveling	 must	 occur	 mainly	
from	 the	 C-terminus.	 A	 schematic	 diagram	 of	 the	 equilibrium-unfolding	 pathway	
proposed	by	our	results	is	shown	in	Figure	4.17.	
	
4.3.6.3 Thermodynamic	Stability	of	Monomeric	vs	Dimeric	LcrH	
To	complete	the	stability	studies	conducted	on	LcrH,	the	stability	and	flexibility	of	the	
monomeric	mutant	L65E	LcrH	was	investigated.	In	vivo	studies	have	shown	that	when	
SycD	 is	 made	 monomeric	 through	 the	 L65E	 mutation,	 non-invasive	 bacteria	 are	
produced	[168,207].	This	suggests	that	the	dimeric	interface	is	important	for	function.	
When	we	produced	L65E	 tr-LcrH,	we	also	obtained	a	monomer	 (at	50	µM	there	 is	a	
single	 SEC	 elution	 peal	 of	 10.7	 ml,	 which	 is	 similar	 to	 an	 elution	 peak	 of	 10.55	 ml	
obtained	 for	 a	 monomeric	 designed	 TPR	 protein	 of	 similar	 dimensions	 (3.5	 stacked	
TPRs,	Figure	4.2).	Furthermore	at	25	°C,	L65E	has	the	same	α-helicity	by	CD	to	dimeric	
tr-LcrH	(Figure	4.20a).	However,	chemical	denaturation	of	L65E	shows	that	the	mutant	
was	 substantially	 destabilised	 compared	 to	 dimeric	 tr-LcrH	 with	 a	 single	 sharp	
transition	 between	 native	 and	 denatured	 states	 and	 little	 native	 baseline	 (Figure	
4.20b).	 This	 was	 confirmed,	 as	 fitting	 the	 data	 to	 a	 two-state	 model	 showed	 the	
midpoint	 of	 the	 transition	 ([D]50%)	 is	 only	 1.6	 ±	 0.1	 M	 urea,	 the	 m-value	 of	 the	
transition	is	1.4	±	0.1	kcal	mol-1	M-1	and	thus	its	stability	(Δ𝐺!!!!⇌! )	is	2.1	±	0.2	kcal	mol-1	
(Δ𝐺!!!!⇌! 	=	m.[D]50%).	 	
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Figure	4.20	(a)	Far-UV	CD	spectra	comparing	native	fl-LcrH	(black),	tr-LcrH	(blue),	L65E	tr-LcrH	(green),	
and	denatured	L65E	tr-LcrH	in	8	M	urea	(red).	A	protein	concentration	of	50	µM	in	a	1-mm	path	length	
quartz	cuvette	was	used	in	each	experiment.	The	inset	figure	shows	the	same	experiments	conducted	
at	a	protein	concentration	of	3	µM	in	a	5-mm	path	length	cuvette.	Note	that	fl-LcrH	has	~10%	greater	
α-helical	signal	to	tr-LcrH	and	L65E	tr-LcrH	at	222	nm.	(b)	Urea	denaturation	of	L65E	mutant	of	tr-LcrH	
(open	blue	 circles,	 1.5	µM,	 and	 filled	blue	 circles,	 3	 µM)	 and	 tr-LcrH	 at	 3	µM	 (black	 open	 and	 filled	
circles	 for	 comparison)	 monitored	 by	 changes	 in	 far-UV	 CD	 at	 222	 nm	 and	 converted	 to	 relative	
spectroscopic	signal	(see	Equation	2.12).	The	best	fit	 for	L65E	to	a	two	state	folding	model	 is	shown	
(black).	Figure	was	prepared	using	KALEIDAGRAPH	4.0.	
	
This	stability	is	similar	to	the	initial	unfolding	of	the	dimer	tr-LcrH,	but	is	substantially	
more	 cooperative	 and	 results	 in	 a	 complete	 loss	 of	 structure.	 Moreover,	 the	 low	
stability	 of	 L65E	 indicates	 that	 the	 in	 vivo	 results	 may	 well	 be	 caused	 by	 the	
destabilisation	of	 LcrH	 to	 the	extent	 that	 the	monomers	produced	are	unfolded	and	
thus	non-functional.	
	
	
(a)	
(b)	
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4.3.7 Conclusion	
The	 results	 in	 this	 chapter	 show	 that	 LcrH	 is	 a	weak	dimer	 (KD	 ~	 15	µM)	 that	 readily	
unfolds	in	a	non-cooperative	manner	to	a	partially	unravelled	dimeric	intermediate.	In	
contrast,	the	monomeric	mutant	L65E	tr-LcrH	unfolds	more	cooperatively	on	chemical	
denaturation,	 resulting	 in	 a	 complete	 loss	 of	 structure.	 Thus,	 confirming	 the	
significance	 of	 the	 dimerization	 interface	 of	 LcrH	 for	 thermodynamic	 stability.			
Furthermore,	the	chapter	shows	that	although	deletion	of	the	N	terminus	does	remove	
some	 α-helical	 structure	 (10%),	 it	 does	 not	 affect	 either	 its	 stability	 or	 dimerization	
equilibrium.	Excitingly,	the	energy	barrier	for	the	partial	unravelling	of	dimeric	LcrH	is	
low	(ΔGH2O	~	1.7	kcal	mol-1	at	25	°C),	suggesting	that	partially	unfolded	states	of	LcrH	
(held	 together	 at	 the	 dimeric	 interface)	 are	 present	 at	 physiological	 conditions.	 It	 is	
therefore	proposed	that	such	a	loosely	folded	structure	has	biological	relevance,	at	the	
very	 least,	 when	 binding	 its	 cognate	 protein	 partners	 (the	 far	 larger	 membrane	
inserting	translocator	proteins).	
	
	
	
	
	
	
	
	
	
	
	
	
130	
130	
Chapter	5 Conclusions	
The	Black	Death	was	one	of	the	most	devastating	pandemics	in	the	history	of	human	
kind.	It	resulted	in	the	death	of	nearly	50	million	people	in	Asia,	Africa	and	Europe	in	
the	14th	century	AD	[7,207].	The	pathogen	responsible	for	this	deadly	infection	was	the	
bacterium	Yersinia	pestis	which	causes	several	forms	of	plague	[7,208].	On	infection	by	
Y.	 pestis,	 the	 host’s	 defences	 are	 overcome	 by	 a	 combination	 of	 stealth	 and	 active	
immune	suppression	targeting	 innate	 immune	mechanisms.	The	type	three	secretion	
system	(T3SS)	of	Y.	pestis	is	crucial	to	the	suppression	arm	of	this	strategy.	This	system	
injects	a	set	of	effector	(virulent)	proteins	into	the	host	cell	cytoplasm	when	coming	in	
contact	 with	 the	 bacteria	 compromising	 the	 host’s	 immune	 system	 by	 affecting	
phagocytosis	and	cytokine	production[208,209].	Thus,	T3SS	provides	the	key	virulence	
factor	 in	pathogens	 like	Y.	pestis.	 	Furthermore,	 the	T3SS	 is	 found	 in	over	two	dozen	
infectious	Gram-negative	bacteria	such	as	various	strains	of	E.	coli	and	Pseudomonas	
aeruginosa,	 a	 potent	 biofilm	 former	 with	 a	 strong	 connection	 to	 cystic	 fibrosis.	
Without	T3SS,	many	pathogenic	bacteria	are	unable	to	cause	disease	[209].	This	makes	
the	T3SS	an	attractive	target	for	novel	antimicrobial	drugs.		
Recently,	 the	 World	 Health	 Organisation	 (WHO)	 published	 a	 report	 on	 antibiotic	
resistance	and	highlighted	that	it	 is	an	imminent	threat	and	needs	to	be	immediately	
addressed	[5,210].	According	to	the	WHO,	the	true	cost	of	antimicrobial	resistance	will	
be	300	million	premature	deaths	and	up	to	$100	trillion	(£64	trillion)	lost	to	the	global	
economy	by	2050.	 This	will	 severely	 impact	 the	world’s	GDP,	which	would	be	0.5	%	
smaller	by	2020	and	1.4	%	smaller	by	2030	[211].		Approximately	10	%	of	the	microbes	
that	 would	 be	 linked	 to	 these	 deaths	 employ	 the	 T3SS	 making	 it	 an	 extremely	
attractive	target	for	antimicrobial	agents.		In	order	to	develop	drugs	more	efficiently,	a	
complete	 biochemical	 understanding	 of	 the	 T3SS,	 such	 as	 the	 formation	 of	 the	
infection	machinery	and	the	mechanism	of	infection	are	required.			
To	 do	 this,	 I	 began	 studying	 the	 T3SS	 in	 Y.	 pestis	 and	 more	 specifically	 the	 class	 II	
chaperone	 LcrH	 to	 fully	 understand	 the	 conformational	 stability	 and	 biochemical	
behaviour	of	 this	protein.	 	 LcrH	 is	critical	 for	 the	 formation	of	a	 fully	 functional	T3SS	
and	so	too	the	 infection	process	of	mammalian	cells	by	Y.	pestis.	 	Consequently,	any	
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information	regarding	the	biochemical	characteristics	of	such	a	significant	protein	can	
provide	a	potential	therapeutic	drug	target.			
In	order	to	gain	insight	into	the	protein’s	behaviour,	the	full	length	sequence	encoding	
for	the	protein	LcrH	was	cloned	for	protein	production	and	purification.		Despite	being	
able	 to	 produce	 and	 purify	 LcrH	 to	 >95	 %	 the	 protein	 proved	 extremely	 prone	 to	
aggregation.		In	order	to	overcome	this	problem,	a	construct	was	created	with	the	N-
terminal	 20	 amino	 acids	 and	 the	 last	 5	 amino	 acids	 removed	 (tr-LcrH).	 	 Here,	 the	
protein	proved	to	be	significantly	 less	prone	to	aggregation.	 	CD	studies	showed	that	
the	removal	of	the	N-terminus	of	LcrH	caused	some	loss	 in	α-helical	content	but	had	
no	effect	on	the	stability	of	the	protein.			
In	order	to	determine	the	oligomeric	state	of	both	forms	of	LcrH	and	thus	obtain	a	KD	
value	 for	 dimersation,	 SEC	 and	 equilibrium	 sedimentations	 were	 performed.	 	 These	
showed	 that	 both	 full-length	 and	 truncated	 LcrH	 possess	 the	 same	weak	monomer-
dimer	 equilibrium	 (low	 µM	 KD),	 thermodynamic	 and	 conformational	 stability.		
Importantly,	chemical	denaturation	revealed	that	both	full	length	and	truncated	forms	
of	LcrH	unfolded	in	a	3-state	transition,	the	states	being	(i)	folded,	(ii)	partially	folded	
dimeric	intermediate	and	(iii)	unfolded.		This	was	initially	surprising	as	most	proteins	in	
the	 TPR	 family,	 of	 which	 LcrH	 is	 one,	 unfold	 in	 a	 cooperative	 manner.	 	 Such	 non-
cooperative	behaviour	must	be	due	to	the	dimerisation	interface.		The	dimer	is	created	
through	 interaction	 between	 the	 N-terminus	 thus	 the	 weakly	 folded	 intermediate	
transition	must	 be	 caused	by	 fraying	 at	 the	 C-terminus;	 as	 the	 C-terminus	 begins	 to	
unfold,	the	protein	loses	integrity	before	completely	unfolding.			
Next,	 a	 mutation	 was	 introduced	 that	 has	 been	 shown	 to	 disrupt	 the	 dimerisation	
interface	and	 create	a	protein	 that	was	 solely	monomeric.	 	 This	protein	was	 termed	
LE65-tr-LcrH	and	was	produced,	purified	and	characterised	using	identical	biochemical	
and	biophysical	methods	as	the	dimer.		This	revealed	that	the	mutant	had	the	same	α-
helical	 content	 as	 dimeric	 tr-LcrH	 but,	 as	 expected,	 did	 not	 exist	 as	 a	 dimer.		
Furthermore,	 chemical	 denaturation	 studies	 revealed	 that	 the	 mutant	 was	
substantially	destabilised	compared	to	tr-LcrH	with	a	single	sharp	transition	between	
the	 native	 folded	 and	 the	 denatured	 states,	 a	 classic	 2-state	 transition.	 	 Taken	 in	
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conjunction	with	the	information	gathered	from	the	dimer,	it	is	therefore	evident	that	
the	 dimer	 interface	 provides	 additional	 thermodynamic	 stability	 to	 the	 global	
structure.		Consequently,	some	structures	close	to	the	interface	(N-terminus)	remains	
folded	at	equilibrium	while	other	parts	of	the	structure	are	unfolded	(C-terminus).	
Previous	studies	have	illustrated	the	significance	of	the	N-terminus	in	determining	the	
arrangement	of	 the	subunits	within	the	dimeric	structure	of	class	 II	chaperones.	 	For	
example,	 IpgC10-151	 produces	 head	 to	 head	 dimers	 whereas	 full	 length	 IpgC	 forms	 a	
back	 to	 head	 dimer	 [169].	 	 However,	 the	 results	 presented	 here	 clearly	 show	 that	
removal	of	the	first	20	N-terminal	amino	acids	have	no	effect	on	stability	of	LcrH	and	
therefore	 it	 is	unlikely	that	these	residues	are	directly	 involved	in	subunit	positioning	
within	the	dimer.			
Within	 the	 T3SS	 in	 Y.	 pestis,	 LcrH	 interacts	 with	 the	 large	 membrane	 translocator	
proteins	YopB	and	YopD.	However,	 the	mechanism	by	which	these	small	chaperones	
find	 their	 cognate	 sequences	 within	 the	 large	 membrane	 proteins	 remains	 unclear.		
Excitingly,	 the	 results	 presented	 here	 support	 one	 possible	mechanism,	 termed	 “fly-
casting”.	 	 Here,	 the	 weakly	 folded	 C-terminal	 repeats	 of	 the	 chaperone	 adopt	 a	
partially	folded	conformation	allowing	it	to	more	easily	find	the	target	peptide	on	the	
translocator	 protein.	 	 The	 chaperone	 then	 refolds	 and	 remains	 attached	 to	 the	
translocator,	producing	a	more	rigid	structure.	It	is	important	that	the	integrity	of	the	
N-terminus	 is	 retained	 during	 this	 process	 as	 in	 vivo	 studies	 have	 shown	 that	 a	
monomeric	 LE65	 LcrH	 homologue	 in	 SycD	 renders	 the	 bacteria	 non-invasive	 [168].		
Such	a	scenario	is	not	without	precedent.	For	example,	the	three	TPR	motif-containing	
domain	of	PP5	has	been	shown	to	become	more	structured	when	bound	to	its	cognate	
binding	partner,	the	C	terminus	of	Hsp90	[212].	Moreover,	studies	on	the	six	ankyrin	
repeat	protein	IκBα	show	it	also	has	a	weakly	folded	C	terminus.	Here,	repeats	five	and	
six	fold	upon	binding	to	their	cognate	partner,	the	transcription	factor	NF-κB	[198,213].	
It	 has	 been	 shown	 that	 the	 function	 and	 lifetime	within	 the	 cell	 of	 IκBα	 is	 critically	
linked	to	whether	this	region	is	structured	via	ligand	binding	or	not	[199].	This	has	yet	
to	be	explored	for	the	translocator	chaperones.			
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In	summary,	this	result	shows	that	the	chaperone	LcrH	has	a	very	flexible	and	weakly	
folded	 C-terminus	 and	 forms	 a	 dimer	 that	 is	 held	 together	 by	 the	 dimerisation	
interface	at	 the	N-terminus.	We	propose	 that	 such	a	 flexible	 structure	has	biological	
relevance	 that	 is	 important	 in	 binding	 its	 cognate	 protein	 partners.	 These	 results	
should	be	generally	applicable	 to	all	 translocator	 chaperones,	as	 they	all	 contain	 the	
same	 TPR	 motif	 fold.	 Furthermore,	 both	 the	 interaction	 between	 the	 N-terminal	
dimerisation	 interface	 and	 the	 C-terminus	 with	 its	 cognate-binding	 partners	 are	
potential	molecular	targets	as	an	alternative	to	broad-spectrum	antibiotic	therapy.	
	
5.1 Future	work	
	The	 future	 work	 in	 this	 area	 must	 surely	 focus	 on	 the	 protein-protein	 interaction	
between	the	chaperone	LcrH	and	its	cognate	binding	partner	YopB	or	YopD.		YopB	and	
YopD	are	large	transmembrane	proteins.	So,	to	characterise	the	interaction	it	would	be	
the	right	step	forward	to	create	a	peptide	of	the	binding	domain.			
To	 our	 advantage,	 crystallographic	 studies	 have	 been	 carried	 out	 characterising	
peptides	binding	to	various	domains	of	the	cognate	binding	partners	in	P.	aeruginosa	
and	 Shigella	 flexneri	 but	 the	 KD	 values	 have	 been	 weak.	 	 Therefore,	 the	 design	 of	
peptides	that	bind	more	strongly	is	the	next	step.		Indeed,	the	ability	to	disable	binding	
of	 the	 translocator	 to	 the	 chaperone	 through	 competitive	 inhibition	 is	 a	 key	 area	of	
research.	
Such	studies	employing	the	T3SS	from	Y.	pestis	as	a	model	system	will	surely	provide	
an	 excellent	 molecular	 understanding	 that	 could	 lead	 to	 molecularly	 targeted	
treatment.		With	so	many	potent	pathogenic	Gram-negative	bacteria	that	employ	the	
T3SS,	the	significance	of	this	system	cannot	be	ignored.	
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